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The present dissertation represents a joint effort to unravel the role and regulatory function of 
hTAOK2α and of Z-DNA/Z-RNA, two distinct biological molecules. 
The thesis is organized in two main chapters - 1 and 2.  
Chapter 1 is then divided in section 1, which tells us the role of TAOK2α in brain development. 
This work was developed at the laboratory of Prof Li-Huei Tsai (co-supervised by Dr. Froylan 
Calderon de Anda), at the Picower Institute for Learning and Memory, Massachusetts Institute 
of Technology, Cambridge, USA. Section 2 of this chapter, describes the work developed to 
characterize hTAOK2α biochemical and structurally by X-ray crystallography. The work herein 
described was carried out at the Membrane Protein Crystallography laboratory at ITQB, under 
the supervision of Dr Margarida Archer and in collaboration with Dr Gonçalo Real and Dr. Marco 
Patrone (Animal Cell Technology Unit, IBET).  
Chapter 2 describes the data obtained when studying Z-RNA and Z-DNA junctions when 
nucleic acid oligomers bind to the ADAR1 Zα domain. This was a joint collaboration between 
the Macromolecular Crystallography Unit at ITQB (Dr Margarida Archer and Prof. M. Arménia 
Carrondo), the Protein-Nucleic Acids Interactions group at IGC (Dr. Alekos Athanasiadis) and 
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Dissertation Abstract  
 
The neocortex is a unique structure designed for higher cognitive and associative functions. 
Herein, we will refer to the work performed to assess the role of TAOK2α, a specific membrane 
bound kinase, in the mammalian neocortical development. The results obtained, delineate a 
pathway whereby Semaphorin3A and Neuropilin1 transduce signals through TAOK2α and c-Jun 
N-terminal Kinase to regulate basal dendrite development and migration in cortical neurons. 
This work represents the first approach aimed at understanding the mechanisms responsible for 
the delineation of basal and apical dendrites during pyramidal neuron development in the 
embryo, and how such mechanism may evolve to neocortical disconnection disorders. 
Additional work performed on humanTAOK2α focused at the determination of its three-
dimensional structure by X-ray crystallography to elucidate its regulatory mechanism.  
The 20
th
 century exciting discovery of the DNA left-handed conformation, and the fact it binds to 
certain classes of proteins with high affinity and specificity, indicated a biological role to it. 
However, a full function is still to be elucidated. The human double-stranded RNA adenosine 
deaminase (ADAR1) is the best characterized of all Z-DNA binding proteins, where Zα domain 
binds and stabilizes Z-DNA/Z-RNA forms upon binding. The second part of this thesis describes 
the work on the ZαADAR1 domain that binds to Z-RNA/Z-DNA. When a section of a DNA or RNA 
molecule forms a left-handed Z-DNA/Z-RNA segment, two B-Z/A-Z junctions are formed. 
Herein, we describe the study carried out on the formation of Z-Z junctions from DNA and, also, 
the approach on trying to describe the Z-Z junction for RNA when interacting with ZαADAR1. The 
structure of the Z-Z-DNA junction consists of a single base pair that leads to partial or full 
disruption of the helical stacking. The junction region allows intercalating agents to insert 
themselves into the left-handed helix, which is otherwise resistant to intercalation. 
 













Resumo da Dissertação  
 
O neocortex é uma estrutura única, projectada para realizar complexas funções associativas e 
cognitivas. Nesta tese descrevemos o trabalho realizado para elucidar o papel da TAOK2α no 
desenvolvimento neocortical dos mamíferos. Os resultados obtidos revelam uma trajetória na 
qual a Semaphorin3A e Neuropilin1 transduzem sinais através da TAOK2α e da quinase c-Jun 
N-Terminal para regular o desenvolvimento de dendrites basais e a migração de neurónios 
corticais. Este estudo representa a primeira tentativa para compreender os mecanismos 
responsáveis pela delienação entre dendrites basais e apicais no densenvolvimento dos 
neurónios piramidais, e de que forma esses mecanismos podem resultar em doenças de 
disconecção cortical. Apresentamos também o trabalho realizado no âmbito da determinação 
da estrutura tridimensional da humanaTAOK2α por cristalografia de raios-X, para esclarecer o 
seu mecanismo de regulação. 
O ADN de rotação contrária (Z-ADN), foi uma importante descoberta do século XX. O facto do 
Z-ADN se ligar a determinadas classes de proteínas com alta afinidade e especificidade 
auspiciou uma função biológica para o mesmo. No entanto, a sua função continua por 
identificar. A ARN de dupla-cadeia adenosine deaminase humana (ADAR1) é a mais bem 
caracterizada de todas as proteínas de ligação ao Z-ADN, onde o domínio Zα se liga e 
estabiliza a forma Z-ADN/Z-ARN. Sempre que uma secção de ADN/ARN forma um segmento 
Z-ADN/Z-ARN, dá-se a formação de duas junções, B-Z/A-Z respectivamente. Nesta tese, 
descrevemos o trabalho realizado no estudo da formação de junções Z-Z-ADN, de forma 
concomitante ao estudo realizado da junção Z-Z-ARN, aquando em interacção com o ZαADAR1. 
A determinação da estrutura da junção Z-Z-ADN, permitiu verificar que um único par de bases 
é responsável pela disrupção parcial ou total do empilhamento da dupla hélice. Esta região da 
junção permite a inserção de agentes de intercalação na hélice de rotação contrária que, de 
outra forma, é resistente à intercalação. 
 
















aa amino acid 
ADAR1 double-stranded RNA adenosine deaminase type I 
ASDs Autism Spectrum Disorders 
BPs Basal progenitors 
CD Circular Dichroism 
CNS Central Nervous System 
CP Cortical Plate 
DNA Deoxyribonucleic acid 
et al. and other people 
e.g. for example 
F-GFP Membrane-bound GFP 
G Guanine 
GFP Green Fluorescent Protein 
HEPES 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid 
I Inosine 
i.e. in other words/that is 
IFN Interferon 
IMAC Immobilized affinity chromatography 
INM Interkinetic nuclear migration 
IZ Intermediate Zone 
JNK c-Jun N terminal kinase 
kDa kiloDalton 
Ni-NTA Nickel-nitrilotriacetic acid 
MALDI Matrix Assisted Laser Desorption/Ionization 
MAP2K Mitogen-activated protein kinase kinase 
MAP3K Mitogen-activated protein kinase kinase kinase 
MAPK Mitogen-activated protein kinase 
MP(s) Membrane Protein(s) 
MTs Microtubules 
NMR Nuclear Magnetic Resonance 
PAGE Polyacrylamide gel electrophoresis 
PDB Protein Data Bank 
PEGs Polyethyleneglycol(s) 
PSK Prostate-derived STE20-like kinase 
RGCs Radial Glial Cells 
RNA Ribonucleic acid 
XII 
 
SDS Sodim Dodecyl Sulphate - 
SEC Size-exclusion chromatography 
shRNA Short-hairpin RNA 
SVZ Subventricular Zone 
T Thymine 
TAOK2α Thousand-and-one amino acid 2 kinase isorform 1 
TOF Time of Flight 
TM(s) Transmembrane Helice(s) 
VZ Ventricular Zone 
ZαADAR1 ADAR1 Zalpha domain 
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Nothing in biology, it is said, makes sense unless viewed in light of evolution. Thus the 
mechanisms underlying expansion of the cerebral cortex are central to understanding the 
potential and limits of our mental capacity.  
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How neurons develop their morphology is an important and challenging question in 
neurobiology. Little is known concerning the establishment of distinct neuronal dendritic 
architectures. Specifically, how different molecular pathways define distinct compartments, 
including apical versus basal dendrites in pyramidal neurons, remains to be elucidated.  
In this chapter is described a novel pathway that specifically affects the formation of basal 
dendrites and axonal projections in cortical pyramidal neurons, which had a simultaneous role in 
the migration of pyramidal cortical neurons. TAOK2α kinase (thousand-and-one amino acid 2 
kinase isorform 1), the product of an Autism Spectrum Disorder susceptibility gene, plays an 
essential role in dendrite morphogenesis and axonal projection. TAOK2α down-regulation 
impairs basal dendrite formation in vivo without affecting apical dendrites. Moreover, TAOK2α 
interacts with Neuropilin 1 (Nrp1), a receptor protein that binds the secreted guidance cue 
Semaphorin 3A (Sema3A), which has previously been associated with basal dendrite 
morphogenesis and axon elongation. TAOK2α overexpression restores dendrite formation in 
primary cortical neurons cultured from Nrp1Sema-mice, which express an Nrp1 receptor incapable 
of binding Sema3A. TAOK2 overexpression also ameliorates the basal dendrite impairment 
resulting from Nrp1 down-regulation in vivo. Finally, Sema3A and TAOK2 modulate the 
formation of basal dendrites and axonal elongation through the activation of the c-Jun N-
Terminal Kinase (JNK). The TAOK2 pathway through JNK is also associated with the pyramidal 
neuron migration during development. 
The presented results delineate a pathway whereby Sema3A and Nrp1 transduce signals 















Mammalian Brain Development 
The human brain contains more than 10
11
 neurons, each of which, on average, has to make 
connections with a thousand others, according to a regular and predictable wiring plan. Contrary 
to a man-made computer, the wiring between neurons is not so precise, simply because brains 
don’t work as computers and are much more tolerant to failures in wiring between its 
components. Nevertheless, the brain outstrips all other biological structures in its organized 
complexity (Alberts et al., 2002a). 
The adult brain has a diversified and elaborated architecture, a product of genes, signaling 
mechanism and, eventually, the external world. The first stages of brain development occur 
prior to synaptic activity. Those include the establishment of primordial nervous system in the 
embryo; the first born neurons from precursor cells, the migration of neurons from their origin 
towards their final position and the formation of brain regions. If any of these processes goes 
awry, the consequences can be disastrous, as most of the congenital brain defects result when 
an event – genetic mutation, disease, exposure to toxic agent – interferes with these normal 
mechanisms of development. 
Early in the generation of the embryo, the cells that will give rise to the brain become distinct 
quite early. Neurulation in vertebrates, the first event in organogenesis, results in the formation 
of the neural tube which gives rise to the spinal cord and the brain. Neural crest cells, also born 
during neurulation, lie between the neural tube and the overlying epidermis, migrate away from 
the neural tube and will give rise to the diversity of cells present in the brain, including neurons. 
Three different events take place for the formation of the central nervous system (CNS). The 
neural tube and its lumen bulge and constrict to form the chambers of the brain and spinal cord. 
At the cellular level, the neuroepithelial cells differentiate into numerous types of neurons and 
glia present in the brain. Simultaneously, at tissue level, there is a rearrangement of the cell 
populations present in the wall of the neural tube leading to a formation of different functional 
regions of the brain and spinal cord (Alberts et al., 2002a). 
Neurons also differ in their developmental origins; they have different genomic expression and 
electrophysiology patterns, however morphological differences are valuable tools for neuronal 
identification (Figure 1.1.2.1). Branching patterns of dendrites are extremely diversified (Ramón 






Figure 1.1.2.1. Different types of neurons.  
A. Purkinje cell B. Granule cell C. Motor neuron D. Tripolar neuron E. Pyramidal Cell F. Chandelier cell G. 
Spindle neuron H. Stellate cell [Credit: Ferris Jabr; based on reconstructions and drawings by Ramon y 
Cajal (from Jabr, 2012)]. 
 
The mammalian neocortex is a unique structure, an evident hallmark in evolutionary biology. 
Thoughts, consciousness, resolution of intricate mathematical problems, writing an opera or 
simply reading a thesis are high cerebral cognitive and associative functions, all seating in the 
neocortex. The vertebrate cortex is organized in six layers and tangentially subdivided – 
arealization - into functional areas deputed to the elaboration of sensory information, 
association between different stimuli, and selection and triggering of voluntary movements. 
Each area of the cortex is associated with a peculiar function, possesses unique connectivity 
and cytoarchitecture. In mammals, there is an extreme conservation of the neocortical areas, 
their conserved position and wiring within the brain suggested an identical genetic program 
governing the neocortical patterning (Alfano and Studer, 2013). 
With increased microscopical power, the last five decades are sprouted with milestones in the 
field. Raskic and colleagues followed the pioneer work of Poliakov (Poliakov, 1961) and 
together they established the current models of cortical arealization - the neocortex 
subdivisions, i.e. the different functional areas which have unique cytoarchitecture and 
connectivity patterns; and neuronal migration – as most neurons are generated at different sites 
from those in which they permanently reside, they demonstrated that 80 to 90 % of neuronal 
precursors in the cortex migrate along radial glial cells (RGCs) (Angevine and Sidman, 1961; 
Rakic, 1972, 1974, 1990; Sidman and Rakic, 1973). Also, in the recent years, a large diversity 
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of transcription regulators of neuronal polarity and migration had been studied. An intimate 
knowledge of the existing balance between specific transcription factors and highly-regulated 
GTPases is described (Fukata et al., 2003). However, despite the enormous amount of studies, 
little is known about the process of brain development. But certainly, not only neuronal intrinsic 
factors play a role in cortical development, as the sensing of extrinsic molecules is essential 




Motility is one of the primordial features of prokaryotic and eukaryotic cells. A key feature in the 
developing nervous system is neuronal migration. Understanding its molecular mechanisms is a 
milestone for neuroscientists in part because, direct or indirectly, many human disorders are 
related with abnormal migration. Neuronal migration defects have been associated with multiple 
disorders related with development, Autism Spectrum Disorder (ASDs), schizophrenia, epilepsy, 
lissencephaly, between others (Liu, 2011; McManus and Golden, 2005; Murray et al., 1991). 
Neuronal migration occurs during neurogenesis and consists in an accurate execution of 
sequentially molecular processes that confer identity and positioning to neuronal cells with 
subsequent maturation and connection between those cells. A neuron needs to be in the right 
place at the right time for differentiation and integration in a circuit that mediates behavior. 
However, once neurons reach a final position, cell death occurs and there is a decrease in 
number of neurons due to histogenetic cell death mechanisms (Finlay and Slattery, 1983). 
Histogenesis events are extended in time; proceed widely in all areas of the brain, comprising 
structural diversity with unique properties. In the neocortex, cell death is not uniform, e.g. it 
occurs in several of the areas from cyngulate and frontal cortex lack layer IV neurons, while the 
primary visual and sensory cortex have highly developed layer IV; cell loss has been suggested 
to determine local features of cortical differentiation (Finlay and Slattery, 1983). Yet these 
events are coordinated to arrive at a neuronal density that is approximately the same from 
region to region of the same brain and in the brains of diverse mammalian species (Rockel et 
al., 1980; Schüz and Palm, 1989). 
Before the onset of neurogenesis, neuroepithelial cells, the primary stem/progenitor of neuronal 
cells present in the neuroepthelium, expand via symmetric divisions. With the onset of 
neurogenesis, neuroepithelial cells switch the pattern of gene expression to invoke the 
differentiation potential and allow for asymmetrical cell division to happen, generating secondary 
stem and progenitor cells (radial glia cells and basal progenitors) and neurons. Neuroepithelial 
progenitors and RGCs are considered apical progenitors, as they undergo mitosis at the apical, 
ventricular surface (Farkas and Huttner, 2008). Neurogenesis comprehends a combination of 




cells), asymmetrical progenitor divisions (one daughter cell arises as a neuron, the other as a 
progenitor) (Chenn and McConnell, 1995) and symmetrical terminal divisions (generation of two 
neurons – terminally differentiated) (Takahashi et al., 1996). 
The first phenotypic change occurs at E9/E10 of the mouse telenchephalon. With the onset of 
neurogenesis at the telenchephalon germinal zones – the ventricular zone (VZ, also known as 
proliferative zone or germinal matrix, a pseudostratified columnar neuroepithelial region lining 
the lateral ventricles). At the VZ, neuroepithelial cells start to express glial markers, forming 
RGCs (Götz and Huttner, 2005; Kriegstein and Götz, 2003). RGCs are non-neuronal cells 
present in the developing brain which serve as molecular scaffolds for the migration of future 
neurons due to the particularity that these cells have their body in the VZ but extend processes 
to the pial (apical process) and ventricular surface (basal process), covering vertically, all length 
of the nascent cortex (for revision see Campbell and Götz, 2002). As neurons, RGCs also 
perform interkinetic nuclear migration (INM), whereas their nucleus travels within the VZ. RGCs 
are regarded as neural stem cells (Figure 1.1.2.2); they undergo self-renewal by symmetric 
division or give rise to neurons or secondary progenitors by asymmetric divisions (Noctor et al., 
2001, 2004, 2008). Also, there is supporting evidence of an existing lineage relationship 
between neurons and the proliferative RGC, reporting that clonally related neurons migrate 
along radial glial fibers to form functional cortical columns, the radial organization of the 
neocortex (Noctor et al., 2001). 
 
Figure 1.1.2.2. Modes of cell division in the mammalian neocortex.  
Radial glial cells divide asymmetrically in the ventricular zone (VZ), and intermediate progenitor cells divide 
symmetrically in the subventricular zone (SVZ). A radial glial cell (green) divides asymmetrically at the 
ventricular surface to generate a daughter neuron (red). The radial glial cell remains mitotic to generate 
another daughter cell. Radial glial cells (green) also generate intermediate progenitor cells (blue) that 
divide symmetrically in the SVZ to generate two daughter cells, neurons (blue) that migrate toward the 
cortical plate (CP). Terminal symmetric divisions occur in the SVZ (from Noctor et al., 2004). 
 
Basal (intermediate) progenitors (BPs) translocate their nucleus to the basal region of the VZ to 
form a second germinal layer, or subventricular zone (SVZ). BPs retract their basal and apical 
processes and undergo mitosis at the basal SVZ, a region that overlaps the VZ and extend into 
the intermediate zone (IZ) (Boulder Committee, 1970), producing two neurons. It is possible that 
in rodents, BPs can expand their pool by proliferative asymmetric divisions (Kowalczyk et al., 
2009; Noctor et al., 2004, 2008).  
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Postmitotic neurons undergo migration towards the developing cortical plate to reach their final 
destination. Newly generated neurons reach the developing cortex either by somal 
translocation, whereby a neuron cell body travels within a pial contacting radial process, or by 
locomotion, a process by which newborn neurons develop leading and trailing processes and 
migrate along radial glial fibers (for revision see Noctor et al., 2004). 
The distance a population of neurons migrates varies with neuronal type and brain region. In the 
human cerebral cortex, pyramidal neurons migrate radially about 2 cm, to those that travel 




Figure 1.1.2.3. The model of radial glial migration in the mammalian cortex.  
Microscopical picture of the mouse neocortex evidanciating the different cortical layers (left). Scheme 
depicting a neuron (red) undergoing the migration along a radial glial fiber (blue): initial radial migration at 
the VZ, SVZ arrest, establishment of neuronal polarity, second phase of migration until final destination 
and maturation of the neuron (right; credits of picture to Froylan Calderon de Anda). 
 
The earliest generated cortical neurons form a transient structure, the preplate. The next cohort 
of cells will intercalate in the preplate, splitting these structure in the marginal zone (MZ or layer 
I) and in the deeper layer, the subplate. Together they form the cortical plate (CP) that is 
populated by arising neurons forming a total of six horizontal cortical layers (L1-L6) that are 
distinguished cytoarchitectonically and functionally. Neurons of layers II-VI migrate according to 




followed by a sequential wave of migrating neurons that will occupy a more superficial layer 
(Berry and Rogers, 1965; Rakic, 1972; Sidman and Rakic, 1973; SIDMAN et al., 1959). Cortical 
layers are populated by arising neurons and each layer is constituted by a specific subset of 
approximately three quarters of pyramidal neurons (glutamatergic excitatory projection neurons) 
and the remaining are interneurons (GABAergic inhibitory neurons) (Jones, 1986). Deep layer 
and subplate neurons (L5-L6) project mainly to other areas of the nervous system, as spinal 
cord, thalamus and striatum, and other subcortical structures. More superficial neurons (L2-L4) 
are cortical projection neurons. Projection neurons are responsible for connections within the 
cortex: interhemispheric or contralaterally, mostly trough the corpus callosum, and 
intrahemispheric connections (Berry and Rogers, 1965; Rakic, 1972; Sidman and Rakic, 1973; 
SIDMAN et al., 1959).  
During migration, neurons establish interactions between other migrating neurons and the 
surfaces of neighboring cells. Such interactions play a pivotal role in the appropriate selection of 
migratory pathways, as well in orientation, navigation and conclusion of neuronal movement in 
their final destination, where neuronal maturation takes place (Hatten, 2002; Pearlman et al., 
1998). 
The migration of neurons progresses in a way where two consecutive events are repeated, 
those events underlie at first an extension and retraction of the leading neurite, oriented 
forward, together with the centrosome, followed by nuclear displacement (Bellion et al., 2005; 
Gregory et al., 1988; Rakic, 1972). This migratory fashion requires major alterations in the 
cellular cytoskeleton, both in actin and microtubules (MTs), and action of very specialized 
molecules. The leading process is composed of several organelles and usually terminates in 
several protrusions oriented toward the cortical plate that by sensing the extracellular 
environment will determine the migratory pathway. Alteration to this dynamics usually is 
impairment for migration in cortical development studies. 
The precise regulation of neuronal migration is responsible for cortical lamination and critical for 
proper development of the brain architecture. Therefore, its deregulation has a huge impact in 
the whole development of the neocortex causing a diversity of disorders (Dobyns and Truwit, 
1995). The establishment of neuronal polarity with axon development and growth is crucial for 
the migration of neurons. Also, it is well accepted that cytoskeleton dynamics enables the 
movement of the growth cone, determining its direction, and regulating axon elongation during 
migration (Lowery and Van Vactor, 2009). 
Neuronal polarity: axon and dendrites 
In one neuronal cell, differentiation occurs during neurogenesis with a dramatic change in 
neuronal shape – in the establishment of neuronal polarity, two distinct morphological and 
functional compartmentalized structures composed of different proteins and organelles, axon 
and dendrites, become evident. Axons are long and thin, with a uniform thickness through their 
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whole length. Dendrites are short and become thinner with increased distance and undergo Y-
shaped branching, they contain sites of membrane protrusion called dendritic spines the major 
excitatory synaptic site, a specialized structure full of neurotransmitter receptors in order to 
receive information. During the transmission of neuronal information, dendrites receive a 
synaptic input from other neuron through the dendritic spine. The information is integrated at the 
cell body and propagates down to the axon to the presynaptic terminal, and is transferred to 
other neurons. Hence, polarization is an indispensable event during neuronal development and 
a pre-requisite for the integration and transmission of information within the brain (Neukirchen 
and Bradke, 2011). Axon formation is the key event for the initiation of neuronal polarization. 
Banker and colleagues developed a culture system, of embryonic rat hippocampal neurons, for 
the observation in living CNS neurons. With those, they could observe the morphological events 
taking place during differentiation from a neuroblast to a polarized cell (Dotti et al., 1988). This 
in vitro model is a powerful tool to uncover the developmental mechanism of neurons and most 
of the knowledge comes from it, in vivo studies are then necessary for the validation of the 
proposed mechanism. 
 
Figure 1.1.2.4. Schematic depiction of a developing hippocampal neuron during neuronal 
polarization. 
After dissociation and plating, the neuron attaches to the substrate as a round sphere surrounded by 
lammellipodia and filopodia (Stage 1). During neuritogenesis, growth cones form by the condensation of 
lamellipodia and induce the establishment of several short protuberant processes, called minor neurites 
(Stage 2). At this stage, the neuron remains symmetric and unpolarized. One minor neurite strarts to 
enlogate rapidly and becomes the axon while the other neurites remain short, breaking the neuronal 
symmetry (Stage 3). At this stage, polarity is established. With neuronal maturation, minor neuritis become 
dendrites at a later stage (Stage 4).The enlarged view shows an axonal growth cone. Microtubules (green) 
enter the growth cone and interact with the actin cytoskeleton (red). Microtubule associated proteins 
(MAPs) bind along the microtubule lattice or at the growing ends of microtubules (+TIPs), where they 
interact with actin binding proteins. C: central domain; T: transition zone; P: peripheral domain; 






The role of localized instability of the actin network in specifying axonal fate was examined by 
Bradke and Dotti in 1999 (Bradke and Dotti, 1999) with the use of rat hippocampal neurons in 
culture. They proved that local instability of actin, restricted to a single growth cone, present in 
one of the neurites, is a physiological signal specifying neuronal polarization. Disruption of the 
actin network in the growth cone induces axon elongation. From the observation of cultured 
hippocampal neurons, different developmental stages were identified during polarization (Figure 
1.1.2.4.): born as an unpolar and symmetric sphere, neurons end up mature when achieving a 
highly polarized structure. 
Defining the mechanism that regulate growth, guidance and branching of axons will tell us how 
the cerebral cortex becomes wired to appropriate targets during development. In the 
mammalian nervous system, axons establish connections through the activity of the growth 
cone and by extending branches towards a cell target from the collateral primary axon shaft 
branches (Kalil et al., 2000). Once the connectivity is incorrect or damaged; the brain’s ability to 
work normally is severely incapacitated.  
Axon Elongation 
The growth cone responds to attractive cues by turning toward the source of a positive 
guidance cue, in contrary, inhibitory guidance cues repel axons away (Huber et al., 2003). It is 
now clear that the response to attraction versus repulsion is not due to the properties of a 
specific cue, but due to the intrinsic properties of the growth cone – the receptors engaged in 
the growth cone, and its signaling milieu. The growth cone comprises the necessary elements 
to determine how environmental direction lead to a given guidance response during axon 
“navigation” (Chilton, 2006). Neuronal growth cones adhere to extracellular substrates: cell 
adhesion molecules (CAMs) or extracellular matrices, in order to properly migrate towards their 
final destination. Microtubules play an important role, as they are responsible for the 
connectivity between the growth cone and the extracellular substrates, possibly acting as 
guidance sensors, i.e. introducing an adhesive molecule leads to an increase in exploratory 
MTs (Lee and Suter, 2008). 
Microtubules provide structure and rigidity to the axon shaft. When the axon is elongating, 
microtubules populate the central domain of the growth cone and polymerize into the direction 
of the leading edge, transporting vesicles and organelles towards it (Lowery and Van Vactor, 
2009). However, the peripheral domain of the growth cone is composed of actin filaments, 
existing in the form of filopodia (packed actin bundles) or lamellipodia (sheet like actin 
meshwork). Actin forms a meshwork inveil-like lamellipodia and boundless in finger like filopodia 
that protrude from the highly motile lamellipodia towards a leading edge. Actin structures and its 
dynamics shape and direct the growth cone propagation in the surrounding environment. Actin 
and microtubules interact in the transition zone, between the central and peripheral domain, 
which is fundamental for axon extension (Lowery and Van Vactor, 2009). Axon extension 
happens by extending the axon shaft, due to transformation of the C-domain (Figure 1.1.2.4), 
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allowing the growth cone to advance. So, extension underlies a complex rearrangement of the 
cytoskeleton. Polymerization of actin filaments causes extension and protrusion of the growth 
cone – the growing end points to the distal membrane and creates a force that pushes the actin 
network and the closely linked membrane backwards. Myosin-II, a molecular motor that 
generates forces on F-actin, supports the retrograde flow by contraction of actin filaments in the 
T-zone, and generates actin arcs (Medeiros et al., 2006; Schaefer et al., 2008). Actin arcs orient 
perpendicular to the axis of filopodia and hinder the invasion of microtubules into the P-domain. 
So, while actin functions as a steric hindrance for microtubules, microtubules push the actin 
arcs cytoskeleton towards the growth direction, creating an area free of actin, enabling 
microtubules engorgement and delivery of proteins (Forscher and Smith, 1988). Finally, the 
actin cytoskeleton depolymerizes at the neck of the growth cone and microtubules bundle, 
enabling the proximal part of the growth cone to assume a cylindrical shape, becoming part of 
the axonal shaft (Bradke and Dotti, 1999; Lowery and Van Vactor, 2009; Neukirchen and 
Bradke, 2011). 
Interstitial branching mechanism occurs from the axon shaft after the growth cone has extended 
past the target. Such mechanism are extremely important, those possibilitate the wiring of the 
cortical neurons to distinct targets, e.g. spinal cord (efferent corticospinal) and contralateral 
cortex (callosal axons) (Bastmeyer and O’Leary, 1996; Halloran and Kalil, 1994; O’Leary et al., 
1990). 
 
Dendritic arborization mechanims 
Dendrites are the neuronal processes specialized in the input of information, differing 
morphologically and functionally from the axons (Craig and Banker, 1994). The main excitatory 
synaptic sites, spines, are only present in dendrites. Different types of neurons meet different 
requirements accordingly with their physiological function. They are so readily classified based 
on their dendritic field dimensions and dendrite branching patterns (Ram n y  a al, 1995). 
The dendritic field is the region occupied by one neuron dendrites and determines the extent of 
sensory or synaptic inputs to that neuron. The field complexity and circuitry assembly influences 
the range of inputs received by the neuron. On the other hand, the morphological features of the 
dendritic arbor impacts processing and integration of the electrical signals (London and 
Häusser, 2005). The innervation of particular regions of the nervous system out of many 
possible targets will determine the input that a neuron receives and its function in specific 
circuits. Dendritic guidance and targeting programs are controlled primarily by intrinsic programs 
liked to cell lineage and identity. In turn, those intrinsic programs dictate how dendrites respond 
to extrinsic factors – attractive and repulsive cues from the environment. Local interactions 
between dendrites help to define and refine dendritic target boundaries. Dendrites need to have 




dynamic microtubule invasion of spines and NMDA (N-methyl-D-aspartarte) receptor mediates 
signaling that affects dendrite organization in the somatosensory cortex during development 
and in the mature nervous system.  
The development of dendritic branch diversity though guidance and targeting, happens in a cell-
type specific way, where the first level of control arises from intrinsic programs that are linked to 
cell lineage and identity controlling how dendrites respond to attractive and repulsive cues in 
their environment (Kelsch et al., 2007; Komiyama and Luo, 2007). Local interactions between 
dendrites help to define and refine dendritic target boundaries. Later dendritic branching is 
thought to be associated with neuronal activity. As primary dendrites form first, side branches 
emerge later from the shaft of the primary dendrite, first as transient slender projections, or 
filopodia – highly dynamic actin structures. Those transient projections, if stabilized, will become 
a secondary dendritic branch. Stabilization occurs at the formation of a synapse, so, 
postsynaptic signaling may influence such process, at the same time that a dendritic spine is 
stabilized, likely, due to the involvement of calcium signaling (Konur and Ghosh, 2005). Side 
branching formation requires dynamic actin for the formation and remodeling of filipodia, 
followed by actin stabilization as the secondary branching pattern develops. RhoGTPases are 
the best studied molecules that provide regulation of actin dynamics in neuronal development 
(Etienne-Manneville and Hall, 2002). In vitro studies have shown that Rho inhibits dendrite 
growth and branching, while Rac1 play as inducer (Govek et al., 2005). Cdc42, another 
RhoGTPase involved in branching and cell polarity, is thought to be activated more in some 
layers of the cortex than in others, revealing a layer-specific environmental signaling, which is 
thought to interact with other players to determine the dendritic arborization at a specific cortical 
layer (Rosário et al., 2012; Simó and Cooper, 2012).  
Recent genetic studies revealed a complex network of intrinsic and extrinsic regulators, 
transcription factors and ligands for cell surface receptors, respectively, that are needed to 
produce the distinct morphology of the four classes of larval dendritic arborization neurons in 
Drosophila melanogaster peripheral nervous system (revised in Corty et al., 2009). 
 
Semaphorin3A signaling in cortical development  
First characterized as repulsive guidance cues (Kolodkin et al., 1992), semaphorins (Semas) 
are their largest family (20 members), comprising both secreted and membrane-bound proteins. 
In vertebrates, the major receptors of semaphorins are plexins (Plex) and neuropilins (Nrps), 
and all are subdivided in subfamilies (Figure 1.1.2.5). 
Plexins, neuropilins and semaphorins are extremely important, has by their discovery in diverse 
biological systems (Goshima et al., 2002): nervous (McCormick and Leipzig, 2012; Tillo et al., 
2012), epithelial (Fujii et al., 2002; Miao et al., 1999), and immune systems (Kumanogoh and 
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Takamatsu, 2012) as well as diverse cell processes including angiogenesis (Serini et al., 2009), 
embryogenesis (Perälä et al., 2012), and cancer (Micucci et al., 2010; Potiron et al., 2009). 
 
 
Figure 1.1.2.5. Semaphorins and their receptors, plexins and neuropilins, present in 
vertebrates. 
Semaphorins are secreted (Sema3A-G), glycosylphosphatidylinositol (GPI)-anchored (Sema7), or 
transmembrane (Sema4A-G, Sema5A-B and Sema6A-D) family members. Neuropilins consist of two 
transmembrane molecules (Nrp1–2), and plexins consist of transmembrane A (1–4), B (1–3), C1, and D1 
family members. Most class 3 semaphorins require an obligate neuropilin co-receptor. Sema3E binds to 
PlexD1 without neuropilins. Class 4 and 5 semaphorins interact with plexinBs. Class 6 semaphorins 
interact with plexinAs. Sema7A interacts with PlexC1. CUB indicates complement binding. One to seven 
indicate the interactions between semaphorins and their receptors; 1: class 3 semaphorins and 
neuropilin1/2, 2: Sema3E and PlexD1, 3: Sema4D and PlexB1/B2 or Sema4C/4G and PlexB1, 4: 
Sema5A/5B and PlexA1/A3, 5: Sema5A and PlexB3, 6: Sema6A/6B and PlexA2/A3 or Sema6C/6D and 
PlexA1, 7: Sema7A and PlexC1. Other semathorins classes (e.g. Class 8, viral semaphorin) are not here 
respresented, because they are absent in vertebrate (from Yoshida, 2012). 
 
 
Plexins and semaphorins are transmembrane proteins that share a conserved extracellular 
semaphorin domain (Hota and Buck, 2012). The plexins and semaphorins are divided into four 
and eight subfamilies respectively based on their structural homology. Semaphorins are 
relatively small proteins containing the extracellular semaphorin domain and short intracellular 
tails. Plexins contain the semaphorin domain and long intracellular tails (Hota and Buck, 2012). 
The majority of plexin and semaphorin research has focused on the nervous system, 
particularly the developing nervous system, where these proteins are found to mediate many 
common neuronal cell processes including cell movement, cytoskeletal rearrangement, and 




Most class 3 semaphorins (Sema3) bind to Nrps. Plexin A family members associate to Nrps to 
transduce Sema3 signals across the neuronal membrane (Takahashi et al., 1999; Tamagnone 
et al., 1999) Sema3A and Nrp1 are known to play an important role in motor axon fasciculation 
and branching during embryogenesis (Behar et al., 1996; Gu et al., 2003; Kitsukawa et al., 
1997; Taniguchi et al., 1997). Huber and colegueas have found that Sema3A regulates the 
timing motor axons ingrow to the limb (Huber et al., 2005). 
Extensive studies to unravel the role of Sema3A, in the mouse neocortex, showed that Sema3A 
signaling is important for the developmental of axon and dendrites during development. Polleux 
and colleagues show that Sema3A repels axons but attracts dendrites in cortical neurons, so 
Sema3A promotes dendrite formation (Polleux et al., 2000). Quite recently, those findings were 
further proved by several studies (Nishiyama et al., 2011; Shelly et al., 2011). Sema3A signaling 
results in inhibition of PKA activity, and consequently to decreased activity of axon-promoting 
kinases. However, Sema3A knockout mice do not display defects in neuronal polarity, 
suggesting that alternative mechanism may also regulate axon and dendrite specification. 
 
The TAOK2 protein 
Thousand-and-one-aminoacids kinase 2 (TAOK2), a close relative of TAOK1, was first 
described the group of Melanie H. Cobb (Chen et al., 1999), and simultaneously by Moore and 
colleagues (Moore et al., 2000) under the name of PSK (Prostate-derived STE20-like kinase 1), 
as a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family of signaling 
modules, ubiquitous to eukaryotic cell regulation.  
The human Taok2 gene is encoded on the 16p11.2 chromosome, a genomic region associated 
with developmental and psychiatric disorders, where TAOK2 misregulation has been associated 
with Autism Spectrum Disorders (Battaglia et al., 2009; Tabet et al., 2012; Weiss et al., 2008), 
Depression (Degenhardt et al., 2012), Fragile X syndrome (Darnell et al., 2011), Schizophrenia 
(McCarthy et al., 2009) and Alzheimer Disease (Tavares et al., 2013). TAOK2 is subjected to 
alternative splicing to produce the TAOK2α (140KD) and TAOK2β (120KD) isoforms (Yasuda et 
al., 2007).  
TAOK2 has a serine/threonine kinase domain present at the N-terminus, a long C-terminal 
domain composed of 690 residues, possibly containing a nucleotide binding site, a serine, 
proline and leucine-rich region, and an unbroken stretch of 17 glutamic acid residues (Chen et 
al., 1999). STE20-like kinases usually contain a small G protein binding consensus motif, not 
found at TAOK2 (Burbelo et al., 1995). 
Moore and colleagues have identified TAOK2α as a MAP3K signaling molecule that selectively 
activates the c-Jun N terminal kinase mitogen activated protein kinase (JNK MAPK) pathway 
through the activation of MKK4 and MKK7 (MAP2Ks) and induces loss of actin stress fibers. 
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These data suggests a role in actin cytoskeleton organization, by coordinating such event 
TAOK2α most likely plays a role in the regulation of stress response and cell migration (Moore 
et al., 2000). Further microscopically studies show that TAOK2α staining in cells had 
tubulovesicular morphology, a clue that the kinase constitutively associates with vesicular 
compartments present in the cytoplasm. This specific morphological phenotype was only visible 
for the full-length protein, where a truncated version TAOK2α (1-349), constituted of kinase 
domain only, shows a diffusive cytoplasmic localization, showing the relevance of the unknown 
C-terminal domain to the regulatory pathway and function of TAOK2α in the cells.  
TAOK2 was later shown to activate other signaling pathways, e.g. p38 and ERK family 
members (Chen et al., 1999, 2003), however those pathways are activated by the smaller 
isoform of TAOK2 – TAOK2β. TAOK2β endogenous activity is activated by the muscarinic 
agonist carbachol.  
Several other studies reveal the involvement of TAOK2α in regulating cytoskeleton properties 
during stress-like conditions and demonstrate that TAOK2α colocalizes with microtubules (MTs) 
for their stabilization in a kinase independent fashion, producing stabilized perinuclear MTs with 
increased levels of acetylated α-tubulin (Chen and Cobb, 2001; Mitsopoulos et al., 2003). So it 
is possible that TAOK2α is responsible for the stability of actin, playing a major role in the 
dynamics of microtubules. 
TAOK2α is sensitive to cleavage, removing the C-terminal domain (MTs binding domain), 
enabling the N-terminal catalytic region to relocate from the cytoplasm to the nucleus for the up 
regulation of apoptotic morphology (Moore et al., 2000; Zihni et al., 2007). 
In Drosophila melanogaster a homologous protein of TAOK2 is present, Tao-1, that regulates 
dynamic interactions between growing MT plus ends and actin rich cortex, inhibiting MT growth 
when in contact with actin (Liu et al., 2010). This suggests a role of TAOK2 on actin-induced 
changes in MT dynamics directly. Such mechanisms are usually present for the regulation of 




1.1.3. Material and Methods 
 
shRNA and fluorescent proteins. 
The Taok2 shRNA sequences used in this study are: 
Taok2 shRNA 1 = CGAGAGGACTTGAATAAGAAA. 
Taok2 shRNA 2 = GCATCCTAATACCATTCAGTA. 
Taok2 shRNA 3 = GTTCCAGGAGACGTGTAAGATCC. 
Taok2 shRNA 1 and 2 were primarily throughout the study. The Taok2 shRNA 1-resistant 
construct (pCMV human TAOK2) is from imaGenes (Berlin, Germany), Clone: 
IRATp970E03140D. The sequence for the Nrp1 shRNA is: AGAGAAGCCAACCATTATA (Chen 
et al., 2008). The shRNAs sequences used in the experiments were inserted into a pSilencer 
vector. A pSilencer vector containing a random sequence hairpin insert was used as a control 
for the shRNAs. The Venus (pCAGIG) and mCherry (pCAGIG) plasmids were kindly provided 
by Dr. Z. Xie (Boston University). The F-GFP (pCAGIG-GAP 43-GFP) construct was a gift from 
Dr. A. Gartner (University of Leuven, Belgium). The Myc-TAOK2 (pCMV rat TaoK2) was kindly 
provided by Dr. M. H. Cobb (University of Texas Southwestern Medical Center). The Nrp1-
mCherry (plasmid 21934) and the MKK7-JNK1 (Plasmid 19726) are from Addgene (Cambridge, 
MA). 
Lentiviral production. 
Production of plentilox3.7 Taok2 shRNA 
Taok2 shRNA was cloned into the plentilox 3.7 vector (Addgene plasmid 11795) as previously 
described (Mao et al., 2009). Briefly, complimentary 5’ phosphorylated oligonucleotides 
FC_TAO2 sh3pllf and FC_TAO2 sh3pllr with the sequences: 
TGCGAGAGGACTTGAATAAGAAATTCAAGAGATTTCTTATTCAAGTCCTCTCGTTTTTTC; 
TCGAGAAAAAACGAGAGGACTTGAATAAGAAATCTCTTGAATTTCTTATTCAAGTCCTCTCG
CA, respectively, were annealed, digested with XhoI, and ligated into the plentilox 3.7 vector 
that had been digested with HpaI and XhoI. Proper insertion and orientation of the sequence 
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Production and titration of virus. 
Lentiviral particles were made as previously described (Mao et al., 2009). Briefly, HEK-
293Tcells were plated on 10 cm dishes in 10% FBS-DMEM and transfected at 95% confluency 
with 8 μg plenti 3.7, 6ug pCMV-ΔR8.9, and 5 μg pCMV-VSV-G per dish. The culture medium 
was switched to 30% FBS DMEM 12 hours after transfection and viral supernatant was 
collected 48 and 96 hours later. Viral supernatant was filtered through a 0.45 μm cellular 
acetate vacuum filter (Corning 431155), and concentrated by ultracentrifugation at 25,000 x g 
for 90 minutes. Viral pellets were resuspended in DPBS+0.1% glucose and stored at - 80 °C. 
Viral titers were determined on HEK293T cells plated at 2x105 cells / well in 6-well plates, and 
serial dilutions of 1:200, 1:2000, and 1:20,000 were used to determine viral titer. After 48 hours 
of viral supernatant application, percentage of infected cells were determined by determining 
the percentage of fluorescent cells divided by the total number of cells by visual inspection. Four 
fields of view were counted per well, and three wells were inspected per dilution. Infection was 
performed with MOI =10. 
Antibodies. 
The following antibodies were used in these studies: mouse anti-acetylated tubulin (Sigma, 
immunocytochemistry, 1:1000), goat anti-TAOK2 (K-16, Santa Cruz Biotechnology, western blot 
(WB) 1:2000; immunocytochemistry, 1:100), rabbit anti-pTAOK2 (Ser 181; sc-135712; Santa 
Cruz Biotechnology, western blot (WB) 1:250; immunocytochemistry, 1:100), rabbit anti-
pJNK1/2 (Promega, immunocytochemistry, 1:200) mouse anti-pJNK1/2 (Promega, 
immunocytochemistry, 1:200), mouse anti-pan-JNK (BD Transduction Laboratories; WB, 1:500); 
goat anti-rat Neuropilin-1 (R&D Systems, WB, 1:500) rabbit anti-FAK (clone C-20, Santa Cruz 
Biotechnology, WB, 1:500); anti-mCherry (Clontech Cat no: 632543, WB, 1:1000); anti-RFP 
(ABcam, ab62341, WB, 1:400); anti-actin (WB, 1:2000) and anti-GAPDH (WB, 1:500). Nucleic 
acid were visualized with Hoechst (Invitrogen) and F-actin with phalloidin (Molecular Probes). 
Alexa conjugated secondary antibodies (Jackson Immunoresearch, 1:1000) were applied for 1-
2 hr at 25ºC. 
Cell transfection and western blot analysis. 
HEK293T and Ht22 cells (ATCC) were grown under standard cell culture conditions and 
transfected with plasmids using Lipofectamine 2000 according to the manufacturer’s protocol 
(Invitrogen). Proteins from cell lysates were separated on 8% or 12% SDS-polyacrylamide gels 
at 60V and transferred onto Immobilon-P PVDF membranes (Millipore). Membranes were 
blocked in TBS-T (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Tween-20) with 5% non-fat 
dried milk for 1 h at room temperature and then incubated with primary antibody for 2 hours to 
overnight at 4 °C. Membranes were washed for 30 minutes in TBS-T and incubated for 1 hour 




then washed for 30 minutes in TBS28 T. Immunoreactivity signals were detected by enhanced 
chemiluminescence (Perkin Elmer). 
Immunoprecipitation. 
HEK293T cell lysates: For transient transfection, HEK293T cells were cotransfected with equal 
amounts of overexpression plasmids carrying myc-Taok2 and mCherry-Nrp1 cDNA. The total 
amount of transfected DNA was between 3.5 – 4.0 μg / 35 mm plate. The cells were allowed to 
express the constructs for 24 h before lysis and analysis. Transfected cells were washed once 
with ice-cold 1X PBS and immediately lysed in 1X lysis buffer with protease inhibitors. The Bio-
Rad assay kit was used to determine protein concentration. For TAOK2 and Nrp1 
immunoprecipitation assays, lysates were incubated with protein A sepharose conjugated to 
anti-mCherry antibodies overnight at 4 °C. Lysates containing 0.5 mg of protein were used for 
each condition. The beads were then washed with RIPA buffer twice to remove nonspecific 
proteins, and then washed 5 times with 1X lysis buffer before boiling in Laemmli sample buffer. 
Following SDS-PAGE to separate the proteins, blots were incubated with anti-TAOK2 
antibodies. 
Cortical brain lysates: cortices from P0 Swiss Webster mice were dissected and homogenized 
in 350 μl of sterile-filtered 50 mM Tris-Cl pH 7.4, 120 mM NaCl, 0.5% NP-40 containing 
proteinase inhibitors (Roche) using a 26G-syringe, followed by a 15 min centrifugation at 14000 
rpm at 4 °C and the collection of the supernatant. Following a 60 minutes incubation with 1-2 μg 
of the corresponding antibodies, 20 μl of protein G Sepharose (GE Healthcare) was added to 
the lysates and incubated for 45 min at 4 °C. The bound immune complexes were then 
collected at 8000 rpm for 3 min followed by one wash each in sterile-filtered 50 mM Tris-Cl, pH 
7.4, 500 mM NaCl, 1% NP-40, and sterile-filtered 50 mM Tris-Cl pH 7.4, 120mM NaCl, 0.5% 
NP-40. Samples were boiled for 5 min at 95 °C, run on a 10% SDS gel and analyzed with the 
same primary antibodies used for the immunoprecipitation. 
Cortical cultures. 
Neurons were transfected by in utero electroporation at E15 and the transfected cortices were 
dissected two days later. Cortical neurons were isolated in 1X HBSS (Invitrogen) containing 
papain and DNase at 37 °C (Worthington). Papain was inhibited by the addition of ovomucoid 
(Worthington). Neurons were plated on poly-D-lysine and laminin pre-coated glass coverslips in 
Neurobasal / B27 medium (Invitrogen), maintained in culture for 48 hr, and then fixed for 
immunofluorescent analysis. Neurons treated with Sema3A were dissected from brains 
harvested at E17 and cultured as above. Sema3A (R&D Systems) was applied 48 hr later at a 
final concentration of 2 μg/ml. Cells were fixed as described, for immunofluorescence studies, or 
lysed with cold RIPA buffer supplemented with phosphatase and protease inhibitors (Roche) for 
western blot analysis. 





Quantitative immunofluorescence of pTAO2, pJNK, tubulin, and MAP2 in neuritis of 
cultured cortical neurons. 
Neurons were cultured for 2 DIV and 7 DIV after plating and then fixed as described (see 
immunofluorescence). pTAO2, pJNK, tubulin, and MAP2 were visualized by indirect 
immunofluorescence. The mean intensity gray value of a line drew along the neurites was 
measured using ImageJ. 
Sholl analysis. 
All GFP-positive image stacks from transfected cortical neurons were taken as described (see 
Confocal imaging). All Sholl analyses use cortices that displayed relatively low transfection 
efficiencies in order to be able to select and analyze isolated transfected neurons in the cortex. 
Sholl analysis was performed by drawing concentric circles centered on the cell soma using 
Adobe Illustrator CS3. The starting radius was 15 μm and the ending radius was 55-100 μm; the 
interval between consecutive radii was 5 μm. All analyses were performed blindly. 
In utero electroporation. 
The Institutional Animal Care and Use Committee of Massahusetts Institute of Technology 
approved all experiments. Pregnant Swiss Webster mice were anesthetized by intraperitoneal 
in ection of Ketamine 1% / Xilazine 2 mg/mL (0,01 μl/g body weight), the uterine horns were 
exposed, and plasmids mixed with Fast Green (Sigma) were microinjected into the lateral 
ventricles of embryos. The shRNA plasmid concentration was 2 to 3-fold higher than that of 
mCherry, Venus, or F-GFP. Five current pulses (50 ms pulse / 950 ms interval; 35-36V) were 
delivered across the head of the embryo. 
Immunofluorescence. 
Dissociated neurons: Neurons were fixed with 4% formaldehyde (FA) at 37 °C for 2 min 
followed by fixation for 3 min in methanol at -20 °C. After blocking in goat serum (Zymed), 
neurons were incubated with the primary antibodies. Cortical sections: Brains were removed 
and fixed overnight in 4% FA and thereafter transferred to 30% sucrose/PBS (4 °C, overnight). 
Brains were embedded in OCT compound and sectioned in a cryostat. The 20-30 μm 






Images were taken with a Zeiss LSM 510 confocal microscope. Z-series images were collected 
with 1 μm steps. To perform 3D reconstructions on stacks of images of transfected cells, only Z 
sections in the same focal plane as GFP were used for analysis and for producing figures. 3D 
reconstructions and Z-stack analyses were produced using ImageJ software. The adjustment of 
brightness and contrast was performed on images. 
Quantitative phalloidin-fluorescence determination in growth cones. 
Neurons were cultured for 2DIV after plating and then fixed as described above (see 
immunofluorescence). F-actin was visualized by the binding of fluorescentlylabeled phalloidin. 
The mean intensity gray value of phalloidin in the growth cone area was measured using 
ImageJ. 
Organotypic slice cultures. 
Mouse embryos were electroporated at embryonic day 15 (E15), and acute coronal brain slices 
(240 μm) were prepared at E17 and E18 (at which time TAOK2 was downregulated via shRNA). 
Slices were transferred onto slice culture inserts (Millicell) in cell culture dishes (35 × 10 mm; 
Corning) with Neurobasal medium (Invitrogen) containing the following: B27 (1%), glutamine 
(1%), penicillin/streptomycin (1%), horse serum (5%), and N2 (1%). Slices were used for 
imaging (1–2 h after slicing) or for pharmacological treatments (incubated at 37°C in 5% CO2, 
for 1–2 d). 
Time-lapse imaging. 
GFP- and RFP-positive cells were imaged on an inverted Nikon microscope (TE 2000-S) with a 
20× objective lens [numerical aperture (NA) 0.45]. During the time-lapse imaging, slices were 
kept in an acrylic chamber at 37°C in 5% CO2. We captured time-lapse images with a 
CoolSNAP EZ camera (Roper Scientific) using NIS-Elements software (Nikon). 
Statistical analysis. 
Compiled data are expressed as mean ± SEM. We used the two-tailed Student’s t test and one-
way ANOVA, with posthoc Tukey or Dunnett tests, for statistical analyses. The P values in the 
Results are from t tests unless specified otherwise. P<0.05 was considered statistically 
significant. 
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1.1.4. Results and Discussion 
 
Expression profile of TAOK2 in cultured cortical neurons and in the developing cerebral 
cortex. 
 
To examine the subcellular expression profile of TAOK2, we analyzed TAOK2 immunoreactivity 
in cultured cortical mouse neurons dissociated at embryonic day 17 (E17). 







Figure 1.1.4.1. Distribution of TAOK2 and activated TAOK2 (pTAOK2) in cultured 
neurons. 
(a) TAOK2 localizes to the growth cones (white arrowheads) of isolated cortical neurons. (b) TAOK2 (red) 
co-localizes with actin (green) in growth cones. (c) Activated TAOK2 (pTAOK2; green) localizes to the 
neurite shaft of isolated cortical neurons. Scale bar: 10 μm (a), 200 μm(c). 
 
We found that TAOK2 preferentially localized to growth cones (Figure 1.1.4.1a, b). The growth 
cone is a region where actin, but not microtubules, accumulates (Figure 1.1.4.1b) and where the 
actin cytoskeleton is the most dynamic (Bradke and Dotti, 1999). In contrast, TAOK2 activated 
by phosphorylation on Ser 181 (pTAOK2) localizes to the neurite shaft, where microtubules also 
accumulate (Figure 1.1.4.1c). This pattern of TAOK2 expression suggests that TAOK2 may act 
as a coordinator of actin and microtubule dynamics (King et al., 2011). 
In the mouse brain, TAOK2 and pTAOK2 are preferentially expressed in the intermediate zone 
(IZ) and the cortical plate (CP) of the developing cortex (E18), and their expression in the 








Figure 1.1.4.2. Distribution of TAOK2 and activated TAOK2 in the developing cerebral 
cortex. 
TAOK2 and pTAOK2 are preferentially expressed in the IZ and CP of the developing cortex (E18). Scale 
bar: 200 μm. 
 
Western blot analysis using whole-cell extracts from the cortices of mice at different embryonic 
and postnatal ages demonstrates that the long isoform of TAOK2 (TAOK2α; 140 KD) is 
expressed throughout the early cortical embryonic development. However, in perinatal (E19, 
P0) and adult mice, the TAOK2α isoform was considerably increased in expression. In contrast, 
the short isoform of TAOK2 (TAOK2β; 120KD) was only observed perinatally and in the adult 
brain (Figure 1.1.4.3).  
 
Figure 1.1.4.3. Distribution of TAOK2 in the early cortical embryonic mouse brain.  
Western blotting reveals that TAOK2α expression levels are constant during early cortical embryonic 
development, but increase considerably at perinatal (E19, P0) and adult time points. The TAOK2β isoform 
is absent prior to E19. 
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In addition, in freshly cultured (DIV2) E17 cortical neurons, we detected expression of TAOK2α, 
but not TAOK2β, by immunoblot analysis (data not shown). These results suggest that TAOK2α 
is likely to be the TAOK2 isoform most important for neuronal differentiation. We therefore 
focused our subsequent studies on TAOK2α. Therefore, for the remaining of the chapter, 
TAOK2 will be referring to TAOK2α, unless is otherwise stated. 
 
TAOK2 impacts neuronal differentiation in cultured cortical neurons. 
The remodeling of the actin-based cytoskeleton is an important regulatory step in axon and 
dendrite formation (Arimura and Kaibuchi, 2007; Barnes et al., 2008; Witte and Bradke, 2008). 
Since it has been shown that TAOK2 modulates the organization of the actin cytoskeleton in 
non-neuronal cells (Chen et al., 1999), and we find that TAOK2 expression is concentrated in 
actin-rich structures, it was asked whether TAOK2 loss-of- and gain-of-function affects neuronal 
differentiation. To examine the role of TAOK2 in brain development, three specific short-hairpin 
(sh)RNAs were designed, targeting different coding sequences of TAOK2, to acutely knock 
down the expression of TAOK2. The specificity of our shRNA constructs with respect to their 
ability to down-regulate endogenous neuronal TAOK2 was confirmed by immunohistochemistry 
(Figure 1.1.4.4a-d, and data not shown for shRNA 3). To this end, isolated cortical neurons at 
E17 from embryos were transfected by in utero electroporation at E15 with constructs 
expressing Taok2 shRNA- or control shRNA and membrane-bound GFP (F-GFP). Neurons 
were cultured for 48 hr before being processed for immunocytochemistry using antibodies 
against TAOK2 and acetylated tubulin (Figure 1.1.4.4a-d). Additionally, the specificity of our 
shRNA constructs was assessed for their ability to down-regulate endogenous TAOK2 by 
western blot analysis in Ht22 cells (Figure 1.1.4.4e, f, and data not shown for shRNA 3). These 
experiments show that Taok2 shRNAs efficiently down-regulate TAOK2 expression. shRNAs 1 
and 2 were used for all subsequent experiments. 
At first, the impact of TAOK2 knockdown on the cytoskeleton and growth cone morphology was 
examined in primary neurons. The shRNA-mediated knockdown of TAOK2 decreased the F-
actin content in the growth cones of cultured cortical neurons (Figure 1.1.4.5a, b; control, n=44 
cells from three different cultures; Taok2 shRNA 1: n=43 cells from three different cultures; 
Taok2 shRNA2: n=36 cells from 2 different cultures; P<0.0001 by one-way ANOVA and posthoc 
Dunnett test **P <0.01), and the number of intact (non-collapsed) growth cones per neuron, 
compared with control transfected neurons (Figure 1.1.4.5a, c; control: n=160 cells from three 
different cultures; Taok2 shRNA 1: n=133 cells from three different cultures; Taok2 shRNA 2: 








Figure 1.1.4.4. Taok2 shRNA’s specifically down-regulate TAOK2 expression in 
dissociated cortical neurons and Ht22 cells.  
(a) Representative control transfected neuron. Inset: TAOK2 immunoreactivity is enriched in growth cones. 
(b-c) TAOK2 down-regulation with two different shRNAs reduces TAOK2 immunoreactivity in the growth 
cones of shRNA-transfected cells (inset, white arrowheads). (d) The expression of shRNA-resistant human 
TAOK2 cDNA is detected in growth cones by immunofluorescence in cultured neurons expressing Taok2 
shRNA1 (right panel, inset). (e) Western blot of extracts from Ht22 cells transfected with control plasmid 
and Taok2 shRNA 1 and 2. Blots were probed with antibodies against TAOK2. (f) Quantification of the 
TAOK2 signal from lysates of Ht22 cells. Taok2 shRNA 1 and 2 decreases endogenous TAOK2 
immunoreactivity (*P=0.02 by one-way ANOVA, posthoc Dunnett test *P <0.05, n=3 experiments). (g, h) 
rTAOK2 overexpression in Ht22 cells increases levels of active TAOK2 (pTAOK2). (g) rTAOK2 
overexpression produces doublets (Moore et al., 2000; Zihni et al., 2007) and increases levels of pTAOK2. 
(h) Quantification of the pTAOK2 upper band signal (~ 140 kDa; **P = 0.0084 by t test, n = 3). Mean ± 
s.e.m. Scale bar: 10 μm. 





Figure 1.1.4.5. TAOK2 down-regulation or overexpression affects the differentiation of 
isolated cortical neurons.  
(a) TAOK2 down-regulation and overexpression have opposite effects in the complexity of cortical 
neurons. Control neurons were transfected with F-GFP and labeled with phalloidin (actin), anti-acetylated 
tubulin, and Hoechst (DNA). Taok2 shRNA-transfected neurons display fewer branched neurites, with 
collapsed growth cones. Expression of a shRNA-resistant human TAOK2 cDNA (hTAOK2) counteracts 
TAOK2 downregulation in dissociated cortical neurons. Rat (r)TAOK2 overexpression increases neuronal 
complexity with more primary neurites. (b) Quantification of F-actin content in growth cones of cultured 
neurons. TAOK2 silencing decreased the levels of F-actin in growth cones. (c) Quantification of the 
number of intact (noncollapsed) growth cones per transfected cell. TAOK2 silencing decreased the 
number of intact growth cones per cell. (d, e) TAOK2 down-regulation decreases the number of primary 
and secondary neurites per transfected cell. TAOK2 overexpression increases the number of primary 





In addition, TAOK2 down-regulation decreased the number of neurites per neuron (Figure 
1.1.4.5a, d; control: n=168 cells from three different cultures; Taok2 shRNA 1: n=149 cells from 
three different cultures; Taok2 shRNA 2: n=36 cells from two different cultures; P<0.0001 by 
one-way ANOVA and posthoc Dunnett test **P <0.01) and the number of secondary branches 
per cell, compared with control transfected neurons (Figure 1.1.4.5a, e; P=0.0102 by one-way 
ANOVA and posthoc Dunnett test *P <0.05).  
TAOK2 autophosphorylation is known to play a role in TAOK2 activation (Chen et al., 1999; 
Zihni et al., 2007), thus the overexpression of TAOK2 increases levels of phosphorylated, active 
TAOK2 (Figure 1.1.4.4g, h). TAOK2 overexpression in cultured cortical neurons increased the 
number of primary, but not secondary, neuritis compared with control neurons (Figure 1.1.4.5a, 
d; rTAOK2: n=119 cells from three different cultures; P<0.0001 by one-way ANOVA and 
posthoc Dunnett test **P <0.01).  
In addition, it was analyzed whether TAOK2 down-regulation or overexpression affects 
polarization in cultured neurons. TAOK2 downregulation impaired axon formation (Figure 
1.1.4.6a; control: 57.57 ± 7.68% of neurons with a neurite longer than 40 μm, n=168 cells from 
three different cultures; Taok2 shRNA 1: 29.69 ± 4.3% of neurons with a neurite longer than 40 
μm, n=149 cells from three different cultures; P=0.0044 by one-way ANOVA and posthoc 
Dunnett test *P <0.05). Interestingly, TAOK2 overexpression did not affect the number of 
polarized (axon-bearing) neurons (Figure 1.1.4.6a), but did increase the proportion of neurons 
that elaborated multiple axons (Figure 1.1.4.6b, c; control: 2.22 ± 1.42% of neurons with multiple 
neurites longer than 40 μm, n=168 cells from three different cultures; rTAOK2: 15.84 ± 3.79 % 
of neurons with multiple neurites longer than 40 μm, n=119 cells from three different cultures; 
*P=0.0386 by t test). 
 




Figure 1.1.4.6. TAOK2 down-regulation or overexpression affects axon elongation of 
isolated cortical neurons.  
(a) TAOK2 down-regulation decreases the number of neurons that elongate an axon (control: 57.57 ± 
7.68% of neurons with a neurite longer than 40 μm, n=168 cells from three different cultures; Taok2 
shRNA 1: 29.69 ± 4.3% of neurons with a neurite longer than 40 μm, n=149 cells from three different 
cultures; Taok2 shRNA 1 + TAOK2: n=48 cells from three different cultures; P=0.0044 by one-way ANOVA 
and posthoc Dunnett test *P <0.05). (b, c) rTAOK2 overexpression increases the number of neurons with 
multiple axons (control: 2.22 ± 1.42% of neurons with multiple neurites longer than 40 μm, n=168 cells 
from three different cultures; rTAOK2: 15.84 ± 3.79 % of neurons with multiple neurites longer than 40 μm, 
n=119 cells from three different cultures; *P=0.0386 by t test). Mean ± s.e.m. Scale bar: 10 μm. 
 
To determine if these phenotypes resulted specifically from the down-regulation of TAOK2, 
Taok2 shRNA1 was co-expressed with a shRNA resistant version of TAOK2 cDNA (hTAOK2), 
which rescued the Taok2 shRNA1 phenotypes. This molecular replacement experiment further 
demonstrates the specificity of Taok2 shRNA1 treatment (Figure 1.1.4.5a-e and Figure 1.1.4.6a; 
n=48 cells from three different cultures). Together, these data demonstrate that TAOK2 is 







TAOK2 affects basal dendrite formation and axon elongation in vivo. 
The previous results (Figure 1.1.4.5 and Figure 1.1.4.6) demonstrate the impact of TAOK2 upon 
the differentiation of cultured primary cortical neurons. We then sought to determine the effect of 
TAOK2 in the post-migratory differentiation of cortical neurons in vivo. E15 mouse embryos 
were in utero electroporated with Taok2 shRNA, control shRNA, or rTAOK2 (rat TAOK2 cDNA) 
plasmids together with F-GFP. Mice were sacrificed at postnatal day 7 (P7), and the dendritic 
morphology of control, Taok2 shRNA, and rTAOK2-expressing neurons was evaluated. It was 
found that both the knockdown and overexpression of TAOK2 disrupted cortical neuronal 
differentiation in vivo. In layer II-III of the in utero electroporated brains, the Taok2 shRNA-
transfected neurons had significantly fewer primary dendrites compared to controls (Figure 
1.1.4.7a, b; control: n=19 cells from three brains; Taok2 shRNA 1: n=23 cells from three brains; 
Taok2 shRNA 2: n=20 cells from two brains; P<0.0001 by one-way ANOVA and posthoc 
Dunnett test **P <0.01). TAOK2 overexpression, on the other hand, increased the number of 
primary dendrites (Figure 1.1.4.7a, b; rTAOK2: n=31 cell from three brains).  
Sholl analysis of the dendritic arbors from shRNA-transfected neurons revealed that TAOK2 
down-regulation produced less complex basal dendritic arbors than control shRNA transfection. 
Taok2 shRNA-transfected neurons had significantly fewer dendritic processes with intersections 
at a distance between 15 μm and 55 μm from the cell soma (Figure 1.1.4.7c; P<0.0001 by one-
way ANOVA and posthoc Dunnett test **P <0.01). In contrast, TAOK2 overexpression 
increased the complexity of the basal dendritic arbor compared to control-transfected neurons 
(Figure 1.1.4.7c; P<0.0001 by one-way ANOVA and posthoc Dunnett test *P <0.05). 
Importantly, Sholl analysis demonstrated that TAOK2 down-regulation or TAOK2 
overexpression did not affect the apical dendrites of transfected neurons (Figure 1.1.4.7d; 
Figure 1.1.4.8a). 




Figure 1.1.4.7. TAOK2 down-regulation or overexpression affects basal dendrite 
arborization in layer V neurons in the developing cortex.  
(a) TAOK2 knockdown or up-regulation have opposite effects in basal dendrite development in vivo. (b) 
The number of primary dendrites decreases following TAOK2 knockdown and increases following rTAOK2 
overexpression. (c) Sholl analysis of the dendritic arbor from upper cortical layer transfected neurons 
reveals significantly fewer and more dendritic process intersections at a distance between 15 μm and 55 
μm from the cell soma in the TAOK2-silenced neurons or rTAOK2-overexpressed neurons, respectively, 
compared with control transfected neurons. (d) Sholl analysis of the apical dendrite does not show any 
differences between Taok2 shRNA-mediated down-regulation, rTAOK2 overexpression, and control 
conditions. Scale bar: 10 μm (a). *P < 0.05, **P < 0.01. 
 
To determine if the basal dendrite phenotype was exclusive to upper-layer neurons, or was a 
more general feature of pyramidal neurons in the different cortical layers, TAOK2 expression 
was knocked-down in deeper layer neurons (layer V) by in utero electroporating E13 embryos 
with Taok2 shRNA or control shRNA plasmids together with F-GFP. Animals were harvested at 
P4 to evaluate the dendritic morphology of transfected neurons in layer V. TAOK2 
downregulation using either shRNA 1 or 2 also impaired the basal dendrite complexity of layer V 
pyramidal neurons (Figure 1.1.4.8b, c; control: n=32 cells from three brains; Taok2 shRNA 1: 
n=37 cells from three brains; Taok2 shRNA 2: n=20 cells from two brains; P<0.0001 by one-way 
ANOVA and posthoc Dunnett test **P <0.01), without affecting apical dendrite complexity 
(Figure 1.1.4.8d). These findings demonstrate that TAOK2 loss-of- or gain-of-function impairs 

















Figure 1.1.4.8. TAOK2 down-regulation or overexpression affects basal dendrite 
arborization in layer II-III neurons in the developing cortex.  
(a) Neurons with TAOK2 down-regulation or overexpression in the upper cortical layers (layers II-III) 
develop apical dendrites that are similar to those from controltransfected neurons. (b) Lower cortical layer 
(layer V)-transfected neurons show underdeveloped basal dendrites following the shRNA-mediated 
knockdown of TAOK2 expression compared to control-transfected neurons. (c) Sholl analysis of the 
dendritic arbors of layer V neurons show significant differences between Taok2 shRNA expressing 
neurons and control neurons at a distance between 15 μm and 55 μm from the cell soma (control: n=32 
cells from three brains; Taok2 shRNA 1: n=37 cells from three brains; Taok2 shRNA 2: n=20 cells from two 
brains; P<0.0001 by one-way ANOVA, posthoc Dunnett test **P <0.01). (d) Apical dendrites from layer V 
transfected neurons are not affected following TAOK2 down-regulation. Scale bar: 10 μm (a, b). 
 
 




Figure 1.1.4.9. TAOK2 down-regulation affects callosal axon projection in the developing 
cortex. 
(a, b) Taok2 shRNA-mediated down-regulation diminishes the number of callosal axons traversing the 
midline. (a) Control transfected neurons in both hemispheres (Venus: left hemisphere; mCherry: right 
hemisphere) project callosal axons that crossed the midline. Right panel: inset of the corpus callosum. (b) 
Taok2 shRNA-mediated knock-down in Venus-positive neurons prevents axons from these cells from 
crossing the midline, However, control transfected neurons positive for mCherry, from the contralateral 
hemisphere, project axons that cross the midline. Upper panel: coronal brain section. Lower panel: 
horizontal brain section. Right panels: inset of the corpus callosum from the coronal (upper panel) and 
horizontal section (lower panel). Scale bar: 500 μm (a, b).  
 
We also estimated the contribution of TAOK2 to axon elongation during brain development. A 
sequential in utero transfection was performed, as previously reported (de Anda et al., 2010). 
mCherry expression and control shRNA constructs were introduced into E15 mouse cortex, 
followed by the introduction of a Taok2 shRNA and a Venus-expressing constructs into the 
contra-lateral hemisphere. Callosal axons from transfected neurons crossing into the midline 
were examined at P7. TAOK2 down-regulation impaired axon elongation and axons were 
absent in the midline (Figure 1.1.4.9a, b; n=3 brains analyzed, per condition). On the other 
hand, TAOK2 overexpression caused some transfected axons to deviate from the axonal tract 
(Figure 1.1.4.10, black arrowheads). These results strongly support the role of TAOK2 in axon 






Figure 1.1.4.10. TAOK2 overexpression affects axonal projection at the corpus callosum 
in the developing cortex.  
rTAOK2 overexpression produces minor defects in axons crossing the corpus callosum. Some transfected 
axons deviate from the axonal tract (arrowheads). Mean ± s.e.m. Scale bar: 100 μm. 
 
TAOK2 interacts with the Neuropilin 1 receptor to modulate neuronal differentiation. 
Previous studies have shown that the Sema3A – Nrp1/PlexinA4 signaling cascade controls 
basal dendritic arborization (Chen et al., 2008; Gu et al., 2003; Tran et al., 2009). Nrp1
Sema- 
mice 
also develop axonal projection defects in the corpus callosum and the hippocampus (Gu et al., 
2003). These defects vary from mild, in which some axons deviate from the axonal tract, to 
more severe phenotypes, where callosal axons defasciculate and do not cross the midline (Gu 
et al., 2003). We hypothesized that TAOK2 may collaborate with this pathway to modulate 
neuronal differentiation. To test this idea, coimmunoprecipitation experiments were performed to 
probe for an interaction between TAOK2 and Nrp1. TAOK2 and Nrp1-mCherry were co-







Figure 1.1.4.11. TAOK2 interacts with Nrp1.  
(a) Immunoprecipitation with anti-mCherry antibodies demonstrates the interaction of Nrp1 and TAOK2. 
HEK293T cells were transfected with Nrp1- mCherry and Myc-TAOK2. The input lane represents 5% of 
the total protein quantity used for immunoprecipitation. (b) TAOK2 co-immunoprecipitates with Nrp1 in the 
developing cortex. P0 mouse cortical lysates were subjected to immunoprecipitation with anti-Nrp1 or anti-
TAOK2 antibodies, and membranes were immunoblotted with anti-TAOK2 and anti-Nrp1 antibodies. The 
input lane represents 5% of the total protein quantity used for immunoprecipitation. 
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To investigate whether this complex also forms in vivo, cortices from P0 mice were 
homogenized and subjected to co-immunoprecipitation using antibodies against Nrp1 and 
TAOK2. Nrp1 was found to associate with TAOK2 in lysates from P0 mouse cortices (Figure 
1.1.4.11b). TAOK2 is activated by phosphorylation on Ser 181, which resides in the activation 
loop of the kinase (Zhou et al., 2004). To determine whether Sema3A/Nrp1 activates TAOK2, 
we examined whether active TAOK2 (pTAOK2) co-localizes with Nrp1. In the mouse E19 
cerebral wall, we found that pTAOK2 and Nrp1 co-localized preferentially in the IZ and lower 
CP, where axons elongate and deeper layer neurons begin to form dendrites (Romand et al., 

















Figure 1.1.4.12. TAOK2 interacts with Nrp1 at the intermediate zone and cortical plate in 
the developing cortex. 
(a) Nrp1 and pTAOK2 are preferentially expressed in the IZ and CP of the developing cortex. (b) Inset 





Next, we examined whether the Nrp1 ligand Sema3A modulates TAOK2 phosphorylation in 
cultured primary neurons. Cortical neurons dissociated from E17 mouse embryos and cultured 
for 48 hr were treated with Sema3A (2 μg/ml) for 30 min, 1 hr, 2 hr, or 6 hr. pTAOK2 
immunoreactivity was significantly increased between 1 and 6 hr following Sema3A treatment in 
the longest neurite analyzed (the putative axon) compared to that of non-treated control cells 
(Figure 1.1.4.13a, b; 40 μm < neurite length < 150 μm; control: n=77 cells from three different 
cultures, Sema3A 30 min: n=25 cells from two different cultures, Sema3A 1 hr: n=32 cells from 
three different cultures, Sema3A 2 hr: n=99 cells from three different cultures, Sema3A 6 hr: n= 




Figure 1.1.4.13. TAOK2 interacts with Nrp1 to modulate TAOK2 phosphorylation.  
Sema3A treatment (2 µg/ml) increases pTAOK2 immunoreactivity in cultured cortical neurons. (a) 
Representative control neuron (upper panel) and a neuron treated with Sema3A for 2 hr (lower panel) (b) 
Quantification of pTAOK2 immunoreactivity from the longest neurite (40 µm < neurite length < 150 µm) of 
control and Sema3A-treated cultured cortical neurons. Following 1-6 hr of Sema3A stimulation, 
immunoreactivity for pTAOK2 significantly increases compared to control. (c) Immunoblot of cultured 
cortical neuron lysates shows that the 2 hr Sema3A treatment increases pTAOK2 immunoreactivity. (d) 
Quantification of (c), pTAOK2 immunoreactivity in lysates of cultured cortical neurons that were treated for 
2 hr with Sema3A. Sema3A treatment increases pTAOK2 immunoreactivity. (e) Immunoblot of cortical 
lysates from Nrp1
Sema- 
heterozygous (+/-) and Nrp1
Sema-
 homozygous (-/-) P7 mice littermates shows a 
decrease in pTAOK2 immunoreactivity in the (-/-) mouse compared with the (+/-) littermate. (f) 
Quantification of (e), pTAOK2 immunoreactivity in lysates of cortices from Nrp1
Sema-
 (+/-) and (-/-) mice. 
FAK and tubulin are used as the loading controls. Scale bar: 10 μm (a). *P < 0.05, **P < 0.01. 
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Western blot analysis of lysates harvested from neurons following 2 hr of Sema3A treatment 
revealed that endogenous TAOK2 phosphorylation was also induced following Sema3A 
treatment (Figure 1.1.4.13c, d; n=3 experiments per duplicate; *P=0.0401 by t test). Finally, we 
examined the levels of pTAOK2 in cortical extracts from mice homozygous for a knock-in 
mutation that renders the endogenous Nrp1 receptor incapable of binding Sema3A (Nrp1
Sema-
). 
In agreement with the in vitro experiments, pTAOK2 levels are reduced in the cortical neurons 
of homozygous Nrp1
Sema-
 mice compared with heterozygous littermates (Figure 1.1.4.13e, f; 
n(+/-) = 9 brains, n(-/-) = 4 brains; *P=0.0310 by t test). These results suggest that Sema3A 
signaling activates TAOK2 kinase activity. 
 
TAOK2 and Sema3A modulate the activity of JNK in cortical neurons. 
We next sought to elucidate the downstream effectors by which the interaction of TAOK2 with 
the Sema3A-Nrp1 signaling pathway modulates neuronal differentiation in cortical pyramidal 
neurons. The c-Jun amino-terminal kinases (JNK) have been shown to be important for many 
aspects of neuronal differentiation (Polleux and Snider, 2010). It was shown that TAOK2α, 
unlike TAOK2β, stimulates the JNK pathway in cell lines (Zihni et al., 2007). TAOK2 
overexpression indirectly activates endogenous JNK1 in HEK293 cells via the preferential 
phosphorylation of MEK3 and MEK6 (Chen and Cobb, 2001). In addition, TAOK2 was shown to 
modulate the dual phosphorylation of JNK1 at Thr183/Tyr1855 (Chen and Cobb, 2001; Huangfu 
et al., 2006). Sema3A has also been shown to activate the JNK1/c-Jun signaling pathway in 
cultured dorsal root ganglion neurons (Ben-Zvi et al., 2006). Phosphorylated JNK1/2 can 
modulate neurite initiation, axon formation, and dendritic architecture in cultured (Barnat et al., 
2010; Bjorkblom, 2005; Oliva et al., 2006; Rosso et al., 2005; Tararuk et al., 2006) and is 
required for the maintenance of neuronal microtubules in axons and dendrites in vivo (Chang et 
al., 2003). The deactivation of JNK1 by BDNF treatment destabilizes microtubules and induces 
axonal branching (Jeanneteau et al., 2010). Based on these findings, we hypothesized that 
JNK1 may mediate the effect of TAOK2 and Sema3A on neuronal differentiation. 
To determine whether TAOK2 modulates JNK1 in cortical neurons, Taok2 shRNA 1 or control 
plasmids together with F-GFP were introduced into E15 mouse embryos via in utero 
electroporation and isolated cortical neurons at E17. These neurons were cultured for 48 hr 
before being subjected to immunocytochemistry using antibodies against phosphorylated JNK1 














Figure 1.1.4.14. TAOK2 and Sema3A modulate the activity of JNK1: TAOK2 down-
regulation descreases JNK1 signal in isolated neurons.  
(a) shRNA mediated TAOK2 down-regulation decreases pJNK1 immunoreactivity in the longest neurite 
(40 µm < neurite length < 150 µm) of cultured cortical neurons.Control-transfected cells display an 
increasing proximal to distal gradient of pJNK1 signal in the longest neurite (left panel, white arrowheads). 
Taok2 shRNAtransfected neurons have a decreased pJNK1 signal in the longest neurite (right panel, white 
arrowheads and inset). (b) Quantification of pJNK1 immunoreactivity in the longest neurite (40 µm < 
neurite length < 150 µm) of cultured control and TAOK2 down-regulated cortical neurons. shRNA-
mediated knock-down of TAOK2 decreases the levels of pJNK1. (c, d) Western blotting with Ht22 cell 
lysates shows that TAOK2 down-regulation decreases JNK1 phosphorylation. (d) Quantification of pJNK1 
immunoreactivity from Ht22 lysates. TAOK2 down regulation decreases JNK1 phosphorylation (pJNK1 in 
c, top panel, 46 kD) compared to control. Scale bar: 10 μm. *P < 0.05, ***P<0.0001. 
 
 
TAOK2 down-regulation decreased pJNK1 immunoreactivity in the longest neurite analyzed 
from shRNA transfected neurons, compared to that from control-transfected neurons (Figure 
1.1.4.14a, b; 40 μm<neurite length<150 μm; control: n=72 cells from two different cultures; 
Taok2 shRNA 1: n=29 cells from two different cultures; ***P<0.0001 by t test). Additionally, in 
Ht22 cells transfected with Taok2 shRNA 1, endogenous pJNK1 (top panel, lower band, 46 kD) 
was significantly reduced (Figure 1.1.4.14c, d; n=3 experiments per duplicate; *P=0.02 by t 
test). 
 




Figure 1.1.4.15. TAOK2 and Sema3A modulate the activity of JNK1: Sema3A treatment of 
isolated neurons increases JNK1 signal.  
(a-b) Sema3A treatment (2 µg/ml) increases pJNK1 immunoreactivity in cultured cortical neurons. (a) 
Representative control neuron (upper panel) and a neuron treated with Sema3A for 2 hr (lower panel). (b) 
Quantification of pJNK1 immunoreactivity from the longest neurite (40 µm < neurite length < 150 µm) of 
control and Sema3A-treated cultured cortical neurons. Following 2 hr and 6 hr of Sema3A stimulation, 
immunoreactivity for pJNK1 significantly increases compared to control. (d) Immunoblot of cultured cortical 
neuron lysates shows that the 6 hr Sema3A treatment increases pJNK1 immunoreactivity. (c) 
Quantification of pJNK1 (in d, top panel, 46 kD) immunoreactivity in lysates of cultured cortical neurons 
that were treated for 6 hr with Sema3A. Sema3A treatment increases pJNK1 immunoreactivity. Scale bar: 
10 μm. *P < 0.05, **P < 0.01. 
 
As TAOK2 interacts with Nrp1, we asked whether treatment with the Nrp1 ligand Sema3A 
modulates JNK1 phosphorylation in cultured primary neurons. Since JNK1 phosphorylation is 
enriched in developed axons (Oliva et al., 2006), we used cultured neurons during the initiation 
of polarization to avoid endogenous JNK1 phosphorylation that could mask that induced by our 
Sema3A treatment. Cortical neurons dissociated from E17 mouse embryos and cultured for 48 
hr were treated with Sema3A (2 μg/ml) for 30 min, 2 hr, or 6 hr. The levels of pJNK1 were 
measured using immunocytochemistry and western blot analysis. pJNK1 immunoreactivity was 
significantly increased at 2 and 6 hr following Sema3A treatment in the longest neurite analyzed 
(the putative axon) compared to that in non-treated control cells (Figure 1.1.4.15a, b; 40 
μm<neurite length<150 μm; control: n=71 cells from three different cultures, Sema3A 30 min: 
n=42 cells from two different cultures, Sema3A 2 hr: n=97 cells from three different cultures, 
Sema3A 6 hr: n= 64 cells from three different cultures; P<0.0001 by one-way ANOVA and 
posthoc Dunnett test **P<0.01). Western blot analysis of lysates harvested from neurons 
following 6 hr of Sema3A treatment revealed that endogenous JNK1 phosphorylation (pJNK, 
top panel, lower band, 46 kD) was also induced following Sema3A treatment (Figure 1.1.4.15c, 




We also examined the levels of pJNK1 in cortical extracts from Nrp1
Sema- 
mice. In agreement 
with our in vitro experiments, the pJNK1 levels were reduced in the cortical neurons of 
homozygous Nrp1
Sema- 
mice compared with heterozygous littermates (Figure 1.1.4.16a, b; n(+/-) 
= 9 brains, n(-/-) = 4 brains; *P=0.029 by t test). Sema3A and TAOK2 may modulate JNK1 via a 
common mechanism; alternatively, they may regulate JNK1 via distinct pathways. To 
differentiate between these possibilities, JNK1 activation was evaluated following Sema3A 
treatment in the absence or presence of TAOK2. Primary neurons were infected with 
recombinant lentivirus carrying control or Taok2 shRNA 1 soon after plating. Three days later, 
we assessed levels of pJNK1 following the addition of exogenous Sema3A (2 μg/ml). Sema3A 
increased levels of pJNK1 in control shRNA-treated neurons by about 30% - 40% (Figure 
1.1.4.16a, b; n=2 experiments per triplicate; P<0.0001 by one-way ANOVA and posthoc 
Dunnett test **P<0.01, *P<0.05). Importantly, Sema3A failed to elevate pJNK1 when TAOK2 
was knocked-down (Figure 1.1.4.16c, d). These results indicate that TAOK2 is required for 
Sema3A to induce pJNK1. Together, these data suggest that the interaction of TAOK2 with the 
Sema3A-Nrp1 signaling complex activated JNK1 phosphorylation to mediate neuronal 











Figure 1.1.4.16. TAOK2 and Sema3A modulate the activity of JNK1: Nrp1 knock-out 
mouse has decreased activity of JNK1. 
(a) Immunoblot of cortex lysates from Nrp1
Sema-
 (+/-) and (-/-) P7 littermate mice shows a decrease in 
pJNK1 immunoreactivity in the (-/-) mouse compared with the (+/-) littermate. (b) Quantification of pJNK1 
(in a, top panel, 46 kD) immunoreactivity in lysates of cortices from Nrp1
Sema-
 (+/-) and (-/-) mice. (c, d) 
TAOK2 is necessary for Sema3A to exert an effect in JNK activation. Isolated cortical neurons infected 
with Taok2 shRNA 1 lentivirus failed to increase levels of pJNK1 in the presence of Sema3A. (d) 
Quantification of pJNK1 (in c, top panel, 46 kD) immunoreactivity in lysates of cultured cortical neurons 
infected with Taok2 shRNA 1 lentivirus and treated for 6 hr with Sema3A. Sema3A treatment does not 
increases pJNK1 immunoreactivity in TAOK2 down-regulated neurons. FAK and GADPH are used as the 
loading controls. *P < 0.05, **P < 0.01. 
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TAOK2 modulates basal dendrite formation downstream of Sema3A-Nrp1. 
Little is known about the molecular pathways that determine the formation of basal dendrites in 
pyramidal neurons. Therefore, we decided to analyze whether TAOK2 modulates basal dendrite 
formation downstream of Sema3A-Nrp1. To this end, we examined whether TAOK2 
overexpression is sufficient to restore the defect in dendrite arborization observed in neurons 
from Nrp1
Sema- 
mice (Gu et al., 2003; Tran et al., 2009). These mice exhibit markedly reduced 
branching and growth of basal dendrites in layer V cortical neurons (Gu et al., 2003; Tran et al., 
2009). In contrast, wild-type neurons in situ treated with Sema3A increase their dendritic 
complexity (Fenstermaker et al., 2004). We overexpressed TAOK2 in neurons dissociated from 
the E13.5 cortex of Nrp1
Sema-
 and wild-type mice. At 7 days in vitro (DIV7), Sema3A treatment of 
Nrp1
Sema-
 neurons did not restore the reduced dendritic arborization complexity to wild-type 
levels, confirming the inability of the Nrp1
Sema-
 receptor to bind Sema3A (Figure 1.1.4.17a, b). 
However, TAOK2 overexpression ameliorated the defective dendritic arborization in Nrp1
Sema-
 
neurons (Figure 1.1.4.17a, b). Sholl analysis of the dendritic arbors located between 10 μm and 
100 μm from the cell soma reveals that dendritic arborization is restored to wildtype levels in the 
Nrp1
Sema-
/TAOK2 overexpressing neurons, compared to either neurons from Nrp1
Sema-
 mice or 
Nrp1
Sema- 
neurons treated with Sema3A (Figure 1.1.4.17b, n=20 cells per condition from two 
different cultures, ***P<0.001 by t test). 
 
Figure 1.1.4.17. TAOK2 counteracts the dendritic arborization deficit in neurons 
expressing a deficient Nrp1 receptor.  
(a) rTAOK2 overexpression ameliorates the dendritic arborization deficit in primary cortical Nrp1
Sema- 
neurons. (b) Sholl analysis of the dendritic arbors reveals no statistical differences between wildtype (WT) 
and Nrp1
Sema- 
+ rTAOK2 overexpressing cultured neurons at a distance between 10 µm and 100 µm from 
the cell soma. Scale bar: 10 μm. **P < 0.01, ***P < 0.001. 
 
To further confirm the functional interaction of TAOK2 and Nrp1 in vivo, we acutely knocked 
down the expression of Nrp1 using a shRNA construct, while simultaneously overexpressing 
TAOK2, in layer II-III cortical neurons by in utero electroporation. The Nrp1 shRNA sequence 
was previously reported to down regulate Nrp1 expression in the cortex (Chen et al., 2008), and 
we confirmed that it efficiently knocks down the expression of Nrp1-mCherry in HEK293 cells 











Figure 1.1.4.18. Nrp1 shRNA specifically down-regulates Nrp1-mCherry expression in 
HEK293Tcells.  
(a) Western blot of extracts from HEK293Tcells transfected with control plasmid and Nrp1-mCherry cDNA, 
and HEK293Tcells transfected with Nrp1-mCherry cDNA and the Nrp1 shRNA construct. Blots were 
probed with antibodies against mCherry. (b) Quantification of the Nrp1-mCherry signal from lysates of 
HEK293Tcells. Nrp1 shRNA considerably decreases Nrp1-mCherry immunoreactivity (n=3 experiments 
per duplicate; ***P<0.0001 by t test; Mean ± s.e.m.). 
 
E15 embryos were in utero electroporated with the Nrp1 shRNA plasmid, or a control shRNA 
plasmid, together with F-GFP and rTAOK2 cDNA, and sacrificed at P7. The dendritic 
morphology in neurons of the layer II-III cortex from control and Nrp1 shRNA-expressing brains 
was evaluated. The knockdown of Nrp1 impaired the formation of basal dendrites in the upper 
cortical layers (II-III; Figure 1.1.4.19a), as has been previously reported (Chen et al., 2008). 
Strikingly, TAOK2 overexpression ameliorated the basal dendrite arborization deficit in Nrp1 
shRNA-expressing neurons (Figure 1.1.4.19c). TAOK2-overexpressing neurons show a 
significantly increased primary basal dendrite number in neurons with Nrp1 knockdown that is 
not significantly different from controls (Figure 1.1.4.19b; control: n=16 cells from two brains; 
Nrp1 shRNA: n=47 cells from three brains; Nrp1 shRNA + rTAOK2: n=35 cells from three 
brains; P<0.0001, by one-way ANOVA and posthoc Dunnett test **P<0.01). However, using 
Sholl analysis, we found that the basal dendritic branching (secondary branching) is not 
restored to control levels (Figure 1.1.4.19c; P<0.0001 by one-way ANOVA and posthoc Dunnett 
test **P<0.01). Importantly, Sholl analysis also demonstrated that Nrp1 down-regulation did not 
affect the apical dendrite of transfected neurons (Figure 1.1.4.19d). These results reflect a 
partial restoration of the formation of basal dendrites following TAOK2 expression in Nrp1-
deficient neurons. 
Our results provide evidence that Nrp1 and TAOK2 constitute a pathway that regulates basal 
dendrite development in pyramidal neurons of the developing cortex. 




Figure 1.1.4.19. TAOK2 counteracts the dendritic arborization deficit in neurons with 
Nrp1 down-regulation.  
(a) rTAOK2 overexpression reverses the basal dendritic arborization deficit in Nrp1 shRNA-transfected 
neurons from II-III layer cortex. (b) rTAOK2 overexpression restores the number of primary dendrites in 
Nrp1 downregulated neurons. (c) Sholl analysis of the dendritic arbors shows significant differences 
between Nrp1 shRNA-expressing neurons and Nrp1 shRNA + rTAOK2-expressing neurons. (d) Sholl 
analysis of the apical dendrite does not show any differences between Nrp1 down-regulation, Nrp1 shRNA 
+ rTAOK2 overexpression, and control conditions. Scale bar: 10 μm. **P < 0.01, ***P < 0.001. 
 
 
Activated JNK modulates basal dendrite formation downstream of TAOK2. 
Activated JNK1 has been shown to preferentially localize to the longest neurite, presumably the 
axon, of cultured hippocampal neurons (Oliva et al., 2006). However, pJNK1 has also been 
reported to be involved in the regulation of microtubule dynamics in axons, as well as dendrites, 
in both hippocampus and cortex (Chang et al., 2003). Furthermore, JNK1-deficient mice exhibit 
a progressive loss of microtubules within both axons and dendrites (Chang et al., 2003). 
Previous to the current report, it has remained unclear whether pJNK1 modulates microtubules 









Figure 1.1.4.20. Activated JNK1 predominates in basal dendrites.  
(a) Representative cortical pyramidal neurons in primary culture. Cortical neurons were dissociated at E17 
and cultured for 7 days. Activated JNK1 is enriched in the axon (white arrowheads). (b) The insets show 
the apical dendrite (1) and basal dendrites (2, 3, 4) from the cell in (a) immunolabeled for tubulin (green) 
and pJNK1 (red). (c) The quantification of the ratio of pJNK1 and tubulin or MAP2 fluorescence intensities 
shows a higher ratio of pJNK1/tubulin and pJNK1/MAP2 in basal dendrites compared with apical 
dendrites. Values are normalized to the mean of apical dendrites. Scale bar: 10 μm. *P < 0.05, **P < 0.01. 
 
To assess the localization of pJNK1 in cortical pyramidal neurons, we examined its subcellular 
localization in DIV7 mouse cortical neurons dissociated at E17. We analyzed cells that 
displayed a pyramidal morphology bearing a thick “apical” dendrite and several thin “basal” 
dendrites. We observed that pJNK1 is enriched in developed axons (Figure 1.1.4.20a, 
arrowheads) as previously reported (Oliva et al., 2006). Interestingly, the basal dendrites 
showed a significant increase in the intensity of pJNK1 immunoreactivity, normalized to tubulin 
or MAP2 immunoreactivity, compared with the apical dendrite (Figure 1.4.20a-c; tubulin: 1.3 ± 
0.05-fold ratio increase, **P=0.0051 by t test; n=23 cells from three different cultures; MAP2: 
1.95 ± 0.24-fold ratio increase, *P=0.0154 by t test; n=20 cells from three different cultures). 
Thus, the compartmentalization of pJNK1 might play a role in the preferential elongation of 










Figure 1.1.4.21. Activated JNK1 ameliorates deficient basal dendrite formation following 
TAOK2 down-regulation.  
(a) Upper cortical layer (II-III) transfected neurons show underdeveloped basal dendrites following shRNA-
mediated knockdown of TAOK2 compared with control-transfected neurons. MKK7-JNK1 overexpression 
ameliorates the basal dendrite deficit following Taok2 shRNA-mediated downregulation. MKK7-JNK1 
overexpression alone increases the number of basal dendrites compare with control-transfected cells. (b) 
The number of primary dendrites increases following MKK7-JNK1 overexpression. (c) Sholl analysis of the 
dendritic arbors demonstrates significant differences between Taok2 shRNA expressing neurons and 
Taok2 shRNA + MKK7-JNK1 or MKK-JNK1-expressing neurons at a distance between 15 μm and 55 μm 
from the cell soma. (d) The apical dendrite of transfected neurons is not affected by MKK7-JNK1 
overexpression. Quantifications for control and Taok2 shRNA 1-transfected cells are the same as in Figure 
3b-d. Scale bar: 10 μm. *P < 0.05, **P < 0.01. 
 
To further investigate the relationship between TAOK2 and JNK1 in basal dendritic arborization, 
we determined whether the addition of pJNK1 is able to abrogate the basal dendrite phenotypes 
caused by TAOK2 loss-of-function. It was previously shown that fusing MKK7 to JNK1 (MKK7-
JNK1) renders JNK1 constitutively active, thus mimicking the activity of pJNK1 (Lei et al., 2002; 
Yamasaki et al., 2011). E15 mouse embryos were electroporated in utero with Taok2 shRNA 1 
or control shRNA together with F-GFP and MKK7-JNK1 cDNA, and sacrificed at P7. TAOK2 
down-regulation impaired the formation of primary dendrites in layer II-III neurons (Figure 
1.1.4.21a, b; control: n=19 cells from three brains; Taok2 shRNA 1: n=23 cells from three 
brains; Taok2 shRNA 1 + MKK7-JNK1: n=32 cells from three brains; MKK7- JNK1: n=42 cells 




Interestingly, the number of primary dendrites of transfected neurons was markedly increased 
when MKK7-JNK1 was expressed alone or co-expressed with Taok2 shRNA1 (Figure 
1.1.4.21a, b). Sholl analysis demonstrated significant differences in the dendritic arborization 
between Taok2 shRNA 1-expressing neurons, Taok2 shRNA 1 + MKK7-JNK1-expressing 
neurons, and MKK7-JNK1-expressing neurons at a distance between 15 μm and 55 μm from 
the cell soma. (Figure 1.1.4.21c; ***P<0.0001 by one-way ANOVA and posthoc Dunnett test 
**P<0.01, *P<0.05). However, neurons co-expressing Taok2 shRNA and MKK7-JNK1 produced 
basal dendrites that were not as elaborated as those produced from control shRNA-transfected 
neurons (Figure 1.1.4.21c). This result reflects a partial restoration of the branching of basal 
dendrites in Taok2 shRNA-transfected neurons following the expression of MKK7-JNK1. 
Importantly, MKK7-JNK1 overexpression with or without TAOK2 down-regulation did not affect 
apical dendrite morphology compared with control-transfected neurons (Figure 1.1.4.21d), 
further supporting a preferential basal dendrite compartmentalization of pJNK. The active JNK1 
also rescued the callosal axon deficit in the midline following TAOK2 down-regulation (Figure 
1.1.4.22). Together, these experiments provide evidence that TAOK2 and JNK1 modulate 
neuronal differentiation in cortical pyramidal neurons. 
Collectively, these results delineate a molecular pathway whereby TAOK2 plays a key role in 
governing the morphogenesis of pyramidal neurons in the developing cortex. 
 
Figure 1.1.4.22. Activated JNK1 ameliorates axonal projection deficits following TAOK2 
down-regulation.  
MKK7-JNK1 overexpression rescues the deficit of callosal axons in the corpus callosum from cells 
transfected with Venus and TaoK2 shRNA. Right panel: inset of the corpus callosum. Scale bar: 500 μm. 
 
TAOK2 down regulation affects cortical neuronal migration, JNK1 rescues the phenotype 
The migratory process requires major alterations in the cellular cytoskeleton, both in actin and 
microtubules, and action of very specialized molecules. The leading process is composed of 
several organelles and usually terminates in several protrusions oriented toward the cortical 
plate that by sensing the extracellular environment will determine the migratory pathway. 
Alteration to this dynamics usually is impairment for migration in cortical development studies. 
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TAOK2 was first described by Moore and colleagues under the name of PSK. In their study the 
authors describe how PSK selectively activates the JNK MAPK pathway through the activation 
of MKK4 and MKK7, and also, they show the relevance of the unknown c-terminal domain to 
the regulatory pathway and function of TAOK2 in the cells (Moore et al., 2000). Several other 
studies reveal the involvement of TAOK2 in regulating cytoskeleton properties during stress-like 
conditions and demonstrate that TAOK2 colocalizes with microtubules for their stabilization in a 
kinase independent fashion (Chen and Cobb, 2001; Mitsopoulos et al., 2003). So it is possible 
that TAOK2 is responsible for the stability of actin, having a major effect in the dynamics of 
microtubules present in the neurites and axons of pyramidal neurons.  
To see if TAOK2 down-regulation had an effect in the migratory pathway, E15 mouse embryos 
were electroporated in utero with Taok2 shRNA 1 or control shRNA together with F-GFP and 
MKK7-JNK1 cDNA. Mice were sacrificed at E17 and the pattern of neuronal migration was 
evaluated. We found that the knockdown of TAOK2 was responsible for a significant arrest of 
pyramidal neurons in the intermediate zone when compared to control neurons where the 
higher percentage of cells were already present in the upper cortical plate. TAOK2 down-
regulation impaired the proper migration of neurons, with an increased accumulation of cells in 
the IZ when compared with the control brain, although when overexpressing MKK7-JNK1 there 
is a partially rescue of the migratory phenotype (Figure 1.1.4.23a, b; control: n=2 brains; Taok2 
shRNA 1: n=2 brains; Taok2 shRNA 1 + MKK7-JNK1: n=2 brains; ***P<0.0001 by one-way 
ANOVA and posthoc Dunnett test **P<0.01).  
The latter results suggest that TAOK2 has a role in the regulatory mechanism of neuronal 







Figure 1.1.4.23. TAOK2 down-regulation affects neuronal migration in the developing 
cortex, while the overexpression of MKK7-JNK1 partially rescues the phenotype .  
(a) Cortical mouse embrios were electroporated at E17 with F-GFP together with control shRNA (left 
panel), Taok2 shRNA (central panel) and Taok2 shRNA + MKK7-JNK1 cDNA (right panel). The 
knockdown of TAOK2 leads to a clear defect in neuronal migration, where the migration on pyramidal 
neurons is arrested in the intermediate zone. However, the defect in neuronal migration is not so clear 
when together with the knockdown of TAOK2 we overexpress a constitutively active form of MKK7-JNK1, 
having no absolute statistical difference from the control brains. (b) The quantification of migratory defect 
and partially rescue was done by quantifiyng the number of cells arrested in the Ventricular Zone (VZ), 
Intermediate Zone (IZ), Low-Cortical Plate (LCP) and Upper-Cortical Plate (UCP).  
 
It is prooved that JNK1 is involved in axon formation, elongation and maintenace in vivo through 
the phosphorylation of diverse cytoeskeleton proteins and, also, that JNK1 modulates axon 
transport (Björkblom et al., 2005; Chang et al., 2003; Stagi et al., 2006; Tararuk et al., 2006; 
Yamauchi et al., 2006). We know that TAOK2 activates the JNK1 pathway. In our experiments 
we observed a partial rescue of the migration defect, when overexpressing an active form of 
JNK1 (MKK7-JNK1). The inactivation of JNK1 together with absence of TAOK2 may explain the 
migration defect observed, since the inability of the growth cone to expand and explore the 
environment will inhibit the detachment of the axon and consequently, inhibit the motility of the 
cell toward the CP. Also, the JNK1 molecule as been studied in neurons for its direct binding to 
motor molecules, kinesins (Stagi et al., 2006). The transport of molecules in the neurons 
between axon and nucleus will be impaired by the inactivation of JNK1. JNK1 is concluded to 
be a major player in neuronal development and migration. 
We next sought to elucidate the effect of the in vivo TAOK2 down-regulation in the cortical 
layering in the post-migratory brain. Mouse embryos were electroporated bilaterally, the left 
hemisphere was electroporated with Taok2 shRNA together with Venus, while the right 
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hemisphere was electroporated with control shRNA together with mCherry. The mice were 
sacrificed at posnatal day 7 (P7). A quantification of the distance from the most rostral labeled 
positive neuronal cell to the marginal zone was measured and a highly significant difference in 
average distance was observed in the brain between left hemisphere (TAO shRNA + Venus, 
Figure 1.1.4.24) and the right hemisphere (control shRNA + mCherry, Figure 1.1.2.24). 
Neuronal cells, where TAOK2 was down-regulated, ended in a higher layer of the cortex, i.e. in 
a most dorsal position, when compared to the control neurons, suggesting a delay in migration 
but not a complete arrest of the migratory mechanism. TAOK2 down-regulation affects the end 
fate of the pyramidal neurons and so they surpass the correct layer position, ending in a most 




Figure 1.1.4.24. TAOK2 downregulation affects cortex layering.  
(a) Brain coronal section showing that Taok2 shRNA-mediated knock-down in Venus-positive neurons 
(bottom inset - left panel) appear in upper cortical layers when  compared with control transfected neurons, 
at the contralateral hemisphere, positive for mCherry (bottom inset - right panel). (b) Quantification of 
distance (microns) from marginal zone to the base of transfected cells. shRNA-mediated knock-down of 







Figure 1.1.4.25. The overexpression of the constituve active form MKK7-JNK1 rescues 
the cortial layering defect.  
(a) Layering markers are compared between Taok2 shRNA-mediated knock-down in Venus-positive 
neurons and control transfected neurons positive for mCherry present in the contralateral hemisphere of 
the same mouse brain. (b) Immunoprecipitation with antibodies for the different six cortical layers: layer VI 
(anti-TBR1), layers II-IV (anti-CUX1) and layer (anti-BR1). TAOK2 down-regulation afects layering of upper 
cortical neurons. (c) Layering markers are compared between Taok2 shRNA-mediated knock-down 
rescued with MKK7-JNK1 overexpression in Venus-positive neurons and control transfected neurons 
positive for mCherry present in the contralateral hemisphere of the same mouse brain. (d) Quantification of 
immunoreactivity to cortical layer markers as in (b). A significant rescue of neuronal position in the cortex is 
evident for markers Br-1 and Tbr-1. 
Knowing that the in vivo knock-down of TAOK2 leads to defects in neuronal migration and cell 
positioning, we proceed  to study TAOK2 influence in the neuronal fate of the cells. On that 
purpose, bilateral in utero electroporation to the mouse embryo at E15 was performed. The left 
hemisphere was electroporated with TAOK2 shRNA and Venus, while the right hemisphere was 
electroporated with control shRNA and mCherry. The mice were sacrificed at P7 for the analysis 
of the immunoreactivity of the cells with antibodies against cortical layer markers Br-1, Tbr-1 
and Cux-1 (Figure 1.1.4.25a,b). We observed a highly significant difference in the Tbr-1 marker 
when compared to the control hemisphere. To assert if the overexpression of active JNK1 
would rescue this phenotype, bilateral electroporation of the mouse embryo was performed as 
previously, however, the left hemisphere was electroporated with TAOK2 shRNA together with 
MKK7-JNK1 cDNA and Venus for labeling and the right hemisphere was electroporated with 
control shRNA and mCherry (Figure 1.1.4.25c,d). The quantification of the immunoreactivity 
against the refered (as in Figure 1.1.4.25a,b) markers for cortical layering show a decrease 
difference between Tbr-1 positive cells in the rescued hemisphere when compared to control. 
However, the rescue is not complete (Figure 1.1.4.25d).  
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TAOK2 is here proven to have a role in the proper organization of the neocortex. TAOK2 down 
regulation leads to a clear slow movement of the neuron towards the cortical plate which 
accounts for layer surpassing. Neurons end in an upper layer when compared to the ones that 
express TAOK2, having a mild different in cortical layering markers, suggesting that the TAOK2 
mechanism might influence cell fate. 
It is known that MyosinIIA and MyosinIIB are the most prominently expressed type II Myosins in 
projection neurons during migration. Schaar and McConnel have found that Myosin II activity is 
correlated with nuclear movement, being specifically activated in the leading and trailing 
domains at the time of translocation (Schaar and McConnell, 2005). Several Myosin were 
shown to be concentrated in the growth cones of neurons at the time of migration, as it is actin, 
which is responsible for the motility of the growth cone (Vallee et al., 2009). We have previously 
shown that disruption of TAOK2 expression leads to the collapsment of growth cones in vitro. It 
is plausible to accept that TAOK2 may interfere with Myosins motor molecules machinery, 
through the increased destabilization of actin. However, neurons with impaired actin dynamics 
can still migrate and their axons can move forward but the abnormal morphology of the growth 
cone confounds its selectivity (Marsh and Letourneau, 1984). 
 
TAOK2 down-regulation affects in vivo leading process displacement and speed of 
migration 
We next sought to understand the behavior of the neuronal cells after TAOK2 down-regulation. 
We have in utero electroporated mouse embryos at E15 with F-GFP for cell labeling and control 
shRNA or TAOK2 shRNA. Mice were sacrificed at E17 and we have captured images of the 
transfected cells migration behavior every 10 minutes at the inverted fluorescence microscope. 
The comparison between control cells and TAOK2 downregulated cells (Figure 1.1.4.26a, b) 
showed a significant decrease in the speed of migration. TAOK2 downregulation leads to slower 
speed of migration (Figure 1.1.4.26b). Also, we observed a significant difference in the 
displacement (microns) of the neuronal leading process between control neurons and shRNA-
TAOK2 transfected neurons. Displacement of the leading process was much reduced in the 
TAOK2 knock-down neuron when compared to a control cell (Figure 1.1.4.26c). However, this 
phenotype was not so evident in the displacement of the neuronal cell body. So, depleting 
TAOK2 causes a major disability in the cells cytoskeleton inhibiting their proper migration since 
the leading and trailing process are unable to protrude and retreat, losing the capability to sense 





Figure 1.1.4.26. TAOK2 down-regulation affects in vivo cell body movement speed and 
displacement. 
(a) Time-lapse fluorescent microscopy of pyramidal neuron transfected with EGFP  and control shRNA (left 
panel) and of pyramidal neurons transfected with EGFP and shRNA-TAOK2. Over a period of 250 minutes 
is visible a slower migratory path for the knock-down neuron. (Green: time = o min; Red: time = 110 min; 
Blue: time = 250 min). (b) Quantification of average speed of cell body movement every 10 minutes. 
TAOK2 knock-down affects cell body movement in the mouse cortex. (c) Analysis of cell displacement 
over time. Down-regulation of TAOK2 impairs the movement of the neuronal tip during pyramidal neurons 
interkinetic nuclear migration. 




In the current report, we describe a novel molecular pathway that preferentially modulates the 
formation of basal dendrites in cortical pyramidal neurons, and which also plays a role in axonal 
projection. Extensive work has addressed the roles of several molecules in dendrite arborization 
(for review, Jan and Jan, 2010). However, little is known about the molecular differences that 
may direct the formation of different domains within the same dendritic tree. This work 
represents the first approach aimed at understanding the mechanisms responsible for the 
delineation of basal and apical dendrites during pyramidal neuron development in the 
embryonic cortex. 
Over a decade ago, electron microscopy studies in cultured neurons indicated that axons 
contain microtubules of uniform polarity, while dendrites contain microtubules of mixed polarity 
(Baas et al., 1989). These data support the concept of the molecular homogeneity of the 
dendritic tree. However, it was recently found that apical dendrites from hippocampal CA1 and 
cortical layer V pyramidal neurons ubiquitously have polarized microtubule arrays (Kwan et al., 
2008), suggesting that the morphogenesis of dendritic subtypes (i.e. basal versus apical 
dendrites) may rely upon distinct cellular and molecular pathways. Accordingly, it was shown 
that post-Golgi membrane trafficking is polarized toward the apical dendrites of pyramidal 
neurons, and that the disruption of Golgi polarity produces neurons with symmetric dendritic 
arbors, which lack a single longest principal, or apical, dendrite (Horton et al., 2005). 
 
The Sema3A-Nrp1 signaling cascade is coupled to TAOK2-JNK1 to modulate 
differentiation of cortical pyramidal neurons. 
In previous reports, activation of the Nrp1 receptor by Sema3A appeared to orient the apical 
dendrites of cortical pyramidal neurons towards the marginal zone (MZ) of the developing cortex 
and to regulate neuronal polarization (Nishiyama et al., 2011; Shelly et al., 2011). It was also 
shown that Sema3A – Nrp1 signaling via PlexinA4 controls the basal dendritic arborization of 
cortical neurons (Chen et al., 2008; Gu et al., 2003; Tran et al., 2009). Since the Nrp1 receptor 
is likely to be uniformly distributed on all dendritic processes (Tran et al., 2009), as well as the 
axon (Polleux et al., 2000), one question that arises is how this ubiquitous receptor specifically 
controls the formation of basal dendrites. The asymmetric localization of soluble guanylate 
cyclase to apical dendrites has been suggested to mediate the distinct Sema3A responses of 
axons and dendrites, allowing for the orientation of the apical dendrite towards the MZ (Polleux 
et al., 2000). However, the downstream effectors by which Sema3A and its receptor regulate 




We now show that TAOK2 down-regulation specifically impairs the formation of basal dendrites, 
without affecting apical dendrites. These data strongly suggest that TAOK2 acts in concert with 
the Sema3A-Nrp1 pathway to sustain basal dendrite formation. Our biochemical analyses 
demonstrate that TAOK2 and Nrp1 form a complex, and that acute Nrp1 down-regulation 
specifically impairs the formation of the basal dendrite. Importantly, we report that the deficit in 
basal dendrite formation following Nrp1 down-regulation can be counteracted by TAOK2 
overexpression. 
Our data also show that TAOK2 appears to be uniformly distributed in the growth cones of 
cultured developing cortical neurons, without any preference for dendritic or axonal neurites. It 
is possible that our methods could not detect a differential subcellular distribution of TAOK2. 
Alternatively, the subcellular compartmentalization of molecules that sustain basal dendrite 
formation may occur downstream of TAOK2. 
The current work implicates activated JNK1 (pJNK1) as an effector of TAOK2 that modulates 
basal dendrite morphogenesis. It has been shown that pJNK1 is enriched in axons of 
hippocampal neurons in culture (Oliva et al., 2006). We also found that pJNK1 was 
preferentially localized to the longest neurite, presumably the axon, of DIV2 cultured cortical 
neurons. It has also been reported that pJNK1 is involved in the regulation of microtubule 
dynamics in both axons and dendrites of the hippocampus and cortex (Chang et al., 2003), and 
that JNK1(-/-) mice exhibit a progressive loss of microtubules within both axons and dendrites 
(Chang et al., 2003). However, the role of pJNK within the different domains of the dendritic tree 
has not been clear. In vivo experiments examining the loss-of-function of the MAP kinase 
phosphatase 1 (MKP-1), which deactivates JNK1, show reduced dendritic arborization of the 
basal dendrites of cortical pyramidal neurons, as well as impaired axonal branching 
(Jeanneteau et al., 2010). In agreement with these findings, we found that pJNK1 is 
preferentially enriched in the basal dendrites and the axons of cortical pyramidal neurons. 
Moreover, the overexpression of the constitutively active JNK1 counteracted defects in basal 
dendrite formation and axonal projection following TAOK2 down-regulation. 
Therefore, it is plausible that the subcellular compartmentalization of pJNK1 may explain, at 
least in part, the specific role of TAOK2 in basal dendrite formation and axonal projection (see 
model in Figure 1.1.4.27). Our results demonstrate that Sema3A/Nrp1-mediated activation of 
pJNK1 requires TAOK2 (Figure 1.1.4.16c, d), which indicates that the three proteins act in the 
same pathway. Although additional independent pathways could activate JNK, the existence of 
such pathways does not preclude the importance of the observed TAOK2-mediated activation 
of JNK1 in regulating dendrite morphogenesis. 
We have concluded previously that TAOK2 down-regulation affects the capability by the neuron 
to properly guide the cell toward the cortical plate. Depletion of TAOK2 expression leads to actin 
destabilization and, ultimately, to an improper migration mechanism. However, the neuron 
keeps the ability to migrate, but it’s much slower in movement. This phenotype may be due to 
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the cell inability to properly stabilize actin, which would impair substratum selectivity of the 
growth cone. Since the cortex substratum confers information to the neurons, the slow migration 
creates a delay causing neurons to surpass their true final destination (they miss the information 
to stop migration), by adjustment they end more superficially than expected. When they are 
signaled by molecules for migratory arrest, they are already in a more superficial layer. Also, the 
down-regulation of TAOK2 affects axon formation, most likely by inactivation of JNK1, a known 
player in axon formation. The delay in the axon development and the difficulties for its 
maintenance will have an effect in the establishment of a connection between the axon and 
another target neuron, an encounter that dictates the end of migration to that specific neuron 
(Baird et al., 1992). More experiments are needed to understand in deep this phenotype, 
because we know that the activity of TAOK2 is through actin stabilization but we do not know 
exactly the mechanism involved. Also, overexpression of the constitutively active form of JNK1 
(MKK7-JNK1) did not rescue entirely the migration defect, not only because TAOK2 directly 












Figure 1.1.4.27. TAOK2 modulates the formation of basal dendrites and axonal elongation 
in pyramidal neurons.  
(a) Flowchart of the key signaling pathway involved in TAOK2-induced formation of basal dendrites. (b) 
Model: Basal dendrites and axon have enriched activated JNK1 (green, pJNK1) compared with the levels 
of activated JNK1 in the apical dendrite. If TAOK2 is down regulated, then JNK1 is not active in the basal 
dendrites and the axon, thus precluding their proper elongation. TAOK2 overexpression increases number 




TAOK2 and Autism Spectrum Disorders. 
Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental syndrome for which 
there is not a clear neurobiological etiology. Although the genetic underpinnings of ASD remain 
elusive in most cases, a unifying model for ASD has recently been suggested (Geschwind and 
Levitt, 2007). This model proposes that ASD results from a developmental disconnection of 
brain regions that are involved in higher-order associations. Emerging literature, which shows 
functional and anatomical cortical under-connectivity in autistic patients, supports this model 
(Geschwind and Levitt, 2007; Just et al., 2007). The cellular basis for dysfunctional circuits, 
however, remains poorly understood. Several genes have been described as contributing to 
ASD (Pinto et al., 2010; Walsh et al., 2008; Weiss et al., 2009), and it has been proposed that 
aberrant synaptic protein synthesis may represent one pathway leading to an autistic phenotype 
(Kelleher and Bear, 2008). Recently, a novel, recurrent microdeletion, and a reciprocal 
microduplication, of chromosome 16p11.2 has been identified that carries substantial 
susceptibility to autism and appears to account for approximately 1% of cases (Weiss et al., 
2008). One of the genes from the affected region encodes for TAOK2. 
Therefore, our findings of immature basal dendrite development and axonal projections deficits 
following TAOK2 down-regulation support the hypothesis that underdeveloped neuron 
morphology contributes to the disconnection of brain regions that may underlie the autistic 
phenotype. 
It is unknown how depletion of TAOK2 influences the specificity and connectivity between 
projection neurons, but TAOK2 absence leads to improper migration and basal dendrite 
formation with a marked diminution of colossal axon development with a pronounced disability 
to cross the midline. If inhibiting the expression of TAOK2 described in our studies leads to such 
marked phenotypes, it is most plausible that it will have an effect in the patophysiology of an 
individual where the TAOK2 gene happens to be misregulated or absent, most likely, leading to 
a psychiatric disorder associated with neocortical disconnection, the accepted model 
mechanism for Autism Spectrum Disorders (ASD). Recently, several studies suggest the 
involvement of TAOK2 in other brain disorders such as Fragile X syndrome (Darnell et al., 
2011), schizophrenia (McCarthy et al., 2009), depressive disorders (Degenhardt et al., 2012) 
and Alzheimer disease (AD) (Tavares et al., 2013), suggesting not only a role in the considered 
brain developmental disorders with a pronounced pathology since infancy,  but expanding to a 
relevance in brain disorders with onset in adult life. This may suggest that the disorders which 
happen in adults may have an underlying developmental defect. Further work is necessary to 
understand how the TAOK2 biological role and activity affects the human brain and how much 
contribution is given in the complexity of molecules where regulation fails, resulting in a 
neurological disorder. 
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In order to determine the structure of a protein by X-ray crystallography, well ordered three-
dimensional crystals are required. At present, despite the wealth of experience accumulated in 
the course of crystallization and structural analysis of several hundred soluble globular proteins 
and their complexes, the process of crystallization still remains something of an art, and is often 
one of the rate limiting step for any crystallographer. Particularly for membrane proteins this 
represents an additional challenge by virtue of their amphipathic nature, and so their production 
and purification is troublesome. As a result, to date fewer than 400 structures of membrane 
proteins are known, less than 0.5% of all the known structures deposited in the Protein Data Bank 
(PDB). For higher eukaryotes the story is even starker, with less than 50 mammalian integral 
membrane proteins (IMPs) solved. 
Membrane protein production and purification is therefore one of the most important remaining 
frontiers for structural biology research. One way to improve the throughput of eukaryotic 
membrane protein structures is to develop methods that reliably facilitate the identification of well 
expressing IMPs that are stable and functional. In this work, we used the multi-spanning human 
membrane MAP3K kinase TAOK2 isoform 1 (further referred as hTAOK2) as a model to setup a 
GFP-based approach, for the fast and cost effective multi-host expression screening towards the 
purification of eukaryotic IMPs.  
The hTaok2 gene was cloned fused to GFP with either a polyhistine or Strep-tag into pOPIN-F, a 
vector designed to enable high-level target gene expression in multiple systems. A GFP-based 
expression screening and optimization was carried out using different E. coli strains, mammalian 
and insect cells to determine the host best suited for hTAOK2 production. GFP fluorescence was 
further used to facilitate detergent screening and downstream processing. The measurement of 
GFP fluorescence intensity was found to be a fast measure of expression and localization, and 
with higher accuracy when comparing to the in-gel fluorescence.  
Accordingly, by monitoring expression through GFP fluorescence, we show that hTAOK2 fusion 
protein only localizes correctly throughout the cell membrane when expressed in mammalian cells 
and only when GFP is present at the N-terminus. We show the practical steps that constitute our 
GFP-based pipeline for evaluation of expression, as well as to speed up membrane extraction 
detergent screening up to protein purification. Therefore, GFP-tag is very useful to facilitate the 
production process that all IMPs are required to go through on the way to obtain stable and 
homogeneous material for functional and structural studies, although the functionality of the IMP 
still has to be checked/confirmed at the end of the purification. 
  




The biological membrane 
 
The first cell had origin when a membrane was formed, inclosing a watery solution and separating 
it from the rest of the universe. In 1972, Singer and Nicolson presented to the scientific 
community a model for biological membranes, the fluid mosaic model (Figure 1.2.2.1). This model 
introduces an organized bilayer of phospholipids, creating an amphipathic structure, which 
provide an hydrophobic interior environment - with nonpolar groups buried, facing each other, at 
the bilayer core, whereas ionic and highly polar groups protrude outward from the membrane into 
the aqueous phase (Singer and Nicolson, 1972). Embedded in the membrane are proteins, held 
by hydrophobic interactions between the lipids and hydrophobic domains in the protein. Because 
most of the interactions between the membrane components are noncovalent, the proteins are 
free to move laterally within the lipid bilayer by membrane diffusion, reason why it is named fluid 
mosaic model of the cell membrane. 
 
 
Figure 1.2.2.1. Model of fluid mosaic membrane first described by Singer and Nicolson. 
Like a mosaic, the cell membrane is a complex structure composed mainly of phospholipids, proteins and 
cholesterol. Biological membrane components are diversified, depending on the type of lipid constituting the 
membrane and its function (Alberts, 2009). 
Biological membranes share fundamental properties: all are impermeable to most polar groups or 




appear trilaminar at the electron microscope (Lehninger et al., 2000). The relative proportion of 
proteins and lipids varies with the type of membrane. 
 
From Gene to Protein – recombinant DNA 
In 1868, a Swiss physician, Friedrich Miescher, isolated a total new compound from the nucleus. 
That thing no one has ever seen before was named nuclein at the time, but it is now best known 
as DNA, the deoxyribonucleic acid (Dahm, 2008). The connection between DNA and genes 
wasn’t made until 1944 by Oswald Avery, in his study about bacterial transformation (Severs and 
Whiting, 2002): 
"If we are right, and of course that is not yet proven, then it means that nucleic acids are not 
merely structurally important but functionally active substances in determining the biochemical 
activities and specific characteristics of cells and that by means of a known chemical substance it 
is possible to induce predictable and hereditary changes in cells. This is something that has long 
been the dreams of geneticists."  
Oswald T. Avery, 1943 
 
From this point, scientists started to unravel more details about DNA, its constitution and 
biochemical properties, even the pairing of bases was known, however the models of how its 
constituents assembled to form a molecule were highly controversial. The big breakthrough 
happened in 1953 when Watson and Crick (1962 Nobel prize of medicine) revealed the first true 
model of DNA (Watson and Crick, 1953). This model aroused because it was finally possible to 
analyze the X-ray crystallographic data of a DNA fiber produced by Rosalind Franklin´s work. 
The knowledge on how genetic material is stored and copied allowed an advance to a new era of 
bioprocess manipulation. New techniques were developed to understand the specific role of 
different genes. Within the first lights of molecular biology, molecules of DNA stretches were cut-
out and inserted in a different place – the birth of recombinant DNA technology.  
In recombinant DNA, the donor organism DNA (or GOI, gene of interest) in study is extracted by 
specific enzymes, cut in fragments and inserted individually into bacterial plasmids. The bacterial 
plasmids act as carriers, or vectors. The vector plus its DNA insert consists of the recombinant 
DNA, a novel combination of DNA from completely different sources (Figure 1.2.2.2). The 
technology of recombinant DNA allowed to transform bacterial cells with those vectors and 
cultured them in plates, where a single transformed cell will form a colony by sequential divisions, 
carrying the same recombinant DNA – a clone (Griffiths et al., 2000a). In recent years, 
advancements in technology permitted the transfer of DNA from any origin, not only to bacteria, 
as to eukaryotic cells, virus, and highly complex organism, e.g. mouse, flies, worms and others. 




Figure 1.2.2.2. Recombinant DNA technology.  
Individual fragments of DNA from any genome are inserted into a vector, e.g. plasmid. The vector-DNA 
combination is amplified by a single bacterial cell originating a DNA clone (Griffiths et al., 2000a). 
 
In the last century, basic science has evolved to a complex system of genomics and proteomics 
of entire organisms as the human body, hoping that in a near future, it will contribute to a better 
understanding of the mechanisms of biological processes. 
 
Studying Membrane Proteins 
Membrane proteins (MPs) are a class of proteins that play specific roles in the communication 
between biological compartments allowing these to take on specialized functions. Integral 
membrane proteins (IMPs) can act as receptors, channels, transporters, and are also involved in 
cell adhesion and signaling, whereas peripheral membrane proteins are primarily implicated in 




About 20 to 35% of open reading frames from the currently known genomes encode for MPs 
(Boyd et al., 1998). Moreover, 70% of the current pharmaceutical targets are MPs, leaving no 
doubt to their extreme importance in medicine, and creating an immediate need for high 
resolution structural to functional information (Hopkins and Groom, 2002). Protein structures 
provide relevant insights into their reaction mechanisms. The most reliable method to acquire high 
resolution structures of proteins is X-ray crystallography. The first membrane protein crystal 
structure, the bacterial photosynthetic reaction center complex, was solved by Johann 
Deisenhofer, Robert Huber  and Hartmut Michel in 1985 (Deisenhofer et al., 1985). Since then, 
increasing numbers of membrane protein structures have been reported (Figure 1.2.2.3), to an 
actual number of 427 unique membrane protein structures present at the ‘Membrane protein of 
known 3D structure’ database (http://blanco.biomol.uci.edu/mpstruc/). However, despite the 
increased advances in the field, less than 0.5% of unique structures in PDB belong to MPs (PDB: 
http://www.rcsb.org/pdb), largely because of difficulties inherent to membrane proteins. Eukaryotic 
membrane proteins are particularly difficult and underrepresented, with less than 50 unique 
known 3D structures. 
 
Figure 1.2.2.3. Number of unique membrane protein structures. Currently, 427 unique 
membrane protein structures are present at the ‘Membrane protein of known 3D structure’ 
database (http://blanco.biomol.uci.edu/mpstruc/).  
 
MPs represent a challenging class of proteins for structural biochemistry due to the difficulties 
associated with their expressing and handling, as they are often flexible and unstable, and only 
available when extracted from the membrane by the use of detergents. The hydrophobic nature of 
MPs makes them unsoluble in a simpler aqueous solution or in organic solvents of low dielectric 
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soluble proteins. Those low yields can be associated with toxicity to the host cell, due to the 
overload of membrane translocation machinery or to the potential accumulation of protein 
molecules incorrectly incorporated into the membranes. For high resolution structure 
determination, a protein must be soluble at high concentrations and remain intact and stable for a 
period of time that allow crystals to form (Bowie, 2001). The most common problem is poor 
stability, leading to inactivation of the protein, which becomes biochemically intractable. Usually, 
obtaining membrane proteins in sufficient quantity and quality for structural and 
biochemical/biophysical analysis can be a challenging and time consuming task. 
Because of the obstacles related to stability and solubility of membrane proteins, it is often difficult 
to study these proteins using common biophysical techniques such as x-ray scattering, magnetic 
and optical spectroscopy. Despite the advance those methodologies have taken recently, X-ray 
crystallography remains the top choice technique for structure-to-function analysis (Bolla et al., 
2012).  
 
Overexpression of membrane proteins 
Suitable starting material is often in short supply. Membrane proteins can be obtained directly 
from the source organism, as by enriching a membrane preparation that will naturally be enriched 
in the target protein. However, the amount of a membrane protein purified and present in nature 
is, quite usually, very low. Over time, scientists have developed strategies for the overexpression 
of proteins in order to increase its yield. The challenge then, is to find a suitable temporary 
hosting environment for the excised protein and a means for ratcheting it into crystal 
lattice in native conformation (Caffrey, 2003). 
Following the discovery of the tools allowing DNA manipulations in vitro, Escherichia coli became 
the most widely used expression host of recombinant proteins. It provided a source for producing 
proteins in high quantity and quality, which were previously difficult or impossible to achieve from 
their natural source. E. coli can be grown to high cell density, having a duplication time of only 20 
minutes, the fastest and inexpensive techniques applied in a fermentation process and 
consequently, very high yields are to be expected. Biotherapeutics and proteins associated with 
industrial scale are thoroughly expressed in this system (Robert C. Hockney, 1994). 
Having cloning as an option for our gene of interest, leads to the advantage taken at the ability to 
engineer the sequence for overexpression resulting in modifications at the N- and/or C-terminal, 
as well at the internal sequence, for the removal of troublesome co- and post-translational 
modification sites. The wide use of affinity tags, fusion proteins and amino acid analogs, for 
phasing purposes, facilitates purification and structure determination. Protein sequences are 
many times engineered (mutations) to improve stability or to enable determination of different 




crystallography (Caffrey, 2003). Exploring the crystallizability of homologues of the target protein 
in other organisms is a strategy that has proved successful (Bass et al., 2002).  
Apparently, E. coli was a good starting point for the herelogous expression of relatively small 
proteins or proteins with simple structural properties. However, the isolation of complex proteins, 
particularly those requiring post-translational modifications for their biological activity, i.e. the 
eukaryotic proteins, is limited in such a system. Many overexpressed proteins can cause toxicity 
to the host and kill it; or it may happen that the target ends accumulating in inclusion bodies (IBs). 
Overexpression of proteins is not a trivial subject and many developments and reports on the 
subject highlight the necessity of a cautious high-throughput approach of host strains. Meanwhile, 
vectors availability have increased enormously, and also protein tagging have been extensively 
studied, becoming important parameters to be taken in consideration when experimenting the 
overexpression of a protein, even more, if it is an eukaryotic protein (due to their higher structural 
complexity). To overcome the difficulties of finding satisfactory expression condition when using 
Escherichia coli strains as host, C-terminal tagging of MPs with green fluorescent protein (GFP) 
has been tested as an expression/folding marker. Correctly folded GFP is fluorescent, as 
opposed to overexpressed GFP in inclusion bodies which does not fluoresce, allowing to 
discriminate between correctly membrane insertion and folding versus inclusion bodies and 
aggregates formation (Drew et al., 2001). 
Some proteins, when overexpressed, may accumulate in an insoluble and inactive form, and 
agglomerate forming an inclusion body. To retrieve the protein from IBs, it is necessary to use 
strong denaturating agents and refolding processes. Even if refolding has proved to be capable of 
producing authentic protein in a biological active form, it most often fails. In addition, the 
complexity of experiments totally abolish the simplicity expected when using E. coli (Bolla et al., 
2012). Also, the fact that such proteins never encounter a natural membrane raises questions 
regarding the fidelity of the structure determined (Caffrey, 2003). On the other hand, membrane 
proteins are extremely hard to work with and when present in IBs, especially those less complex 
or with lower size, but that are prone to cause cell death, are many times powerful candidates for 
IBs and successfully refolded to soluble ones (Buchanan, 1999; Caffrey, 2003). Overexpression 
in inclusion bodies became a powerful strategy followed by many lead researchers (Diefenderfer 
et al., 2009). 
Other bacteria like Lactococcus lactis, or yeast cells as Pichia Pastoris and Saccharomices 
cerevisae are being increasingly used for overexpression of MPs. With increased knowledge on 
cell culture techniques, insect and mammalian cell lines also became widely used, especially for 
complex eukaryotic proteins (Junge et al., 2008). It is necessary to adequate the target protein to 
the expression system to use. As an example, mammalian membrane proteins are most 
commonly purified from native sources. The nature of the lipid usually affects the stability of the 
protein and its insertion within the membrane, as different systems have different lipid 
compositions, nature sources are more suitable for isolation of a target protein (Opekarová and 
Tanner, 2003). Also, bacteria are unable to perform post-translational modifications due to the 
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absence of the required enzyme systems, demanding for alternative expressing systems (Junge 
et al., 2008; Mancia and Hendrickson, 2007). However, some mammalian MPs have been 
successfully produced in yeast systems (Binda et al., 2002; Long et al., 2005; Martinez Molina et 
al., 2007), insect cells (Rasmussen et al., 2007) and also E. coli (Bracey et al., 2002; Ferguson et 
al., 2007). 
It is often necessary to explore a variety of expression systems for a single protein target (Bill et 
al., 2011). Another relevant approach is the use of small fraction of a complex protein (by 
genomic truncation, limited proteolysis) and use it in crystallization trials, enhancing the probability 
of structure determination when compared to a multidomain membrane protein. However, 
functional insights so derived must be taken cautiously, as those structures can be misleading to 
some degree. 
 
Detergent-based crystallization of membrane proteins 
Generating stable conditions for membrane proteins after extraction from their lipid bilayer 
environment is essential for subsequent characterization. The use of detergents is required for 
extraction from the cellular membrane and for solubilization in solution. Detergents are widely 
used to obtain this stable environment; however, different types of membrane proteins have been 
found to require detergents with varying properties for optimal extraction efficiency and stability 
after extraction (Caffrey, 2003). Mild detergents are used in handling membrane proteins, 
however, many MPs tend to aggregate or denature when subjected to solubilization by these 
amphiphilic chemicals. Researchers usually test a diverse range of detergents with the purpose of 
increasing extraction while conferring stability to the MP, so that the optimal conditions for 
solubilization of MPs must be found before proceeding to protein purification and crystallization. 
Also, purification of IMPs requires in-depth screening to identify the proper physicochemical 
features that confer stability to the MP of interest. Ionic strength along with suitable blends of 
lipids, detergents and other factors are all involved in supporting the active conformation of IMPs. 
This is particular acute in IMPs from higher eukaryotes, which are often post-translational 
modified.  
Tagging of membrane proteins with GFP facilitates the monitorization of protein expression, but 
also allows the development of a good purification scheme for the target protein (Drew et al., 
2005, 2008, 2001). GFP fluorescence from whole-cell culture and from SDS-polyacrylamide gel 
electrophoresis provides a direct measurement for the quantity of the membrane protein 
integrated at the membrane when overexpressed (Drew et al., 2006). When successfully 
overexpressed, a target protein fused with GFP can be further screened for detergent extraction 
using fluorescence-detection size-exclusion chromatography (FSEC) by accessing 
“monodispersity” of the sample at the crude detergent solubilized extract prior to purification. 




purification, enabling a fast optimization for the condition that render the highest stability (Drew et 
al., 2008; Kawate and Gouaux, 2006). 
As it happens with soluble proteins, membrane proteins used in crystallization must be as pure 
and homogeneous as possible. Different techniques can be used for their assessment, as gel 
electrophoresis, circular dichroism spectroscopy, dynamic light scattering and mass spectrometry. 
The latter, has recently emerged as a very powerful tool routinely used as alternative to the other 
methods, given that, it offers picomole sensitivity, high-mass accuracy, high-throughput capability, 
in a fast and cost effective way easily accessibility at every research institution (Cohen and Chait, 
2001). 
In protein crystallization a large variety of crystallization reagents are tested. The first experiments 
are usually done at 96 well plates making use of robotic instruments. Advances in technology 
allowed successive reduction in the volumes required for initial experiments, with most of the 
robotic equipment performing drops as small as 100 nl. There are several commercial screens 
that were specifically designed for membrane proteins, such as MemStart, MemGold and 
MemSys (Newstead et al., 2008). Moreover, testing the detergent used in the crystallization 
process has proven to be extremely important (Privé, 2007). Vapor-diffusion (Sutton and Sohi, 
1994); micro-batch (Iwata and Chayen NE., 2003; Loll et al., 2003), dialysis (Fromme, 2003), 
counter-diffusion (Ng et al., 2003, 2008) and micro-fluidics (Leng and Salmon, 2009) are methods 
applied to crystallize proteins embedded in detergent micelles (Figure 1.2.2.4). 
 
Figure 1.2.2.4. Schematic diagram of detergent-based crystallization of membrane 
proteins.  
The membrane protein is removed from native cell membrane using detergent micelle. The purified protein is 
then crystallized in detergent micelles. The membrane protein molecule is in orange color, detergent micelle 
are colored red, and the cell membrane is gray (adapted from Bolla et al., 2012). 
 
Crystallization of membrane proteins can also be achieved recurring to lipidic cube or sponge 
phases. Detergent bicelles have also been used instead of the detergent micelles, however those 
will develop a 2D crystal packing type, which may not be the most suitable for achieving a good 
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diffracting crystal and permit structure resolution (Caffrey, 2003, 2011; Caffrey and Cherezov, 
2009). 
 
TAOK2 secondary structure predictions 
First described by Moore and colleagues with the name PSK (Prostate-derived STE20-like kinase 
1), TAOK2 is a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family of 
signaling modules, ubiquitous to eukaryotic cell regulation. TAOK2 selectively activates the JNK-
MAPK pathway through the phosphorylation of MKK4 and MKK7, and it is regulated by a still 
undefined mechanism via its C-terminal domain (Moore et al., 2000). TAOK2 was later shown to 
activate other signaling pathways, i.e. p38 and ERK family members (Chen et al., 1999, 2003). 
Several other studies revealed the involvement of TAOK2 in regulating cytoskeleton dynamics 
during stress-like conditions and demonstrated that TAOK2 co-localizes with microtubules for 
their stabilization in a kinase independent fashion (Chen and Cobb, 2001; Mitsopoulos et al., 
2003). So it is possible that TAOK2 would be responsible for the stability of tubulin, playing a 
major role in the organization of the microtubules network. 
Thousand-and-one-aminoacids kinase 2 isoform 1 (TAOK2α) is a large (1235 aa) integral 
polytopic type II membrane Ser/Thr protein kinase, with a 963 aa-long N-terminal cytosolic portion 
(containing the kinase domain located in the first 320 aa) followed by 4 predicted transmembrane 
helices (Table 1.2.2.1) and a C-terminal domain of uncertain topology (Figure 1.2.2.5a, b).  
 
Table 1.2.2.1. Predicted transmembrane helices (TMs) for humanTAOK2α. 
TMs structure prediction using SOSUI engine ver. 1.11: (http://bp.nuap.nagoya-u.ac.jp/sosui/) (Hirokawa et 
al., 1998) predicted 4 TMs, in accordance to other engines for TMs predictors. 
 
N terminal transmembrane region C terminal 
952 LAGLSFAVGSSSLLGLLPLLLLLLL 974 
985 LQAALLALEVGLVGLGASYLLLC 1007 
1012 LPSSLFLLLAQGTALGAVLGLSW 1034 






Figure 1.2.2.5. Schematic diagram of secondary structure predictions for humanTAOK2.  
(a) Topology of the different domains identifiable at hTAOK2 using SMART (Schultz et al., 1998). (b) 
Transmembrane helices (as in Table 2.2.1) scheme created by SOSUI (Hirokawa et al., 1998). 
Abbreviations: N-ter: N-terminal Domain, C-ter: C-terminal Domain, S/T KD: Serine/Threonine Kinase 
Domain, TMs: Transmembrane Helices.  
 
A typical protein kinase two-domain architecture was revealed by x-ray crystallography when the 
kinase domain structure of hTAOK2 was solved in its phosphorylated active conformation (Figure 
1.2.2.6) (Zhou et al., 2004). In the same paper, the authors evaluate the kinase activity of the 
truncated form of the kinase domain versus the full-length construct and conclude that the full-
length enzyme exhibits a decreased activity, suggesting that TAOK2 self-inhibits/activates by a 
segment located downstream of the kinase domain. Despite all the work in understanding 
TAOK2α signaling pathway, further experiments are necessary to understand the structural roles 
of the noncatalytic domain, which is most likely involved in the functional regulation of TAOK2. 




Figure 1.2.2.6. Crystal structure of the TAOK2 kinase domain. 
Cartoon representation (colored spectra) of the crystal structure of TAOK2 kinase domain (PDB ID 1U5Q) 
showing the interaction between 2 polipetide chains in the asymmetric unit. Structure solved at 2.1 Å 










































1.2.3. Materials and Methods 
 
High-throughput small scale overexpressing tests in Escherichia coli strains – Pcube – 
OPPF platform 
The OPPF platform offered a cloning and expression screening of 48 contructs, where 47 
belonged to the hTAOK2 gene and 1 of GFP alone (control). The procedures are standardized by 
the host laboratory. Briefly, the primers are designed for In-Fusion
TM 
(Clontech Laboratories, Inc.) 
cloning. The vector to use depended on the fusion tag required for the resulting protein construct. 
Polimerase chain reaction (PCR) for clone amplification was done using KOD Xtreme
TM
 Hot Star 
DNA Polymerase (Novagen). The thermal cycling was performed using the following parameters: 
94ºC - 2 minutes; 98ºC – 10 seconds; 60ºC – 30 seconds; 68ºC – 4 minutes (1 min/kbp); repeat 
from step 2 29 times; 68ºC – 2 minutes; 4ºC – hold. If another round of PCR was needed then we 
would use Phusion Flash Mastermix (NEB). 98ºC – 10 seconds; 98ºC – 1 second; 60ºC – 5 
seconds; 72ºC – 1 minute (15 sec/kbp); repeat from step 2 29 times; 72ºC – 2 minutes; 4ºC – 
hold. PCR products were analyzed on a 1.25% TBE agarose gel with 4 μl of Hyperladder I 
(BioLine) as reference. P R products of good quality (i.e. few multiple bands and “smeared” 
products) across the plate were purified using the AMPure XP (Agencourt/Beckman) magnetic-
bead purification step. If a significant number of the PCR products showed multiple bands or were 
smeared,then gel purification and extraction were performed. Cloning to the appropriate and 
previously linearised pOPIN vector was done by In-Fusion reaction, followed by immediate HTP 
transformation into OmniMaxII competentes E. coli cells (Invitrogen) in a 96 deep-well plate 
(Matrix). The transformation reaction was plated onto LB agar supplemented with the appropriate 
antibiotic, X-Gal and IPTG. Two white colonies per construct were selected (blue colonies are 
derived from inefficiently linearised parental plasmid and are non-“recombinant”) and added to 
Deep-well blocks (BD Falcon) containing Power Broth supplemented with antibiotic and cultured 
over-night (37ºC, 220 rpm). A glycerol stock was prepared by transferring 100 μl from each well to 
a microplate MTP (Greiner V-bottom) containing 100 μl/well of filter-sterilized Luria-Bertani Broth 
with 30% v/v glycerol followed by storage at -80ºC. Cells from the remaining culture were 
harvested by centrifugation at 5,000 g for 15 minutes (Beckman JS5.3 rotor). HTP mini plasmid 
preparation using wizard SV96 purification plates was performed in the Bio-Robot 8000 (Qiagen) 
and constructs verified by setting an HTP PCR reaction with KOD Polymerase Master. E. coli 
expression strains B834(DE3) and Rosetta(DE3)pRARELysS (plasmid retained by the addition of 
chloramphenicol to the culture media, 34 μg/mL) were aliquotted in loose tubes racked in 96-well 
(Matrix) format and stored at -80ºC. Both E. coli strains were transformed, by heating-shock the 
cells for 30 seconds at 42ºC and immediately returning to ice for 2 minutes. HTP small scale 
expression screenings were done as following: deep-well blocks (BD Falcon), containing 0.5 mL 
of Power Broth supplemented with 1% glucose and 50 μg/mL of the appropriate antibiotic, were 
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inoculated with the strain/construct to culture a pre-inoculum overnight at 37ºC. IPTG induction 
was done by diluting the overnight culture in 2.5 mL Power Broth, supplement with 1% glucose 
and appropriate antibiotic, and incubated at 37ºC until O.D.(595 nm) reached ≈ 0.5 (3-5 hours). At 
this point the temperature was lowered to 20ºC and IPTG was added to a final concentration of 
0.5 mM, and expression carried overnight (≈18 hours). Auto-induction screening was done by 
diluting 62.5 μl of the pre-inoculum cultured overnight in 2.5 mL of OvernightExpress
TM
Instant TB 
Medium (TBONEX) supplemented with appropriate antibiotic. After 3-5 hours at 37ºC, plates were 
transferred to an incubator at 25ºC and left for 24 hours. Cells were harvested by centrifugation at 
5,000 g and subjected to a Nickel-nitrilotriacetic acid (Ni-NTA) miniature expression screen 
purification using a standard protocol available for the Qiagen BioRobot 8000 by lysing the cells 
and using Ni-NTA magnetic beads to isolate the His-Tagged expressed protein from the 
remaining extract. Insoluble fraction was collected and subjected to an HTP denaturing 
purification protocol using Ni-sepharose and a vacuum manifold as purification system. 
Expression was evaluated by analyzing purified proteins on SDS-PAGE. 
 
Construction of the pOPIN-hTAOK2-GFP-His vector for Expression in E. coli and HEK293T 
cells 
pOPINF was obtained from Oxford Module Consortium (OMC), OPPF, Wellcome Trust Centre for 
Human Genetics, Roosevelt Drive, Headington, Oxford, OX3 7BN. UK. The hTAOK2 sequence 
was amplified from I.M.A.G.E. clone 40148752 (Open Biosystems) with primers TEV-TAOK2_D 
(5’-GAAAACCTGTATTTTCAGTCTCCAGCTGGGGGCCGGGCCGGGAGCC-3’) and TAOK2 
(HindIII)_R (5’-CGTGTCAAGCTTCTACTACCTCCAGGGGGGCAGGGCCCGGG-3’). The 8xHis-
GFP encoding sequence was amplified from pTarget-OpIE2eGFP (Fernandes et al., 2012) with 
primers 8xHis-GFP (EcoRI BspHI)_D (5’-
GGATGAATTCTCATGAACCATGGCACATCACCATCACCATCACCATCACAGATCTGTGAGCA
AGGGCGAGGAGCTG-3’) and TEV-GFP_R (5-
CTGAAAATACAGGTTTTCAGATCTCTTGTACAGCTCGTCCATGCCGAGAGTGATCCCG G-3’). 
All polymerase chain reactions were carried out using Phusion High-Fidelity DNA Polymerase 
(Thermo Scientific). The two products were joined together using the splicing by overlay extension 
(SOE) technique (Horton et al., 1989) and primers 8xHis-GFP (EcoRI BspHI)_D and hTAOK2 
(HindIII)_R. The resulting amplicon was digested with BspHI and HindIII and cloned into 








Plasmid construction for initial Baculovirus expression screening 
Plasmids were constructed by using Phusion High-Fidelity DNA Polymerase (Thermo Scientific) 
for PCR with primers listed in Table 1.2.3.1, and In-Fusion® HD (Clontech) for ligase independent 
cloning (LIC). I.M.A.G.E. clone 40148752 was obtained from Open Biosystems and used as a 
source for hTAOK2 open reading frame (ORF). GFP ORF was amplified from pTarget-
OpIE2eGFP (Fernandes et al., 2012) with either primers setA or setB and G RV.1, to generate N-
terminal His-tag or Twin-Strep-tag® GFP coding DNA respectively by 5’ extension P R. hTAOK2 
ORF was amplified with primers Fw.1 and Rv.1. The resulting tagged GFP variants and TAOK2 
amplimer had overlapping sequences at 3’ and 5’ respectively, each encompassing a TEV site 
coding region. Each GFP amplimer was then cloned along with hTAOK2 by LIC into flashBAC 
pOET1 transfer vector (Oxford Expression Technologies) digested with BamHI and XhoI, 
obtaining pOET-His-GFP-hTAOK2 and pOET-strep-GFP-hTAOK2, respectively. 
 
Table 1.2.3.1. PCR primers list for In-Fusion protocol to obtain the His-GFP-hTAOK2 and 
the strep-GFP-hTAOK2 constructs for Baculovirus expression. 
setA Fw.1 5’-CCATCACCATCACCATCACAGATCTGTGAGCAAGGGCGAGGAGCTGT-3’ 
setA Fw.2 5’-TATAAATATAGGATCCCGCCACCATGGCACATCACCATCACCATCACCATCACAGATC-3 
setB Fw.1 5’-TATAAATATAGGATCCCGCCACCATGTCGGCCTGGAGCCACCCGCAA-3’ 
setB Fw.2 5’-TCGGCCTGGAGCCACCCGCAATTTGAAAAAGGCGGTGGCTCGGG-3’ 
setB Fw.3 5’-TTTGAAAAAGGCGGTGGCTCGGGTGGAGGCTCGGGAGGCTCTGC-3’ 
setB Fw.4 5’-TGGAGGCTCGGGAGGCTCTGCGTGGTCGCATCCGCAATTCGAAAA-3’ 
setB Fw.5 5’- TGGTCGCATCCGCAATTCGAAAAGAGATCTGTGAGCAAGGGCGAGGA-3’ 
G Rv.1 5’-CCAGCAGACTGAAAATACAGGTTTTCAGATCTCTTGTACAGCTCGTCCATGCCGA-3’ 
Pr Fw.1 5’-GAAAACCTGTATTTTCAGTCTGCTGGGGGCCGGGCCGGGA-3’ 
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Cell cultures, generation of recombinant Baculovirus derivatives and infections 
S. frugiperda Sf9 and T. ni HighFive™ (the latter abbreviated Hi5 hereafter) were maintained as 
suspension cultures in Sf-900™ II SFM (Life Technologies) and Insect-XPRESS™ (Lonza) 
culture media, respectively. Cell density and viability were routinely assessed with Trypan Blue 
test. Recombinant Baculoviruses expressing either hGhTAOK2 (His-GFP-hTAOK2) or 
stGhTAOK2 (strep-GFP-hTAOK2) were generated in Sf9 with flashBAC methodology according 
to manufacturer’s guidelines and lipofection with  ellfectin® II. Viral stocks were titrated by GFP 
flow cytometry with CyFlow® space (Partec). For expression tests, both Sf9 and Hi5 cells were 
infected at 2.5x 10
6
 cell/mL with a multiplicity of infection (m.o.i.) of 5. At the indicated time points, 
aliquots of infected cell cultures were sampled for immunoblot analysis. Total protein extracts 
from infected insect cells were prepared at a ratio of 10
7 
total cells/mL in 25 mM Tris-HCl, 0.15 M 
NaCl, 0.5% N-Lauroylsarcosine, 20% Glycerol, 1 mM DTT, 1.25 U/mL Benzonase® (Merck 
Millipore), cOmplete EDTA-free protease inhibitor cocktail (Roche), pH 8.0. Insoluble material was 
sedimented by 13,000 g centrifugation at 4°C for 10 min and the supernatant from 10
5 
cell 
equivalents loaded onto 4-12% Novex® NuPAGE® Bis-Tris pre-cast gel (Life Technologies) 
followed by blotting to nitrocellulose membrane.  
 
Expression in E. coli and protein purification  
pOPINE-His-GFP-hTAOK2 was transformed into E. coli BL21(DE3) (Novagen) or C43(DE3), an 
Escherichia coli mutant host that allows synthesis and over-production of some membrane 
proteins and globular proteins at high levels (Miroux and Walker, 1996). Plates were incubated for 
18 h at 37°C before individual colonies were used to inoculate 10 mL LB medium supplemented 
with 1% w/v glucose and 100 µg/mL ampicilin and shaken at 225 rpm. at 37°C for 18 h. For IPTG 
induction, 500 µl of each overnight culture was used to inoculate in duplicate, 30 mL of LB 
supplemented with 100 µg/mL ampicilin. The diluted cultures were grown at 37°C with shaking at 
225 rpm for 3 h, afterwards the temperature was reduced/set to 20°C, ITPG added to a final 
concentration of 0.5 mM to one of the duplicates and shaked for further 4h at 20°C. Expression of 
His-GFP-hTAOK2 in induced and uninduced cultures was monitored on hourly intervals by 
fluorescence microscopy and fluorimetry. At the end of the induction period, cells were collected 
by centrifugation, ressuspended in 10 mL of 100 mM Tris-HCl pH 8.0, 500 mM NaCl, 15% 
Glycerol, 10 mM MgCl2, 1 mM ATP, containing 1000 KUnits/ml DNAse I (Sigma, Poole Dorset, 
UK) and Complete EDTA-Free Protease inhibitors (Roche), and disrupted by 2-fold passages 
through a One Shot (Constant Cell Disruption Systems, Northants, UK) at 17,000 psi. Whole cell 
extracts were centrifuged at 10,000 g for 10 min, at 4°C (J2-MI, Beckman Coulter, Inc.), and the 
supernatant transferred into Ti70 (Beckman Coulter, Inc.) tubes for further ultracentrifugation at 
100,000x g for 1 h, at 4°C (XL-100, Beckman Coulter, Inc.). Membrane proteins present in the 




mM MgCl2, 1 mM ATP, 1% DDM, pH 8.0 and incubated with gentle stiring at 4ºC for 12 h.  After 
an additional centrifugation at 100,000 g for 30 min at 4°C (Optima
TM
 TLX, Beckman Coulter, 
Inc.), solubilized membrane proteins were applied to Ni-NTA spin columns (Qiagen). Protein 
purification was performed according to the manufacturer's instructions (Ni-NTA spin kit; Qiagen) 
under native conditions (without using denaturating reagents). All solutions included 1% DDM and 
10% glycerol. Proteins purified by elution from the Ni-NTA spin columns were analyzed by SDS-
PAGE and Western blot. 
 
Expression and purification from HEK 293T cells 
HEK293-EBNA cells were routinely maintained in Freestyle medium (InVitrogen) supplemented 
with 1% FBS (InVitrogen). For expression screening, fresh cells were seeded onto a 6-well plate 
at a concentration of 1x10
6
 cells/mL and in a final volume of 1,5 mL. Transfection with pOPIN-
hTAOK2-GFP-His was performed using polyethylenimine (PEI). In brief and per well, 2 µg of 
plasmid DNA and 4 µL of PEI (1 mg/mL) were diluted separately in 250 µL Freestyle medium. The 
PEI/Freestyle mix was added dropwise to the DNA/Freestyle medium while gently shaking. The 
DNA/PEI complex was incubated for 15 min at room-temperature after which it was added to the 
cells. Transfected cells were incubated at 37°C/5% CO2/95% air environment and at an agitation 
of 120 rpm. hTAOK2-GFP-His expression in mammalian cells was monitored by fluorescence 
microscopy, fluorimetry, SDS-PAGE and Western blot. 
Scale-up and purification of hTAOK2-GFP-His from HEK293T cells was carried out as follows. 
Cells were grown in 5 L flasks and transfected with plasmid DNA using PEI, as previously 
described. 48 h post-transfection cells were collected by centrifugation, ressuspended to a final 
concentration 1x10
7
 cells/mL with 25 mM Tris-HCl pH 8.0 and 150 mM NaCl containing 1 Unit/mL 
OmniCleave
TM
 Endonuclease (Epicentre, Germany) and Complete EDTA-Free Protease inhibitors 
(Roche), and disrupted by 2-fold passages through a One Shot (Constant Cell Disruption 
Systems, Northants, UK) at 8,000 psi. Membrane protein was solubilized as previously described 
(solubilization buffer: 100 mM Tris-HCl pH 8.0, 500 mM NaCl, 15% Glycerol, 10 mM MgCl2, 1 mM 
ATP, 1% DDM). hTAOK2-GFP-His was purified on an ÄKTA Xpress instrument (GE Healthcare, 
Uppsala, Sweden) at 4ºC. The solubilized fraction was applied to a HiTrap TALON superflow 
column (GE Healthcare, Uppsala, Sweden), previously equilibrated with binding buffer 
(composition of solubilization buffer, but with 0.1% DDM), at 0.6 mL/min constant flow. The 
column was washed with binding buffer until UV cell reached the baseline. The protein was eluted 
using a gradient of the binding buffer supplemented with 500 mM of imidazole (Sigma-Aldrich). 
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Solubilization screen of hTAOK2 expressed in HEK293T and insect cells  
All manipulations were done at 4ºC. Membranes were resuspended to a final concentration of 4-5 
mg/mL in 20 mM KH2PO4, 500 mM NaCl, 20% glycerol, 0.1 mM DTT, 10 mM MgCl2, 2.5 mM ATP, 
pH 7.6; using a glass tissue homogenizer. The total volume of homogenized membranes was 
divided equally in a black bottom 96 well plate (Greiner). To each well was added a specific 
detergent (supplementary information Table 1). The plate was covered with aluminum foil and left 
overnight under mild shaking. GFP intensity signal was quantified on the total solubilized fraction 
using a FLUOstar OPTIMA microplate reader (BMG labtech). To a sample of 15 μl was added 5 
μl of 4X Laemmli buffer (0.25 M Tris base, 15% SDS, 10% β-mercaptoethanol, 30% glycerol, 
0.02% bromophenol blue, pH 6.8). The mixture was stored at 37ºC for 30 minutes and applied to 
a pre-cast 4-14% acrylamide gel (Biorad) and ran at constant 150 V for 50 minutes.  The 
remaining of the fractions was ultracentrifuged at 100,000 g for 30 minutes (Optima
TM
 TLX, 
Beckman Coulter, Inc.). Supernatant was collected to a 96 well plate and GFP signal was 
quantified. A SDS-PAGE was done as described before but samples were applied to a home-
made 6% polyacrylamide gel. All gels were in bidistilled water for 30 minutes, scanned for 
detection of GFP labeled protein using a 430-nm laser (Fuji TLA-5100) and stained with 
coomassie (Fazekas de St Groth et al., 1963). 
 
Antibodies and Immunoblots 
Total protein extracts from infected insect cells were prepared at a ratio of 10
7 
total cells/mL in 25 
mM Tris-HCl, 0.15 M NaCl, 0.5% N-Lauroylsarcosine, 20% Glycerol, 1 mM DTT, 1.25 U/mL 
Benzonase® (Merck Millipore), complete EDTA-free protease inhibitor cocktail (Roche), pH 8.0. 
Insoluble material was sedimented by 13,000x g centrifugation at 4°C for 10 min and the 
supernatant from 10
5 
cell equivalents loaded onto 4-12% Novex® NuPAGE® Bis-Tris pre-cast gel 
(Life Technologies) followed by blotting to nitrocellulose membrane. Goat polyclonal anti-TAOK2 
(αTAOK2) and mouse monoclonal anti-GFP (αGFP) clone GFP-20 antibodies (from Santa Cruz 
Biotechnology and Sigma-Aldrich, respectively) were used to assess expression levels and ECL 
signal recorded by ChemiDoc XRS+ (Bio-Rad). 
 
Fluorescence microscopy 
Insect cells infected in suspension were briefly left to adhere in 6 multiwell plates and observed 






1.2.4. Results and Discussion 
 
Expression tests of 47 hTAOK2 constructs 
To facilitate a high-throughput screening, of a multiple number of constructs from the human gene 
encoding for the TAOK2 protein, we had access though the Protein Production Platform (P
3
) to 
the Oxford Protein Production Facility (OPPF-UK) located in the Research Complex at Harwell. 
Primers were designed by Dr. Louise Bird (OPPF-UK) for insertion into the pOPIN vector by In-
Fusion
TM
 cloning (Figure 1.2.4.1). A variety of pOPIN derived vectors had been constructed in 
order to test protein expression in multiple tags (6xHis; Maltose Binding Protein, MBP; Small 
Ubiquitin-like Modifier, SUMO; and Green Fluorescent Protein, GFP) and using different 
segments of the hTaok2 gene (Table 1.1.4.1). The majority of the pOPIN vectors allow the 
expression of proteins within multiple hosts, i.e. a single vector is capable of expression in E. coli, 
mammalian cell lines (e.g. HEK293T cells) and insect cells (e.g. Sf9 cells) enabling to screen for 
target expression in multiple hosts in parallel. 
SUMO, MBP and GFP are widely used for the overexpression of eukaryotic proteins with 
increasing success (Arnau et al., 2006; Kiedzierska et al., 2008). However, GFP is mostly used to 
evaluate solubilization conditions of the expressed membrane protein, as it facilitates the 
application of a simpler technique, FSEC, to establish the target solubilization and stability in 
different detergents. As it happens with most affinity tags, GFP, MBP and SUMO may hinder the 
crystallization process. To overcome that problem a 3C cleavage site for the protease activity is 
available. 
From each construct 2 clones were selected and a PCR reaction was done to evaluate the 
insertion of the correct DNA insert size on an agarose gel. Due to time constraints in this platform 
(2 week experimental trials at OPPF-UK), it was not possible to wait for results concerning the 
sequencing of the different constructs (confirmed latter on). For the same reason, the platform 
was only considered for overexpression trials in Escherichia coli. A clone of each construct was 
selected for overexpression trials in E. coli Rosetta and E. coli B834, under induction with IPTG or 
auto-induction. Together with the 47 constructs, a control vector containing only GFP (target H06, 
Table 1.1.4.1) was used in parallel with the expression of our target protein. 
 
 





Figure 1.2.4.1. pOPIN vector used at the OPPF laboratory for high-throughput screening of 
hTAOK2 in Escherichia coli strains. 
OPPF based constructs (a) pTriEx based vector pOPIN designed to overexpress genes of interest at 








After a small scale overexpression test, affinity chromatography was performed on the soluble 
fraction and the overexpression was evaluated through presence/absence of bands on SDS-
PAGE (see Appendix A1). Purification from the inclusion bodies was also evaluated. Table 1.2.4.1 
shows the detailed information of the different constructs and the observed results concerning the 
overexpression and purification of the different 47 constructs of hTAOK2. In green are the 
constructs showing a band in the SDS-PAGE gel, at the expected molecular weight (MW) size, in 
soluble (S) or insoluble (I) fractions. 
Most of the constructs were overexpressed only in inclusion bodies at the E. coli Rosetta strain 
when using the auto-induction protocol. Also, most of the expressed constructs were the ones 
without the transmembrane helices domain, and those concerning the constructs with fusion tags 
of MBP and SUMO (which may help stabilizing the protein). hTAOK2, as referred earlier in the 
introduction, is a large eukaryotic protein, with 135 kDa. The high molecular weight of the protein, 
together with its complexity, is likely to have a negative effect on its stability, hindering the 
expressing capacity of the E. coli machinery to properly fold and insert in the membrane such a 
complex protein. Also, it was visible, during the expression tests, a low optical density of the 
bacterial culture, even at pre-induction, present at some of the constructs. The observed results 
lead to the conclusion that the target protein seems to exert a toxic effect when expressed, 
provoking death to the bacterial host. Even when there is expression (observed in the SDS-PAGE 
gels) no construct provides a good expressing yield. For structural studies, a reasonable yield is 
obtained when a liter of culture renders ≥ 1 mg of protein target, which appears at the SDS-PAGE 
gel as a thick band upon coomassie staining. Accordingly to the expression results of the 
constructs presented above, the yields obtained should not have been higher than 0.1 mg per liter 
of culture. 
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Abbreviations: aa-N: aminoacid at N-terminal, aa-C: aminoacid at C-terminal, MW: molecular weight, isrt: insert, KDa: 
kiloDalton, pI: isolectric point, ε: molar extinction coefficient, S: protein expressed in soluble fraction, I: protein expressed 
in insoluble fraction. 
  
Well aa_N aa_C Vector MW isrt 
(KDa) 
pI ɛ MW TAG 
(KDa) 
Final MW S I 
A01 2 1235 pOPINE3CeGFP 138 6,88 1,080 27 165 
  
B01 321 1235 pOPINE3CeGFP 101 6,84 1,031 27 128 
  
C01 370 1235 pOPINE3CeGFP 96 8,42 1,062 27 123 
  
D01 460 1235 pOPINE3CeGFP 86 9,78 1,140 27 114 
  
E01 590 1235 pOPINE3CeGFP 71 9,55 1,339 27 98 
  
F01 2 900 F (N-HIS-3C) 102 5,58 0,833 2 104 
  
G01 321 900 F (N-HIS-3C) 66 5,25 0,623 2 68 
  
H01 370 900 F (N-HIS-3C) 61 5,41 0,646 2 63 
  
A02 460 900 F (N-HIS-3C) 51 7,32 0,690 2 53 
  
B02 595 900 F (N-HIS-3C) 35 5,32 0,917 2 37 
  
C02 2 750 F (N-HIS-3C) 86 6,42 0,735 2 88 
  
D02 321 750 F (N-HIS-3C) 50 6,19 0,384 2 52 
  
E02 370 750 F (N-HIS-3C) 44 7,23 0,394 2 47 
  
F02 460 750 F (N-HIS-3C) 34 10,05 0,379 2 37 
  
G02 590 750 F (N-HIS-3C) 19 9,87 0,515 2 21 
  
H02 2 370 F (N-HIS-3C) 41 5,94 1,103 2 43 
  
A03 2 460 F (N-HIS-3C) 51 4,99 0,975 2 53 
  
B03 2 590 F (N-HIS-3C) 66 5,73 0,796 2 68 
  
C03 321 370 F (N-HIS-3C) 5 4,26 0,289 2 7 
  
D03 321 595 F (N-HIS-3C) 31 5,25 0,288 2 33 
  
E03 370 595 F (N-HIS-3C) 26 5,51 0,285 2 28 
  
F03 2 900 S3C(N-HIS-SUMO3C) 102 5,58 0,833 13 115 
  
G03 321 900 S3C(N-HIS-SUMO3C) 66 5,25 0,623 13 79 
  
H03 370 900 S3C(N-HIS-SUMO3C) 61 5,41 0,646 13 74 
  
A04 460 900 S3C(N-HIS-SUMO3C) 51 7,32 0,690 13 64 
  
B04 595 900 S3C(N-HIS-SUMO3C) 35 5,32 0,917 13 48 
  
C04 2 750 S3C(N-HIS-SUMO3C) 86 6,42 0,735 13 99 
  
D04 321 750 S3C(N-HIS-SUMO3C) 50 6,19 0,384 13 63 
  
E04 370 750 S3C(N-HIS-SUMO3C) 45 7,23 0,394 13 58 
  
F04 460 750 S3C(N-HIS-SUMO3C) 35 10,05 0,379 13 48 
  
G04 595 750 S3C(N-HIS-SUMO3C) 19 9,87 0,515 13 32 
  
H04 2 370 S3C(N-HIS-SUMO3C) 41 5,94 1,103 13 54 
  
A05 2 460 S3C(N-HIS-SUMO3C) 51 4,99 0,975 13 64 
  
B05 2 595 S3C(N-HIS-SUMO3C) 67 5,78 0,789 13 80 
  
C05 321 370 S3C(N-HIS-SUMO3C) 5 4,26 0,289 13 18 
  
D05 321 595 S3C(N-HIS-SUMO3C) 31 5,25 0,288 13 44 
  
E05 370 595 S3C(N-HIS-SUMO3C) 26 5,51 0,285 13 39 
  
F05 2 750 M(N-HIS-MBP) 86 6,42 0,735 43 129 
  
G05 321 750 M(N-HIS-MBP) 50 6,19 0,384 43 93 
  
H05 370 750 M(N-HIS-MBP) 45 7,23 0,394 43 88 
  
A06 460 750 M(N-HIS-MBP) 35 10,05 0,379 43 78 
  
B06 595 750 M(N-HIS-MBP) 18 9,81 0,539 43 62 
  
C06 2 370 M(N-HIS-MBP) 41 5,94 1,103 43 85 
  
D06 2 460 M(N-HIS-MBP) 51 4,99 0,975 43 95 
  
E06 2 595 M(N-HIS-MBP) 67 5,78 0,789 43 110 
  
F06 321 370 M(N-HIS-MBP) 5 4,26 0,289 43 48 
  
G06 321 595 M(N-HIS-MBP) 31 5,25 0,288 43 74 
  
H06 - - GFP positive control 27 






In-house expression tests with OPPF constructs 
Despite the low expression yields observed for the high-throughput expression tests executed in 
OPPF-UK, some of the constructs were further experimented under different conditions and 
expression hosts, taking advantage of the multiple host system of the pOPIN vectors.  
The first approach was to try the constructs with GFP in the mammalian HEK293T cells system 

















Figure 1.2.4.2. OPPF constructs of hTAOK2-GFP tested in HEK293T cells.  
Four of the constructs done at OPPF were selected for overexpression experiments using the mammalian 
system HEK293T cells. The constructs were specifically selected because all contained GFP and the TMs. 
In the left panel there is a schematic representation of the constructs. On the right panels a fluorescent 
microscopical photograph of the cellular culture after transfection. (a) Full-length hTAOK2-GFP (OPPF A1), 
(b) aa 321-1235-hTAOK2-GFP (OPPF B1), (c) aa 370-1235-hTAOK2-GFP (OPPF C1), (d) aa 460-1235-
hTAOK2-GFP (OPPF D1), (e) negative control.  
 
To detect GFP, on the different constructs, after overexpression in HEK293T cells (Figure 
1.2.4.2), a picture was taken at a fluorescence microscope. A positive indication that hTAOK2 is 
being overexpressed is the presence of a fluorescence peak in the area determined as the 
membrane, which was only observed for the A01 construct (representing the full-length protein) 
(Figure 1.2.4.2a). The A01 construct was then tested in E. coli strains BL21, C43 and Rosetta 
(Figure 1.2.4.3) with C43 strain showing the best results for this construct. C43 is a strain 
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specifically designed for the overexpression of membrane proteins, with specific properties to 
diminish the toxic effects of the incorporation of proteins in the bacterial membrane. 
 
Figure 1.2.4.3. OPPF construct, full length hTAOK2-GFP, tested in different 
Escherichia coli strains. 
 
Overexpression tests were done with other constructs. However, A01 and F02 were the only 
expressed in higher yields (see Appendix A2) and selected for small scale purification 
experiments (Figure 1.2.4.4). Urea was used during purification in order to maintain a 
denaturating environment, and so overcoming the need of solubilizing membranes with 
detergents, and assuring no occlusion of the tag by embedment with the lipid/detergent layer or 
due to aggregation of the target protein. 
 
Figure 1.2.4.4. Small scale expression and purification of hTAOK2 constructs. 
Different constructs were expressed in different conditions and purified by using a Ni-NTA Qiagen spin 
column under denaturating conditions (8 M Ureia). Loading and elution fractions were probed by 
immunohistochemistry with specific antibodies (left, anti-His tag; right, anti-GFP) for evaluation. Letter code, 
top: A, E. coli C43 construct A01; B, E. coli Rosetta construct A01; C, E. coli Rosetta construct A01; D, E. 
coli Rosetta construct F02; E, HEK293T cells construct A01; F, HEK293T cells construct F02; Ec, expression 





Testing in-house full-length constructs of hTAOK2 
The pOPIN expressing vector has already been validated for high-throughput screening of soluble 
proteins, using different expression hosts, besides Escherichia coli (Bird, 2011). For further 
testing the expression of full-length hTAOK2 in different host systems (mammalian cells, insect 
cells and bacteria), with various C- and N-terminal tagging, together with the possibility of 
monitorization by GFP fluorescence, primers were designed and three constructs were prepared 
(Figure 1.2.4.5) for in-house hTAOK2 overexpression, as described. 
 
Figure 1.2.4.5. Schematic diagram of full-length constructs designed in house.  
Three constructs were designed, two having tag (histidine tail or strep) together with GFP upstream of 
hTAOK2, Hist-GFP-hTAOK2 and strep-GFP-hTAOK2, respectively; and one construct with C-terminal tag 
(histidine tail) together with GFP downstream of hTAOK2, hTAOK2-GFP-His. 
 
The three different constructs were tested in HEK293T cells. At different time points (48, 72 and 
96 hours post induction), the GFP signal was observed under the fluorescent microscope. At mid-
time point (48 hours) it was possible to observe differences in overexpression of the different 
constructs (Figure 1.2.4.6). While the strep-GFP-hTAOK2 constructs showed less green 
fluorescence than the constructs with histidine tags, the GFP seemed to colocalize with the 
membrane. However, the C-terminal His-GFP tagged construct showed that the overexpressed 
protein was not correctly inserted in the membrane. The best construct, showing membrane 
colocalization and substancial GFP signal, was the His-GFP-hTAOK2. 
The overexpression of hTAOK2 was evaluated by Western blot using the αTAOK2 antibody 
(Figure 1.2.4.7).  
 




Figure 1.2.4.6. HEK293T cells 48 hours after transfection with the different constructs.  
 
 
Figure 1.2.4.7. His-GFP-hTAOK2 overexpression evaluated by western blot.  
Anti-TAOK2 antibody was used to probe the membrane. (-) control expression vector, #1, cells collected at 
48 h post-transfection; #2, cells collected at 72 h post-transfection; #3, cells collected at 96 h post-
transfection. 
 
The Western blot shows a specific band at ≈150 kDa, stronger at 48 hours post-transfection. 
However, the strongest band exists at ≈ 120 kDa, 48 hours post-transfection, and gets weaker 
over the time of expression. There is also a very strong band at ≈ 45 kDa, present in all samples 
that could result from: recognition of an unspecific protein by the antibody; a proteolysis product 
resulting from cleaved TAOK2 polypeptide; or as a result of the endogenous expression of the 





Figure 1.2.4.8. E. coli strains 48 hours after transfection with the different constructs.  
This figure shows BL21(DE3) (lower panels) and C43(DE3) (upper panels) E. coli strains 
transfected with His-GFP-TAOK2 without induction (left) or after 48 hours of induction (right).  
 
Figure 1.2.4.9. Western blot of BL21(DE3) and C43(DE3) probed for αTAOK2 polyclonal 
antibody. 
Cells were transformed with the His-GFP-hTAOK2. Western blot with samples from non-induced (n.i.) 
BL21(DE3) cells or C43(DE3) cells (2 and 4 hours p.i.) and with induced cells (ind.). Arrowhead indicates 
expected molecular weight of protein construct.  
 
The overexpression of His-GFP-hTAOK2 in the E. coli strains BL21(DE3) and C43(DE3) shows a 
specific overexpression in BL21(DE3) but none at the C43(DE3) strains (Figure 1.2.4.8). 
However, His-GFP-hTAOK2 does not localize to the cell membranes of E. coli cells and 
expression renders a protein with lower molecular weight, as observed by the Western blot 
probed with the anti-TAOK2 antibody (Figure 1.2.4.9, arrowhead). Only a very faint band with a 
high molecular weight, possibly the band of interest, was visible at ≈160 kDa (Figure 1.2.4.9). 
Moreover, it a highly degradation smear was visible at the induced BL21(DE3) with a large 
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accumulation of a product below 100 kDa at 2 hours post-induction (p.i.), most likely resulting 
from specific cleavage of hTAOK2 or due to extensive degradation by the bacterial proteolytic 
machinery.  
Based on these results, an expression trial of His-GFP-hTAOK2 was performed in HEK293T 
cells, followed by a bench-top purification protocol using Ni-NTA spin columns. The cells were 
harvested and lysed chemically with Bugbuster, and solubilization done at pH 8.0 with 1% DDM. 
After applying the sample to the spin column, protein was eluted with a buffer containing an 
excess of imidazole (500 mM). Western-blot analysis on the fractions after purification revealed a 
specific band for hTAOK2 at ≈ 150 kDa (Figure 1.2.4.10a, arrowhead).  
The total yield of each downstream step towards purification was calculated based on the GFP 
fluorescence, with a calibration curve measured at the time (Figure 1.2.4.10b) and using the 
following equation: 
 
               
                   
               
                        . 
 
According to this equation, hTAOK2 purification had a recovery yield of around 26% (compared to 
the initial amount of overexpressed membrane protein) revealing a high lost of protein during the 
process (Figure 1.2.4.10c). However, due to the presence of diverse proteins in solution, besides 



















(per step, %)  
Membranes  
(40 mL)  
624  32.2  152.9  6.2  -  
Extraction  
(40 mL)  
256  23.8  113.2  4.3  69  
Purification  
(10 mL)  
203  22.6  107.5  1.1  26  
 
Figure 1.2.4.10. Affinity chromatography (Ni-NTA) for hTAOK2 overexpressed in HEK293T 
cells. 
(a) Western blot of the samples from the purification trial: (-), lysed sample of HEK293T cells without 
expression of our construct; L, sample loaded in the column; FT, flow-through of loaded sample; E, eluted. 
(b) Calibration curve of GFP fluorescent signal used at the fluorimeter at the same time point of our 
purification samples, in order to establish a concentration of tagged hTAOK2 during purification. (c) Table 
demonstrating the final concentration at each step (membrane preparation, protein extraction and 
purification) and the recovery yield of the downstream process of overexpressed hTAOK2. 
 
A time-course expression screening of His-GFP-hTAOK2 in Baculovirus-infected insect cell lines 
showed the substantial accumulation at mid-late time points of a ~70-75 kDa fragment and -to a 
lower extent of a ~120 kDa polypeptide (Figure 1.2.4.11a).  
 
c 




Figure 1.2.4.11. Time-course expression screening of His-GFP-hTAOK2 and strep-GFP-
hTAOK2 in Baculovirus-infected insect cell lines  
(a) Sf9 and Hi5 cells were infected and processed as stated in Material and Methods with His-GFP-hTAOK2 
(hGhTAO2) expressing recombinant Baculovirus and harvested at the indicated hours post-infection (h.p.i.); 
(b) Hi5 cells infected with strep-GFP-hTAOK2 (stGhTAOK2) expressing Baculovirus were collected at the 
indicated h.p.i.; hGhTAO2: Hi5 cells expressing hGhTAO2 96 h.p.i.; neg cnt: negative control was by cells 
infected with a recombinant Baculovirus expressing an unrelated protein. Both immunoblots were probed 
with α-TAOK2 polyclonal antibody. 
 
 
The major product is then reminiscent of the caspase-dependent p70 hTAOK2 fragment 
previously reported (Zihni et al., 2007). The full length chimeric protein, with an expected 
molecular weight of 168 kDa, remained undetectable. However, it was observed a time-
dependent increase in the size of TAOK2 fragments: a 55 kDa fragment transiently visible early 
after Baculovirus infection. The latter behaviour is reminiscent of a progressively inhibited site-
specific cleavage rather than a merely unspecific protein degradation (which is nevertheless 
present). Indeed, this up-shifting in the molecular weight occured earlier in Hi5 cells. His-GFP-
hTAOK2 expression appeared stronger earlier in the cells, so it is temptative to speculate that the 
75 kDa major fragment acts as an inhibitor of the 55 kDa form-releasing cleavage. On the other 
hand, using Strep-tag in place of the polyHis repeat resulted in very low expression (Figure 
1.2.4.11b), showing this tag negatively affects the bioynthesis/accumulation of this chimeric 
protein. The expression resulted in a ladder of polypetides between 120 and 75 kDa. The 
difference in the expression levels between the two tagged variants was visible also at cellular 







Figure 1.2.4.12. Hi5 cell cultures were infected with the indicated recombinant 
Baculoviruses. 
At 72 h.p.i., each seeded into a well of a six multiwell plate for 30 min and the GFP fluorescence recorded 
supravitally under an inverted UV microscope. 
 
Yet and independently of the affinity tag present, only few cells displayed an intracellular dotted 
pattern, anyway not suggestive of the described microtubule association via cytosolic vesicles 
(Mitsopoulos et al., 2003). Indeed, the most positive cells were characterized by a total cell GFP 
localization. Moreover, neither the stable 75 kDa nor the 120 kDa form detected in immunoblots 
with the -TAOK2 polyclonal antibody in His-GFP-hTAOK2-expressing cells turned-out to contain 
the N-terminal recombinant HisGFP tag. When tested in IMAC, both hTAOK2 fragments were 
found to bind, though not tightly, the Ni-NTA resin independently of the polyHis-GFP (Figure 
1.2.4.13). However, it was hardly detected a 38 kDa band, corresponding to the polyHis-GFP, in 
the eluted fractions by a -GFP monoclonal antibody (MAb) upon digital intensification of the 
chemo-luminescent signal. The very low abundance of the His-GFP containing polypeptide found 
in the solubilized extracts suggested that the majority of GFP fluorescence observed at cellular 
level in infected insect cells was due to an insoluble His-GFP-hTAOK2 N-terminal portion 
comprising only the first - probably misfolded - 70-75 residues of TAOK2. The His-tag 
independent binding of the 75 and 120 kDa TAOK2 fragments was likely mediated by the polyGlu 
stretches present in this protein (aa 378-392 and aa 900-907 present in the wt hTAOK2 
sequence). As a consequence, the larger 120 kDa accounts for almost the complete sequence of 
unfused TAOK2.  
 
 




Figure 1.2.4.13. Microscale Ni-NTA from Hi5 cells infected with His-GFP-hTAOK2 
expressing recombinant Baculovirus. 
At 72 h.p.i. cells were harvested, extracted with 1% Triton and the extract clarified at 13000x g for 10 min at 
4°C; the supernatant was then loaded onto Ni
+2
-NTA spin columns from Quiagen and the affinity 
chromatography was performed according to the manifacturer’s guidelines; L: loaded clarified extract; F.T.: 
column flow through; E1 - E2: two subsequent elutions performed with 500 mM imidazole; negative control 
was as in Figure 1. Aliquots from each sample were probed in immunoblot with either α-TAOK2 polyclonal 
(a) or α-GFP monoclonal antibody (b). 
 
Actually, the polyclonal antibody -TAOK2 used in this study recognizes several endogenous 
TAOK2 forms. In extracts from human neuron-like teratoma cells and total newborn rat brain 
(Figure 1.2.4.14), two 120 and 40 kDa most prominent bands and 90-95 and 55 kDa less 
abundant forms are present. It is then unlikely that the tendency to proteolytic cleavage displayed 
by this membrane-bound kinase is just the result of recombinant overexpression. Thus, the multi-
platform approach reported here allowed uncovering a complex and possibly dynamic cleavage 
pattern of stable shorter fragments from hTAOK2. Further effort is warranted to map the observed 
cleavage sites, their possible role in regulating hTAOK2 cellular activities and the interplay with 






Figure 1.2.4.14. Immunoblot with α-TAOK2 polyclonal antibody. 
Protein extracts from 10
5
 proliferating (P NT2) or non proliferating (NP NT2) NTera2 cells, and from total 7 
days old rat brain. 
 
High-throughput solubilization tests 
After expressing the full-length hTAOK2 protein in HEK293T cells and Hi5 insect cells, we 
proceeded with our experiments of solubilization and purification of hTAOK2 in higher quantities. 
The first approach consisted on overexpressing His-GFP-hTAOK2 in HEK293T cells and test 
different detergents for solubilization (Figure 1.2.4.15). Detergents were chosen based on their 
successfully use for the solubilization of eukaryotic membrane proteins. SDS being a potent 
denaturating reagent was used as a control. This way, it would be possible to understand if 
hTAOK2 is aggregated or, in contrary, is not even being extracted from the membrane. The 
results show that the protein is not solubilized (no band at soluble fraction), with exception for the 
sample extracted with SDS (Figure 1.2.4.15, left). When looking to the insoluble fraction (1.2.4.15, 
right) several fluorescent bands at ≈ 150 kDa are visible, leading us to conclude that extraction of 












Figure 1.2.4.15. Initial solubilization tests performed on overexpressed His-GFP-hTAOK2 in 
HEK293T cells. 
In-gel fluorescence. After overexpression of His-GFP-hTAOK2 at HEK293 cells, membranes were isolated 
and split in 8 parts, solubilization of the target was done overnight at 4ºC using 8 different detergents: 1, 2% 
DDM; 2, 2% Triton X-100; 3, 2% CYMAL-5; 4, 2% LDAO; 5, 2% SDS; 6, 9 mM CHAPS; 7, 142.5 mM 
Foscholine-8; 8, 1.2% ANAPOE-C13H8. After solubilization, the soluble fraction was separated from the 
insoluble fraction, ran on SDS-PAGE and scanned through a laser to detect GFP fluorescence. 
 
To test for this hypothesis, the extraction of hTAOK2 overexpressed using the two different tags– 
His and Strep – under a high variety of detergents was performed. 
Cultures from Baculovirus induced cells with the strep-GFP-hTAOK2 were used for a second trial 
with a 96 detergent screen (Table 1.2.4.2) for solubilization of the full-length construct from 
TAOK2. Cells were homogeneized and resuspended (in an appropriate buffer as described 
previously), distributed in a 96 well plate (Table 1.2.4.2) with a black-bottom (to allow detection of 
the GFP signal intensity) and measured at the fluorimeter for the total amount of protein and for 
the solubilized protein. Samples from insoluble and soluble fraction were subjected to SDS-PAGE 
and the GFP signal detected in a scanner (Appendix A3). The three best conditions identified on 
the SDS-PAGE (intensity of band in the gel) were selected for analysis on Western blot in order to 






Table 1.2.4.2. Detailed information of the 96 detergent screen. 
 
Abbreviations: W, well position of the 96 conditions of detergents; Type, type of detergent (I) ionic, (N) non-ionic, (Z) 
zwitterionic, (L) lipid; Detergent, classification of the detergent same as for the Anatrace Detergent and Lipids 
(http://www.affymetrix.com); CMC, Critical micelar detergent concentration as in the Anatrace Detergent and Lipids; [], 
final concentration of the detergent in the screen (CMC or % W/V as in the Avanti® Polar Lipids, Inc). SDS – Sodium 
Dodecyl Sulphate, Pluronic F-68 - Polyoxyethylene-Polyoxypropylene Block Copolymer, ANAPOE-35 - a-Dodecyl-w-
hydroxy-poly(oxy-1,2-ethanediyl), ANAPOE-58 - a-Hexadecyl-w-hydroxy-poly(oxy-1,2-ethanediyl), ANAPOE-X-114 - α-
[(1,1,3,3-Tetramethylbutyl)phenyl]-w-Hydroxy-Poly(Oxy-1,2-Ethanediyl), ANAPOE-X-305 - α-[4-(1,1,3,3-
Tetramethylbutyl)phenyl]-w-Hydroxy-Poly(Oxy-1,2-Ethanediyl), ANAPOE-X-405 - α-[4-(1,1,3,3-Tetramethyl-Butyl)Phenyl]-
w-Hydroxy-Poly(Oxy-1,2-Ethanediyl), ANAPOE-20 - Polyoxyethylene(20)sorbitan Monolaurate, ANAPOE-80 - (Z)-Sorbitan 
Mono-9-octadecanoate, ANAPOE-C10E6 - Polyoxyethylene(6)decyl Ether, ANAPOE-C10E9 - Polyoxyethylene(9)decyl 
Ether, ANAPOE-C12E10 - Polyoxyethylene(10)dodecyl Ether, ANAPOE-C13E8 - Polyoxyethylene(8)tridecyl Ether, IPTG - 
Isopropyl β-D-thiogalactoside, HEGA-10 - Decanoyl-N-Hydroxyethylglucamide, C8E5 – Octylpentaglycol, CHAPS - 3-[(3-
Cholamidopropyl)-Dimethylammonio]-1-Propane Sulfonate/N,N-Dimethyl-3-Sulfo-N-[3-[[3α,5β,7α,12α)-3,7,12-Trihydroxy-
24-Oxocholan-24-yl]Amino]propyl]-1-Propanaminium Hydroxide, CHAPSO - 3-[(3-Cholamidopropyl)dimethylammonio]-2-
Hydroxy-1-Propanesulfonate, C-HEGA-9 - Cyclohexylpropanoyl-N-Hydroxyethylglucamide, C-HEGA-11 - Undecanoyl-N-
Hydroxyethylglucamide, HEGA-9 - Nonanoyl-N-Hydroxyethylglucamide, C-HEGA-9 - Cyclohexylpropanoyl-N-
Hydroxyethylglucamide, HEGA-8 - Octanoyl-N-Hydroxyethylglucamide, C-HEGA-8 - Cyclohexylethanoyl-N-
Hydroxyethylglucamide, Nonidet P 40 - octyl phenoxypolyethoxylethanol, BAM – Benzyldimethyldodecylammonium 
bromide, Thesit – ANAPOE-C12E9 [Polyoxyethylene(9)dodecyl Ether], SWITTERGENT 3-14 - n-Tetradecyl-N,N-dimethyl-
3-ammonio-1-propanesulfonate, FOS-Choline-12 - n-Dodecylphosphocholine, DDMAB -  N-Dodecyl-N,N-
(dimethylammonio)butyrate, CYMAL-4 - 4-Cyclohexyl-1-Butyl-β-D-Maltoside, Fos-choline-10 - n-Decylphosphocholine, 
Fos-choline-9 - n-Nonylphosphocholine, MEGA-9 - Nonanoyl-N-Methylglucamide, CYMAL-2 - 2-Cyclohexyl-1-Ethyl-β-D-
Maltoside, ZWITTERGENT 3-08 - 3-(N,N-Dimethyloctylammonio)propanesulfonate inner salt, CYMAL-1 - Cyclohexyl-
Methyl-β-D-Maltoside, SWITTERGENT 3-16 - 3-(N,N-Dimethylpalmitylammonio)propanesulfonate, ANAPOE-C12E9 - α-
W Type Detergent CMC [] W Type Detergent CMC [] 
A1 I SDS 8.27 1% E1 N CYMAL-2 120 1 CMC 
A2 N Triton X-100 0.9 1% E2 Z ZWITTERGENT 3-08 330 1 CMC 
A3 N Pluronic F-68 17.9 1% E3 N CYMAL-1 340 1 CMC 
A4 N ANAPOE-35 0.091 1% E4 Z ZWITTERGENT 3-16 0.06 1 CMC 
A5 N 
2,6-dimethyl-4-heptyl-β-D-
maltopyranoside 27.5 1 CMC E5 N C12E9 0.08 1 CMC 
A6 N ANAPOE-58 0.004 1% E6 N C12E8 0.11 1 CMC 
A7 N ANAPOE-X-114 0.2 1% E7 L Dodecyl-ββ-D-Glucoside 0.13 1 CMC 
A8 N ANAPOE-X-305 N/A 1% E8 Z SWITTERGENT 3-14 0.4 1 CMC 
A9 N ANAPOE-X-405 0.81 1% E9 N MEGA-10 7 1 CMC 
A10 N ANAPOE-20 0.059 1% E10 N C8E4 7 1 CMC 
A11 N ANAPOE-80 0.012 1% E11 N C10E5 0.81 1 CMC 
A12 N ANAPOE-C10E6 0.9 1% E12 N DDAO 10.4 1 CMC 
B1 N ANAPOE-C10E9 1.3 1% F1 N Octyl-β-D-Glucoside 25 1 CMC 
B2 N ANAPOE-C12E10 0.2 1% F2 N MEGA-8 79 1 CMC 
B3 N ANAPOE-C13E8 0.1 1% F3 Z SWITTERGENT 3-8 330 1 CMC 
B4 N IPTG N/A 1% F4 I Na-cholate 0.5 0,01 
B5 Z n-dodecyl-N,N-dimethylglycine 1.5 1 CMC F5 L 
1,2-dioctanoyl-sn-glycero-3-
phosphocholine 0.27 1% 
B6 N HEGA-10 7 1 CMC F6 N Cymal-5 2.4-5 1% 
B7 N C8E5 (Octylpentaglycol) 7.1 1 CMC F7 L 
DMPC (1,2-dimyristoyl-sn-glycero-3-
phosphocholine) 0.006 1% 
B8 Z CHAPS 8 1 CMC F8 N 
DDM (n-dodecyl-β-D-
maltopyranoside) 0.17 1% 
B9 Z CHAPSO 8 1 CMC F9 N LDAO 1-2 1% 
B10 N C-HEGA-11 11.5 1 CMC F10 N n-octyl-β-D-thioglucoside 9 1% 
B11 N HEGA-9 39 1 CMC F11 N DM (n-decyl-β-D-maltoside) 1.8 1% 
B12 N C-HEGA-9 108 1 CMC F12 N NG (n-nonyl-β-D-glucoside) 6.5 1% 
C1 N HEGA-8 109 1 CMC G1 L 
1,2-diheptanoyl-sn-glycero-3-
phosphocholine 1.4 1% 
C2 N C-HEGA-8 277 1% G2 N n-nonyl-β-D-thioglucoside 2.9 1% 
C3 N Nonidet P-40 0.17 1% G3 N n-decyl-β-D-glucoside 2.2 1% 
C4 I BAM N/A 1% G4 Z Fos-choline-14 0.12 1% 
C5 N n-hexadecyl-β-D-maltoside 0.0006 1 CMC G5 Z Fos-choline-16 0.013 1% 
C6 N n-tetradecyl-β-D-maltoside 0.01 1 CMC G6 N n-heptyl-β-D-thioglucoside 29 1% 
C7 N n-tridecyl-β-D-maltoside 0.033 1 CMC G7 N n-decyl-β-D-thioglucoside 0.9 1% 
C8 N Thesit 0.09 1 CMC G8 N Cymal-3 34.5 1% 
C9 Z SWITTERGENT 3-14 0.4 1 CMC G9 N CYGLU-3 28 1% 
C10 N n-undecyl-β-D-maltoside 0.59 1 CMC G10 N n-hexyl-β-D-glucoside 250 1% 
C11 N n-decyl-β-D-thiomaltoside 0.9 1 CMC G11 N n-heptyl-β-D-glucoside 70 1% 
C12 Z FOS-Choline-12 1.5 1 CMC G12 N n-decyl-N,N-dimethylglycine 19 1% 
D1 N n-decanoylsucrose 2.5 1 CMC H1 N n-hexyl-β-D-maltoside 210 1% 
D2 N 1-s-nonyl-β-D-thioglucoside 2.9 1 CMC H2 N n-octyl-β-D-galactoside 29.5 1% 
D3 N n-nonyl-β-D-thiomaltoside 3.2 1 CMC H3 N n-dodecyl-β-D-glucoside 0.19 1% 
D4 Z DDMAB 4.3 1 CMC H4 N Dodecyl-ββ-D-glucopyranoside 0.13 1% 
D5 N n-nonyl-β-D-maltoside 6 1 CMC H5 N n-octyl-β-D-glucoside 18 - 20 1% 
D6 N CYMAL-4 7.6 1 CMC H6 N n-undecyl-β-D-thiomaltoside 0.21 1% 
D7 N n-octyl-β-D-thiomaltoside 8.5 1 CMC H7 I sodium-dodecanoyl-sarcosine 14.4 1% 
D8 Z Fos-choline-10 11 1 CMC H8 N Mega-8 79 1% 
D9 Z Fos-choline-9 39.5 1 CMC H9 I CTAB  1 1% 
D10 N MEGA-9 25 1 CMC H10 N TMAO  N/A 1% 
D11 L 1,s-heptyl-β-D-thioglucoside 29 1 CMC H11 N Borane complex  N/A 1% 
D12 Z Fos-choline-8 114 1 CMC H12 L 
1,2-dihexanoyl-sn-glycero-3-
phosphocholine 15 1% 
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Dodecyl-w-Hydroxy-Poly(oxy-1,2-Ethanediyl), C12E8 - Dodecyl octaethylene glycol ether, ZWITTERGENT 3-14 - n-
Tetradecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate, MEGA-10 - Decanoyl-N-Methylglucamide, C8E4 – 
Octyltetraglycol, C10E5 – Decylpentaglycol, DDAO - n-Dodecyl-N,N-Dimethylamine-N-Oxide, MEGA-8 - Octanoyl-N-
Methylglucamide, ZWITTERGENT 3-8 - n-Octyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate, Cymal-5 - 5-Cyclohexyl-1-
Pentyl-β-D-Maltoside, DMPC - 1,2-dimyristoyl-sn-glycero-3-phosphocholine, DDM - n-dodecyl-β-D-maltopyranoside, 
LDAO - Lauryldimethylamine oxide, DM - n-decyl-β-D-maltoside, NG - n-nonyl-β-D-glucoside, Fos-choline-14 - n-
Tetradecylphosphocholine, Fos-choline-16 - n-Hexadecylphosphocholine, Cymal-3 - 3-Cyclohexyl-1-Propyl-β-D-Maltoside, 
CYGLU-3 - 3-Cyclohexyl-1-Propyl-β-D-Glucoside, Mega-8 - Octanoyl-N-Methylglucamide, CTAB - Cetyl Trimethyl 




Figure 1.2.4.16. Western blot of soluble samples extracted from the membranes of Hi5 cells 
with higher yields. 
Western blot with Anti-strep (left) and Anti-TAOK2 (right) showing the best extraction detergents. M, Marker; 




A second solubilization screen was done using HEK293T cell overexpressing His-GFP-hTAOK2. 
Samples from insoluble and soluble fractions were subjected to SDS-PAGE and the GFP signal 
detected in a scanner as previously (Appendix A4), with the best conditions being selected for 






Figure 1.2.4.17. Western blot of soluble samples extracted from the membranes of 
HEK293T cells with higher yields. 
Western blot probed for TAOK2 showing the best extraction detergents. (-) negative control; (+#0) and (+#2) 
positive controls; B12, C-HEGA-9; D6, CYMAL-4; D12, Fos-choline-8; G1, 1,2-diheptanoyl-sn-glycero-3-
phosphocholine; F3, SWITTERGENT 3-8. 
 
 
The detergent conditions were also evaluated by fluorimetry, measuring the GFP signal intensity 
(Figure 1.2.4.18). The % of solubilization was calculated, based on the ratio of the GFP signal 
obtained in the soluble fraction versus the total fraction after solubilization. From this experiment, 
the best detergents for extraction of hTAOK2α, seem to be n-decyl-β-D-thioglucoside (G7), Fos-
choline 16 (G5), Fos-choline 14 (G4) and DDM (F8), with extractions from the membrane 
preparation fraction above 70%. This has led to the conclusion that theresults based on in-gel 
fluorescence can be misleading, and prone to consider a different detergent from the one best 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Efficiency of Solubilization by Detergent 
% of GFP signal in soluble fraction compared to total 





The strep-GFP-hTAOK2 overexpressed at HEK293T cells was subjected to purification using a 
manual syringe column with streptactin resin (IBA) for affinity chromatography. After extraction 
from the membrane using Tris-HCl buffer supplemented with 1% DDM, the sample was applied 
to the 1 mL column and the purification ran at room temperatute under gravity flow. After 
several washes with the same buffer, the protein of interest was eluted with 5 mM desthibiotin 
and the aggregated protein was eluted with 0.5 M NaOH. The resulting fractions were evaluated 
by Western blot. 
 
Figure 1.2.4.19. Western blot analysis after manual affinity chromatography of strep-GFP-
hTAOK2. 
The Western blot membrane was probed sequentially with anti-TAOK2 (left) and anti-GFP (right) 
antibodies. M, molecular weight marker (Bio-rad); F, flow-through, P, membrane pellet after extraction; L, 
sample loaded in column; W, washing step; E, eluted fraction; N, fraction eluted with 0.5 M NaOH. 
 
The Western blot (Figure 1.2.4.19) shows only specific band for hTAOK2 at ≈90 kDa at the 
eluted fractions. Higher molecular weight bands were found at the flow-through and remaining 
membrane pellet after extraction. This indicates that the used purification column does not 
efficiently binds to the present protein, and also, that the protein was not efficiently extracted 
from the membrane. Moreover, the most intense band present at the eluted fraction, with 0.5 M 
NaOH, only reacts with anti-GFP and not with the TAOK2 antibody, a possible outcome of C-
terminal degradation of the target protein. The eluted fractions were concentrated using a 100 
kDa MWCO centricon (Millipore) to a final volume of 50 µl and applied to a qualitative SEC 
column (S200 5/150 GEHealthcare) for analysis (Figure 1.2.4.20). 
 




Figure 1.2.4.20. Analytical SEC of eluted fractions from affinity column Ni-NTA. 
 
Analysis of peak fractions from SEC chromatogram (Figure 1.2.4.20) together with elution 
volumes of each fraction suggests that most protein was in the soluble fraction with only a minor 
peak seen at the void volume (peak 1). However, the major peak (3) eluted at a volume of 2.4 
mL after injection, corresponding to a molecular weight around 50 kDa, indicates that most 
protein was degraded/fragmented. Peak 2 represents the higher molecular weight molecules 
present in sample (≈ 160 kDa), although it is expected a dimerization of our protein, these peak 
might correspond to the monomeric form of strep-GFP-hTAOK2, as it does corresponds to the 
total expected molecular weight of our constructed protein. 
Some additional purification experiments in both strep-GFP-hTAOK2 and his-GFP-hTAOK2 
overexpressed proteins were conducted. However, the binding efficiency of the affinity columns 
was quite lower than expected. This might have been due to the presence of detergent micelles, 
which may compromise the accessibility of the tag towards the column matrix. Another 
hypothesis is that the low expression yield of the protein - when the tagged protein is not in 
abundance compared to other polypeptides in the sample - may decrease the binding efficiency 
considerably. 
Therefore, after extensively tests with different detergents, matrix columns and overexpression 








Membrane proteins represent a challenging field of research. Their study, not only requests 
additional efforts in the laboratory as it consumes extra time when compared with soluble ones. 
Such efforts may not always pay-off the made investment. However, new techniques and 
knowledge of such systems are being developed in this area, so new strategies are being 
applied resulting in an increase number of known 3D structures of IMPs. Those strategies 
comprise new techniques in protein expression, the applied techniques in tagging and fusion 
proteins, the diversity of available detergents, novel methodologies for MPs crystallization (as 
meso- and sponge-phases) and new beamlines aimed for small and weak-diffraction crystals at 
synchrotron sources, crystallographic-related software developments and the increased power 
of computer calculations. All together with novel advances in high-throughput devices in many 
laboratories worldwide offer the scientists a multiple approach in structure determination of 
MPs. 
The hTAOK2 protein is a complex eukaryotic membrane protein of 135 kDa. Its high complexity 
led us to find a high-throughput platform for cloning and expression a multiple set of constructs. 
The successful application to the P
3 
OPPF expression platform was very exciting, having the 
possibility of expressing 47 different constructs of the selected target. However, the results were 
not satisfactory, since the successfully expressed constructs were only mildly expressed at 
inclusion bodies and lacking the TMs domain. These results indicate that hTAOK2 is a too 
complex protein for Escherichia coli overexpression, and that the use of other systems were 
essential to pursue our work. Because OPPF was using a derived pTriEx vector, the pOPIN, it 
was possible to select a set of clones for overexpression trials using mammalian and insect 
cells. The experimental trials done using the OPPF constructs, especially those with GFP at the 
C-terminal, showed that the localization of the expressed protein was not within the membrane. 
Moreover, the protein, even when expressed, was highly degraded upon processing, which 
might be addressed to the presence of the GFP at the protein C-terminus.  
hTAOK2 was then cloned fused to GFP and with a polyhistine- or Strep-tag, at different protein 
terminus, into pOPIN-F (the same vector designed to enable high-level target gene expression 
in multiple systems). A GFP-based expression screening and optimization was carried out using 
different E. coli strains, mammalian and insect cells, in order to determine the host best suited 
for TAOK2 production. The GFP fluorescence allowed monitorization of the detergent screening 
and the choice of the best suited for protein extraction from membranes and solubilization. This 
method has proved to be a more reliable and faster technique for quantification of target protein. 
The GFP fluorescence would also be very helpful at the downstream processing of the target 
protein, hTAOK2, as it is widely used to assess the monodispersity and stability of the protein 
sample in different conditions by FSEC. GFP fluorescence was found to be a fast measure of 
expression and localization. Accordingly, by monitoring GFP expression, it is shown that the 
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TAOK2 fusion protein only localizes correctly throughout the cell membrane when expressed in 
mammalian cells and only when GFP is present at the N-terminus.  
The practical steps that constitute this GFP-based pipeline approach to evaluate the expression 
and  speed up the screening of detergents for membrane extraction up to protein purification 
are shown along the work presented. Thus, GFP-tag can facilitate the process to obtain stable 
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X-ray crystallography is a powerful technique to determine the three-dimensional structure of 
biomacromolecules and hence very relevant for structural biology studies.  
With the discovery of Z-DNA, in 1979, questions about its biological role held the scientific 
public on to the subject until this moment, mostly due to the fact that a human protein, double-
stranded RNA adenosine deaminase – ADAR1 – binds selectively to the Z-form of DNA and 
RNA at the moment of transcription, within its Zα domain. 
Here, it is described the experimental work done with the ZαADAR1 with specific oligonucleotides 
of RNA and DNA, with a nucleotide sequence with the properties to form the Z double helical 
structure, consisting of alternating cytidines and guanosines. For reasons not entirely 
understood, such dinucleotide repeats in genomic sequences have been associated with 
genomic instability leading to cancer. 
Adoption of the left-handed conformation results in the formation of conformational junctions. In 
DNA a B-to-Z junction is formed at the boundaries of the helix, whereas a Z-to-Z junction is 
commonly formed in sequences where the dinucleotide repeat is interrupted by single base 
insertions or deletions that bring neighboring helices out of phase. B-Z junctions are shown to 
result in exposed nucleotides vulnerable to chemical or enzymatic modification. In RNA, no 
such junctions were described so far. 
Two oligonucleotides sequences of Z-RNA were used and led to a collection of data sets at high 
resolution to determine the complex structure. However, and because RNA does not so easily 
shifts to the Z form, the complex was never crystallized, and we could only have a high-
resolution structure of RNA double helix. 
Here it is also described the three-dimensional structure of a Z-Z junction stabilized by ZαADAR1. 
We show that the junction structure consists of a single base pair and leads to partial or full 
disruption of the helical stacking. The junction region allows intercalating agents to insert 
themselves into the left-handed helix, which is otherwise resistant to intercalation. However, 
unlike a B-Z junction, in this structure the bases are not fully extruded, and the stacking 





















Figure 2.2.1: Diagram of DNA structure as proposed by Watson and Crick in 1953. 
The ribbon symbolizes the sugar-phosphate chain, and the horizontal rods the pairs of bases holding two 
chains together. The vertical line marks the fiber axis. The arrows indicate that each chain runs at opposite 
directions (from Watson and Crick, 1953). 
 
DNA, the deoxyribonucleic acid, is an important macromolecule found in all living cells and 
contains all the information necessary to their survival and expansion. It is formed by four 
different types of nucleotides, the building blocks, constituted by a sugar (2’-deoxyribose), one 
or more phosphate groups and one base of four possible heterocyclic bases (Griffiths et al., 
2000b). The constituting bases are purines (adenine and guanine) or pyrimidines (thymine and 
cytosine) (Figure 2.2.1). Purines pair with pyrimidines, adenine with thymine and guanine with 
cytosine, respectively (Figure 2.2.2). This based model was held together in 1953 only with X-
ray data from DNA fibers from Rosalind Franklin and Maurice Wilkins (Tobin, 2003). The real 
"proof" for the Watson-Crick model of DNA came in 1981 after the B-form of DNA was 
crystallized and the X-ray pattern was solved (Drew et al., 1981). 
The DNA can be found in the A-, B- or Z-DNA form (Figure 2.2.3). The B-DNA is the right 
handed, anti-parallel form, and also, the most predominant conformation of DNA found in 




Watson and  rick in 1953. At the time, Watson and  rick have “put forward a radically different 
structure for the salt of deoxyribose nucleic acid”, not entirely accepted by the community. 
The A-DNA form arises from a conformational change from the B-DNA, induced by a decrease 
in the relative humidity to 75% or below. A-DNA is a wider and flatter helix, closely resembling 













Figure 2.2.2. The chemical structure of DNA. 
The four nucleotides are the fundamental building blocks of 
DNA. The sugar is called deoxyribose because it is a variation 
of a common sugar, the ribose, but with an extra oxygen atom 
(upper panel). The DNA double helix, unrolled to show the 
sugar-phosphate backbones (blue) and base-pair rings (red) 
(left panel). The backbones run in opposite directions; the 5′ 
and 3′ ends are named for the orientation of the 5′ and 3′ 
carbon atoms of the sugar rings. Each base pair has one 
purine base, adenine (A) or guanine (G), and one pyrimidine 
base, thymine (T) or cytosine (C), connected by hydrogen 
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Figure 2.2.3. Representative double-helical structures of DNA. 
Structures of A-DNA (Hays et al., 2005), B-DNA (Privé et al., 1991), and Z-DNA (Wang et al., 1979). 
Abbreviations: Incl. = inclination, x-Disp. = x-displacment, P-Tw = propeller twist. For Z-DNA, the helical 
parameters are given as averages of the alternating dinucleotide steps (from Shing and Carter, 2011). 
 
The DNA, now so familiar to us, was an exciting discovery for the all scientific community at the 
time. Its implications and the way science evolved are at this point visible, so it’s not so striking 
having DNA as one of the most important discoveries of all time. With the discovery of DNA 
structure, it was obvious that the molecule could be replicated, the essential property of a 
genetic molecule. The base pair sequence suggested an influence in the polypeptide chain of 
aminoacids forming a protein; this was the first notion of genetic code - one gene, one protein 
(Griffiths et al., 2000b). 
 
The discovery of Z-DNA, the left-handed conformation of nucleic acids 
In 1979, Alexander Rich and colleagues reported the discovery of an intriguing new acid nucleic 
conformation, the left-handed DNA, or as it is also known Z-DNA confirming the spectroscopic 
studies of Pohl and Jovin (Pohl and Jovin, 1972; Wang et al., 1979). At the time, that was also 
the first DNA molecule to be analyzed by X-ray crystallography. Z-DNA was so named because 
of its zigzag phosphodiester backbone, consisting of two anti-parallel chains, with bases that 
still form the Watson-Crick base pairs (Figure 2.2.4). It is usually found in DNA molecules with 
alternate GC sequences and is favored by specific conditions, such as high salt (Hall et al., 
1984; Pohl and Jovin, 1972), low concentration of certain metal complexes (Behe and 
Felsenfeld, 1981; Woisard et al., 1985), and superhelical torsional stress (Peck et al., 1982). 
This DNA form is stabilized by the negative supercoiling generated upon transcription, indicating 
a transient, although, localized conformational change. This conformational transition between 
two different double helical forms is accompanied by changes of optical rotatory dispersion, 
circular dichroism and ultraviolet absorption, which are methodologies widely used for their 





Figure 2.2.4. B to Z-DNA transition. 
When unwound by negative supercoiling, DNA will first extrude two flipped out base pairs (serving as two 
B-Z junctions). Further unwinding results in the formation of left-handed Z-DNA between the two junctions 
as they migrate in opposite directions (from Shing and Carter, 2011). 
 
 
Two different conformations were observed for the phosphates in the GpC sequences of DNA 
when adopting a Z conformation, as the phosphates are found either facing the helical groove 
or rotated away from it. The latter conformation is often found when hydrated magnesium ions 
are complexed to a phosphate oxygen atom (Wang et al., 1981). 
 
Biologists were intrigued by Z-DNA because it seemed unnecessary. However, the discovery 
that certain classes of proteins bound to Z-DNA with high affinity and great specificity indicated 
a biological role. The new discovery led to a worldwide race to study the Z-DNA form, and once 
again Rich and his co-workers showed that Z-DNA is not only biologically relevant but also 
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RNA - ribonucleic acid 
In living cells, DNA holds the genetic code, some regions are transcribed to RNA that, in its turn, 
will be translated to proteins. DNA is significantly long, mostly present in the nucleus, and much 
longer than RNA, which carries one gene at a time, and is also found in the cytoplasm (Alberts 
et al., 2002b).  
 
 
Figure 2.2.5. The chemical structure of RNA. 
The (A) RNA contains the sugar ribose, which differs from deoxyribose, the sugar used in DNA, by the 
presence of an additional -OH group. (B) RNA contains the base uracil, which differs from thymine, the 
equivalent base in DNA, by the absence of a -CH3 group. (C) A short length of RNA. The phosphodiester 
chemical linkage between nucleotides in RNA is the same as that in DNA (Alberts et al., 2002b). 
 
Despite its similarity to DNA, the RNA molecule comprises two chemical differences. RNA has a 




carbon sugar; also, it contains a uracil base (without methyl group) instead of the thymine base 
(Figure 2.2.5).  
Because RNA contains a ribose instead of a deoxyribose, in the Nature report by Watson and 
Crick from 1953, the authors claim that “It is probably impossible to build this structure with a 
ribose sugar in place of a deoxyribose, as an extra oxygen atom would make too close a van 
der Waals contact”, suggesting that it was unlikely for RNA to have the proposed double helical 
structure (Watson and Crick, 1953). 
In fact, the ribose turns RNA more bulky than DNA, making it harder to form a stable double 
helix. A breakthrough came later in 1956, when it was discovered that double stranded RNA 
(dsRNA) indeed exists (Rich and Davies, 1956). It was then eventually observed that the 
double-stranded RNA molecule adopts a conformation similar to the A-form of DNA (Rich, 
2003). 
Both DNA and RNA form stable double helices, held together by Watson-Crick base pairs. 
However, the presence of an added oxygen atom in the backbone of RNA turns in a different 
geometry when compared to DNA. A-RNA and B-DNA are the most stable forms of these 
double-stranded molecules (Brown and Rich, 2001). With an input of energy, both these 
conformations can be transformed into left-handed double stranded conformations, the Z-DNA 
and Z-RNA. 
As in DNA, the Z conformation of RNA is stabilized in vitro by very high concentrations of salt, 
higher temperatures and other agents that monitor repulsion between electronegative 
phosphate residues, which are closer together in the Z conformation (Hall et al., 1984; Trulson 
et al., 1987). The transition from the A-RNA right-handed duplex to the Z-form is less favorable 
then the B to Z-DNA transition. In fact, the energy for changing the sugar pucker of a 
ribonucleotide to the Z-form is considerably bigger that the energy required for a 
deoxyribonucleotide (Brown and Rich, 2001).  
The A to Z conformational transition in RNA may be of relevance to the biological situations in 
which double-stranded RNA occurs, such as in ribosomes and in some viruses (Hall et al., 
1984).  
The first structure of Z-RNA was determined at very high salt concentration (6M NaClO4) for the 
helix (GCGCGC)2 by Nuclear Magnetic Resonance (NMR) (Figure 2.2.6). However, this Z-RNA 
helix structure shows several conformational features different from Z-DNA, e.g. a unique 
stracking, alternating, low positive and high negative helical twist angle values, a small helical 
rise and base pairs locations close to helix axis. Both helix grooves of Z-RNA are well defined. 
Cytidine 2 –OH groups, deeply buried in the narrow minor groove play a crucial role on the Z-
RNA structure and A to Z helicity reversal (Popenda et al., 2004). 
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Figure 2.2.6. First structure of Z-RNA by NMR. 
First column: superposition of 12 conformers representing the refined structure of (CGCGCG)2 in the Z-
RNA form as viewed from the minor groove and along the helix z-axis. Second and third column: stacking 
pattern within the CpG and GpC steps in Z-RNA as viewed from the minor groove and along the helix z-
axis. For both steps only intra- but no inter-strand stacking is observed (from Popenda et al., 2004). 
Most of the gross conformational features of Z-DNA are also present at the Z-RNA molecule in 
solution, including syn guanosines, anti cytidines, a zigzagged phosphodiester backbone, and 
alternating cytidine 2’-endo and guanosine 3’-endo sugar puckers, making them almost 
indistinguishable, contrary to the right-handed conformations (B-DNA and A-RNA) (Weiner et 
al., 1984). The only ma or difference would be the 2’-hydroxyl group in the Z-RNA, which is not 






Figure 2.2.7. Full-turn model of the Z-RNA helix (12.4 bp per turn) (left) compared to the 
12 bp per turn models of ZI- (middle) and ZII-DNA (right). 
Models are presented in two different conventions, by the top (upper models) and laterally (bottom models) 
in order to show their base pair location and groove architecture. Atoms color code – carbon: black, 
hydrogen: white, nitrogen: blue, phosphorus: yellow, oxygen: red; cytidine 2′ oxygens: green (from 
Popenda et al., 2004). Models for the ZI- (middle) and ZII-DNA (right) were described by Wang et al., 1981. 
 
As it was found for DNA, Z-RNA can also adopt two distinct conformations based on Raman 
spectroscopic studies, with differences both in the base stacking and in the backbone geometry. 
The Z form of poly[r(CG)] named ZR-RNA forms in high salt concentrations of NaBr or NaClO4 
and exhibits a unique and distinct CD spectrum from the ZD-RNA, which is found in 
concentrated MgCl2, and has a CD signature similar to poly[d(GC)] (Trulson et al., 1987).  
Staining with antibodies against Z-RNA suggests its presence in both the cytoplasm and the 
nucleus (Zarling et al., 1990).  
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Proteins that bind Z-DNA/Z-RNA 
 
ADAR1 
After its discovery, the nucleic acid Z-form started losing researchers interest, as it seemed not 
to have any biological function. If this particular form of nucleic acids was to have a biological 
role, it would be highly likely for it to bind specifically to a class of proteins. At the time, the 
problem was to find a method that would enable the isolation of proteins that would bound 
selectively to Z-DNA and simultaneously, exclude those that would bind to B form of DNA (Rich 
and Zhang, 2003a). The supposed method was only described in 1993 (Herbert and Rich, 
1993) and consisted on the utilization of a radioactive labeled oligodeoxynucleotide stabilized in 
the Z conformation together with an excess of thousands fold of B-DNA and single-stranded 
DNA in a bandshift experiment. Also, because the Z-DNA used would contain bromine atoms, 
DNA-complexes would be easily identifiable by UV light crosslink. The technique allowed for the 
detection of proteins that would bind tightly to Z-DNA. One of the first proteins found was 
double-stranded RNA adenosine deaminase type I (ADAR1) (Herbert et al., 1995).  
ADAR1 is an ubiquitous and highly conserved enzyme in metazoan (Figure 2.2.8), acts on 
double-stranded regions formed in precursor messenger RNA (pre-mRNA), selectively 
deaminating adenosine producing inosine (A to I) (Kim et al., 1994). The mammalian genome 
encodes for three ADARs. ADAR1 and ADAR2 are catalytically active (Savva et al., 2012). 
ADAR3 is not editing competent, only present in the postmitotic neurons, where it may play a 
role on the regulation of substrate-specific RNA editing in the brain (Chen et al., 2000). 
RNA editing is essential for mammalian development. Mapping the A-to-I sites in humans 
showed that their primary targets are noncoding regions of the RNA, Alu repeats, and 
suggested a role of editing in controlling dsRNA stability (Carmi et al., 2011; Levanon et al., 
2004). Inosine is later interpreted as guanine during translation, so ADARs will alter the amino 
acid sequence encoded in the gene. ADARs recognize short, imperfect RNA duplexes and their 
function is to deaminate selected adenosines (specific RNA editing). However, ADARs may act 
promiscuously by editing multiple adenosines (non-selected), this process is also known as 





Figure 2.2.8. The ADAR family protein. 
Metazoan ADARs share a common domain architecture, consisting of a variable number of amino-terminal 
dsRNA binding domains (dsRBDs, in orange) and a carboxyl-terminal catalytic deaminase (purple). 
Human ADAR1 have unique Z-DNA binding domains (green). The squid Loligo pealeii contains an 
ADAR2-like gene (sqADAR2) that through alternative splicing produces 2 variants (a and b). C. elegans 
contains two genes (ceADAR1 and 2), while the genome of D. melanogaster encodes only one (dADAR) 
homologous to hADAR2. Although the dsRBMs found in the Hydra magnapapillata genome are highly 
divergent, five such motifs are recognizable in hmADAR, the only identified gene in this species. Human 
and Drosophila ADAT architectures are included (red), as these enzymes are believed to be ancestral to 
present-day ADARs (adapted from Savva et al., 2012). 
 
ADAR1 gene has two transcription start sites and two promoters, giving rise to two variants: an 
interferon induced form ADAR1p150 (longer form, 150 kDa) and a constitutively induced form 
ADAR1p110 (shorter form, 110 kDa), differing in the length of their N-terminal sequence, as 
ADAR1p110 is amino-terminally truncated lacking the first 296 residues. Both contain dsRNA-
binding domains and the demaniase domain, however, Z binding domains is restricted to 
ADAR1p150 (Patterson and Samuel, 1995). They also differ in their cellular distributions: 
ADAR1p110 is exclusive to the nucleus, while ADAR1p150 shuttles between nucleus and 
cytoplasm, suggesting a targeting for mature mRNAs present outside the nucleus (Desterro et 
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ADAR1 Zalpha Domain 
In ADAR1 editing, the substrate if formed by folding an intron back onto the exon that is 
targeted for modification (Figure 2.2.9.). Because it uses introns, editing must take place before 
splicing. It is thought that ADAR1 recognition of Z-DNA is essential for editing of nascent 
transcripts to begin immediately after transcription, ensuring that editing and splicing are 
performed in the correct sequence (Herbert and Rich, 1999a). 
 
Figure 2.2.9. Model for regulation of ADAR1 activity by Z-DNA. 
ADAR1 has been shown to bind Z-DNA and dsRNA with nanomolar affinity (Brown and Rich, 2001). Each 
nucleic acid is bound to a specific domain. Transcription gives rise to regions of dsRNA, when a nascent 
RNA transcript (pre-mRNA) folds back to itself. In vivo, Z-DNA can be stabilized by the negative 
supercoiling generated by an RNA polymerase moving through a gene. It is proposed that binding to Z-
DNA allosterically activates editing by ADAR1, initiating modification of a transcript as it forms and before 
splicing has occurred. This enzyme causes the hydrolytic deamination of adenine within the dsRNA to 
form inosine, which is subsequently translated as guanine. Editing thus changes the read-out of a gene. 
Several editing sites may exist in a particular pre-mRNA. ADAR1 thus utilizes the structural information 
encoded in Z-DNA and dsRNA to alter the linear flow of information from DNA to RNA (adapted from 
Herbert and Rich, 1999b). 
 
Several experiments were carried out to illustrate the interaction of the ZαADAR1 domain with 
DNA in solution. The first prove of evidence for the existence of the left-handed Z-DNA 
conformation in a complex of poly(dGdC) with Zα was done by spectroscopic studies, which 
showed that the typical circular-dichroism spectrum of B-DNA was changed when Zα was 
added to the solution (Berger et al., 1998). 
Typically, Zα domains are 66 amino acids long (Pfam 02295), with a fold constituted by 3 α-
helices (α1 - α3) and 3 β-strands (β1 - β3) arranged with the following topology: α1β1α2α3β2β3 
(Schwartz et al., 1999). 
Further in vitro experiments showed that Zα was capable of stabilizing and maintaining the Z-
form of long DNA molecules, independently of other factors, upon binding. The DNA in study 
was a segment of CG repeat flanked by other segments, which were without properties that 
would favor the alteration to the Z form. In such cases, Zα binds to the central region in the Z 
conformation, while the remaining DNA is in the B-form, forming two B-Z junctions. Not only has 




junctions. Two models are proposed, (1) Zα binds to B-DNA and promotes the B to Z transition 
or (2) Zα captures transient Z-DNA segments formed in small amounts, due to Brownian 
motion, even in conditions that strongly favor B-DNA, thereby shifting the B-Z equilibrium (Kim 
et al., 2000). 
The resolution by X-ray crystallography of the 3D structure of the Z-binding domain of ADAR1, 
Zα, with Z-DNA, made it possible to identify the aminoacid residues involved in the recognition 
of the Z-form (Figure 2.2.10). Intriguingly, the helix-turn-helix-β-sheet motif (α+βHTH), frequently 
used to recognize B-DNA in a variety of proteins, was the one bound to five successive sugar 
phosphate groups, including the syn-conformation of guanine, of the Z-DNA backbone 
(Schwartz et al., 1999). Those results suggest that ZαADAR1 domain, specifically helix 3 (α3) 
and the loop connecting β2 and β3 strands, recognizes the Z-form and not the nucleic acid 
sequence. 
 
Figure 2.2.10. Crystal structure of ZαADAR1:Z-DNA complex (PDB ID 1QBJ). 
The structure evidenciates the need for a Zα dimer for the binding to the 6-bp DNA duplex (colored orange 
to purple). Protein chains are colored blue (from Schwartz et al., 1999). 
 
The first high-resolution structure of Zα alone and in complex with Z-DNA led to the proposition 
that most likely, B-DNA binding is disfavored by steric hindrance, but Z-DNA binding to Zα is 
favored because seven out of the nine contacting residues are prepositioned to bind the distinct 
backbone of Z-DNA. These structural modifications of the α+βHTH fold may enable Zα to 
recognize Z-DNA in the presence of excess B-DNA in the nucleus of a living cell (Schade et al., 
1999). 
A crystal structure of a B-Z-DNA (Figure 2.2.11) junction formed upon binding of a 15-base-pair 
segment of DNA to Zα was determined, revealing a continuity in the base stacking between the 
B and the Z segments, and a break of one base pair at the junction, resulting into an extrusion 
of the adjacent base pair at each side (Ha et al., 2005). Every time a section of DNA forms a 
left-handed Z-DNA segment, two B–Z junctions are formed. Every time a dsDNA segment turns 
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into Z-DNA, such a junction is formed, which may facilitate the use of Z-DNA more widely in 
nature (Du and Zhou, 2013). 
 
Figure 2.2.11. Crystal structure showing a B-Z-DNA junction (PDB ID: 2ACJ). 
Proteins are colored in pink tones; RNA oligomer is colored orange (backbone) to blue (base pairs). 
The significance of the observed junction is that it requires little structural disruption, preserves 
helix integrity and, through maximizing base pairing, it minimizes the energetic cost of the 
junction. This makes it possible to use the Z-DNA conformation more widely and may be related 
to the widespread occurrence of sequences favoring Z-DNA formation. B–Z junctions are easily 
formed in biological systems owing to the widespread occurrence of negative supercoiling. 
These can be further stabilized by Z-DNA binding proteins. The knowledge that these are 
associated with extrusion of bases at the junction is likely to open many new avenues of 
research as a lot more remains to be known. 
It was later shown that ZαADAR1 also binds Z-RNA and stabilizes the Z-conformation, as it was 
expected since left-handed conformations of the distinct nucleic acids are very similar (Brown et 
al., 2000). 
The fist high-resolution structure displaying dsRNA in the left handed conformation bound to 
ZαADAR1 (Figure 2.2.12) was later published by the group of Alexander Rich (Placido et al., 
2007). It was for the first time demonstrated that Z-RNA structure would adopt such 
conformation at almost physiological environment (Figure 2.2.13), closely taking on the helical 
parameters observed for Z-DNA (Wang et al., 1979), adopting a different conformation from that 






Figure 2.2.12. Crystal structure showing a ZαADAR1:Z-RNA complex (PDB ID 2GXB). 
Proteins are colored green and lemon, RNA oligomer is colored orange (backbone) to blue (base pairs), 











Figure 2.2.13. Base Stacking and Backbone Hydration of two Z-RNA Conformations one 
Z-DNA. 
(A and D) Z-DNA (Schwartz et al., 1999), (B and E) Z-RNA cocrystal (Placido et al., 2007), and (C and F) 
NMR structure of Z-RNA in 6 M NaClO4 (Popenda et al., 2004). Dashes show Watson-Crick hydrogen 
bonding (blue) and 2′-OH hydrogen bonds (red/orange). The 2′-OH groups are displayed as larger orange 
spheres. Distances are given in Angstroms. Note the overall similarity and the (D and E) interstrand base 
stacking of CpG steps in the Zα/Z-DNA and Zα/Z-RNA complexes, as opposed to (F) intrastrand stacking 
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Other proteins that bind Z-DNA/Z-RNA 
 
The crystallographic structure of the ZαADAR1:Z-DNA complex allowed the identification of the 
amino acids responsible for the nucleic acid binding (Schwartz et al., 1999). A computer based 
search for proteins with sequence motifs, similar to that of ZαADAR1, identified interferon 
response related proteins such as DLM1 (Fu et al., 1999; Schwartz et al., 2001), E3L (Brandt 
and Jacobs, 2001; Liu et al., 2001) and PKZ (Rothenburg et al., 2005) has containing Zα 




Figure 2.2.14. Proteins containing a Zα domain. 
Domain organization is shown schematically. Numbers to the right indicate the number of residues in 
human ADAR1, vaccinia virus E3L, human ZBP-1 (also known as DLM1), zebrafish PKZ, and human PKR. 
Domains containing a Zα motif (Zα and Zβ) are shown in red. dsRNA binding domains are in green. The 
deaminase domain of ADAR1 (yellow) and the kinase domains of PKR and PKZ (light blue) are labeled. 
The function of the C-terminal region of ZBP-1 (gray) is unknown (from Rothenburg et al., 2005). 
 
The high resolution (1.85 Ă) crystal structure of the Z-DNA binding domain in DLM1 – ZαDLM1 – 
in complex with d(GC)3 showed that the recognition of the Z-DNA was similar to ADAR1, and 
that important residues – Asn, Tyr and Trp - responsible for fold maintenance, were conserved 
between the two otherwise unrelated proteins, whereas additional DNA interacting residues are 
conservatively replaced (Schwartz et al., 2001). This strongly indicates that the Zα family shares 
Z-DNA binding as a common function. 
E3L was another protein identified as a potential Z-DNA binding protein, containing a 
characteristic sequence at the N-terminal domain (ZαE3L) and a dsRNA-binding motif at the C-
terminal domain (Figure 2.2.14). The E3L gene is found in poxvirus, including the vaccinia virus, 
where E3L provides interferon (IFN) resistance and the capability for the virus to be cultured in 
a broad host range, due to its ability to inhibit the antiviral dsRNA-dependent protein kinase, 
PKR (Brandt and Jacobs, 2001). A virus that has mutated or missing E3L maintains the 
capability to reproduce in cell cultures, but is no longer pathogenic to a mouse, where a virus 
without any alteration would kill a mouse within a week post infection (Brandt and Jacobs, 




in which a Z-DNA binding protein is found to be involved in pathogenesis. If other viruses own a 
similar mechanism, Zα domains will be potential targets for anti-viral drugs (Rich and Zhang, 
2003b). Cocrystallization of the Yatapoxvirus Zalpha (ZαyabE3L) bound to Z-DNA show similarity 
with the previous structures, supporting a conformation specific manner for the interaction 
between Zα and DNA (Ha et al., 2004). 
PKZ is the closest relative of PKR found in several fish species, it differs from PKR in having Zα 
domains replacing the normally found two dsRBD while maintaining an intact kinase domain. 
PKR is using its dsRNA binding domains for the detection of viral dsRNA which lead to its 
activation and subsequent shutdown of cellular translation (Rothenburg et al., 2005). Since 
dsRNA can also adopt the Z conformation, it is reasonable to assume a similar role for ZαPKZ 
although for a more specialized feature of viral RNAs, as part of the host antiviral response. 
 
The biological role of Z-DNA 
 
Since its discovery, biologists were puzzled by Z-DNA. It seemed unnecessary, but in fact some 
proteins contain specific domains that bind Z-DNA and Z-RNA with high affinity, the Zα domain. 
RNA editing changes the sequence of mRNAs, which results in synthesis of proteins not 
encoded in the genes (Smith et al., 1997). It had been known for some time that certain RNA 
viruses, e.g. Measles virus, the causative agent of encephalitis that replicate in the cytoplasm, 
undergo considerable changes in sequence – adenines are replaced by guanines, uracyls by 
cytosines -, which were probably the consequence of hyper-editing by ADAR1 (double-stranded 
RNA adenosine deaminase) (Maas et al., 2003). The full length form of this enzyme, the form 
that contains the Z-DNA/Z-RNA binding domain, is upregulated by the interferon response of 
the cell, which is triggered by the measles virus. Furthermore, ADAR1 accumulates in the 
cytoplasm, where the measles virus replicates. So, it is possible that the Zα domain from 
ADAR1 binds to the negatively torsionally strained double-stranded RNA, which might form 
during viral replication, showing that the Z-DNA/Z-RNA binding domain might have a role in the 
attempts of cells to inactivate the invading virus.  
Also, findings indicate a link between the structure of Z-DNA and vaccinia viral pathogenesis 
(Kim et al., 2003). One of the most striking biological effects of a Z-DNA binding protein is seen 
in the vaccinia poxvirus interferon resistance protein (E3L). This virus is lethal for mice, but if Z-
DNA binding ability is diminished, pathogenicity decreases, and if the binding is lost, the virus is 
no longer lethal for the mouse (Brandt and Jacobs, 2001; Liu et al., 2001).These results raise 
the possibility that some diseases as smallpox could be treated by blocking Z-DNA binding in 
variola, which has a nearly identical domain to vaccinia viruses. The findings in the area indicate 
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a clear link between Z-DNA/Z-RNA, viral pathogenesis and cell protection against invading 
virus. 
Because Z-DNA was detected only in negatively supercoiled plasmid, but not in a relaxed 
plasmid, it is suggested that this non-B DNA conformation could exist in vivo under 
physiological conditions as general chromosomal DNA is mostly negatively supercoiled 
(Nordheim and Rich, 1983). Also, methylation of DNA promotes the formation of the Z form of 
DNA, due to the slight modification of its backbone, it requires less energy to switch 
conformation (Behe and Felsenfeld, 1981). So, Z-DNA is thought to play a role in the regulation 
of gene expression; Z-DNA is also thought to be involved in DNA processing events and/or 
genetic instability. Z-DNA-forming sequences have the potential to enhance the frequencies of 
recombination, deletion, and translocation events in cellular systems (Wang et al., 2006).  
Z-DNA is an active element in the genomes of prokaryotes and eukaryotes and its transient 
state and functional activities make it challenging to target and regulate. Although the biological 
function(s) is not fully understood, accumulating experimental and clinical evidence support the 
idea that this conformation is involved in several important biological processes and may 
provide a target for the prevention and treatment of some human diseases. Research on Z-DNA 
has expanded the current insight into its role and new progress should pave the way to further 





2.3. Materials and Methods 
 
Protein Production 
The Zα domain of human ADAR1 was expressed and purified as previously reported by Placido 
et al., 2007. Briefly, the bacteria growth medium was Luria-Bertuni (Sigma; 10 g/L tryptone, 5 
g/L yeast extract, 10 g/L NaCl), supplemented with 50 μg/ml of kanamycin (Sigma). A glycerol 
stock of Escherichia coli BL21 cells was previously prepared. A previous culture of 100 mL was 
grown at 37ºC, 250 rpm, overnight and used as pre-inoculum. Next day, 2 L culture, divided 
within 4 Erlenmeyer’s with 500 mL each, with a pre-inoculum of 15 ml each (1/30 of culture 
volume) were growth at 37ºC, 220 rpm until the optical density at 600 nm (OD600) reached 0.2. 
At this point, expression was induced by adding 1 mM of Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) to the culture. Growth was performed until OD600 reached 0.8-0.9. The culture was 
centrifuged at 7000 rpm, at 4ºC for 6 minutes. The pellet was resuspended in 10 mM HEPES 
pH 7.4 and 20 mM NaCl and centrifuged at 5000 rpm, 4ºC for 5 minutes. The pellet was stored 
at -20ºC until further use for purification. Bacterial cell pellet was resuspended in 1x BugBuster
®
 
Reagent (Novagen) diluted (in a concentration of 5 ml of BugBuster
®
 Reagent per 5 g of cell 
pellet) in Buffer A (50 mM Tris-HCl pH 8.0; 500 mM NaCl; 5 mM Imidazole; 1 mM β-
mercaptoethanol (βME)),  for chemical cellular disruption. Per mL of this solution, 0.1 μl of 
Benzonase®Nuclease (Sigma-Aldrich) was added. The resuspension was left at room 
temperature for 1 hour and then centrifuged at 11000 rpm at 4ºC per 30 minutes. The 
supernatant was applied onto a nickel-nitrilotriacetic acid (Ni-NTA) agarose column (GE 
Healthcare) on the FPLC system (Amersham). After loading of sample, the column was washed 
with 20 times the colum volume (CV) of Buffer A. Sample elution was performed by passing 20 
CV of Buffer B (50 mM Tris-HCl pH 8.0; 500 mM NaCl; 300 mM Imidazole; 1 mM βME). Protein 
sample was collected and immediately stored on ice and concentrated by centrifugation. Buffer 
was exchanged to 10 mM HEPES pH 7.4 and 20 mM NaCl using a desalting column on the 
FPLC system. Thrombin was added to the sample, for His-Tag cleavage overnight. On the day 
after, the sample was applied to a Mono-S HP 5/5 column (Amersham Biosciences) in the FPLC 
system for purification of the cleaved protein. 5 CV of buffer were passed through the column 
before elution. A gradient from 0% to 50% of the buffer constituted by 10 mM HEPES pH 7.4 
and 1 M NaCl was used for protein elution. After elution, the buffer was exchanged to the final 
storage conditions of 10 mM HEPES pH 7.4 and 20 mM NaCl. Protein purity was accessed by 
loading the samples on a 10% Bis-acrylamide gel and running an SDS-PAGE. The protein was 
concentrated by using Centricon filtration devices (Millipore) to a final concentration of 10 
mg/mL in 10 mM Hepes, pH 7.0, 20 mM NaCl. The Hepes-free protein sample was prepared by 
dialysis against a 10 mM Tris-HCl, pH 7.0, and 20 mM NaCl solution. 
 




DNA oligonucleotides: Z-Z DNA: AC(CG)3A(CG)3 and GT(CG)3T(CG)3.  
RNA oligonucleotides: Z-Z RNA: GU(CG)3UA(CG)3 and AC(CG)3UA(CG)3; A-Z RNA: 
GU(CG)3CCAUAAACC and ACGGUUUAUGG(CG)3. 
The oligonucleotides were purchased from IDT (Coralville) and resuspended in 10 mM Hepes, 
pH 7.0, 20 mM NaCl or in 10 mM Tris-HCl, pH 7.0, 20 mM NaCl. The Hepes-free protein sample 
was prepared by dialysis against a 10 mM Tris-HCl, pH 7.0, and 20 mM NaCl solution. The 
duplex (Z-Z DNA; Z-Z RNA; A-Z RNA) oligonucleotides were prepared by heating a 
stoichiometric mixture of the two oligonucleotides to 80°C (10 minutes) and leaving the sample 
to slowly cool down (1ºC per minute) to 20ºC. In order to verify the success of annealing, and to 
assess the size and purity of the oligonucleotides mixture, a 3% agarose gel electrophoresis 
was done (Amersham). 
 
Crystallization of ZαADAR1 complexed with Z-Z RNA oligonucleotide 
Initial crystallization screenings (Classical I and II, Qiagen) were done with the nanoliter 
crystallization robot (Cartesian mini-bee) using a mixture of protein:oligo with a ratio of 4, at 96 
well plates using the sitting-drop vapour diffusion technique. Initial hits were found in drops 
containing ammonium sulphate as precipitant. Further optimization experiments were performed 
around the initial conditions, by varying the concentration of precipitant, testing various additives 
(e.g. polyethylene glycols - PEGs -, sugars, and alcohols), trying different drop size and 
protein:oligo ratios and by doing streak- and macro- seeding. The best crystallization condition 
consisted of 1.8 M Ammonium Sulphate and 100 mM Sodium Acetate pH 4.6 in a 1 + 1 μl drop 
size, with 1000 μl of reservoir solution and using the sitting-drop vapor diffusion technique at 
20ºC. For X-ray diffraction data set collection, different cryopreservants were tested in-house. 
Best cryoprotectant was glycerol, which is supplemented to the crystallization solution to a final 
concentration of 10 to 15%. Two data sets were collected at ESRF, the European Synchrotron 
Radiation Facility in Grenoble, at 1.2 and 2 Å resolution, using 15% glycerol as a cryoprotectant. 
 
Crystallization of ZαADAR1 complexed with A-Z RNA oligonucleotide 
A similar strategy was adopted to crystallize ZαADAR1 in complex with A-Z RNA oligonucleotide. 
Classical screenings I and II (Qiagen) were done with the nanoliter crystallization robot using a 
ratio of protein: oligo of 4. From these initial screenings, further optimization was performed to a 
final optimal solution of 2.2 M Ammonium Sulphate and 100 mM Tris.HCl pH8.5. In addition, 




concentration) and ethylene glycol (20%) supplemented to the crystallization solution. Two X-
ray diffraction data sets were collected at ESRF, the European Synchrotron Radiation Facility in 
Grenoble, at 1.4 and 2 Å resolution, both using 20% ethylene glycol as cryoprotectant. 
 
Crystallization, Data Collection, and Processing of ZαADAR1:Z-Z-DNA 
The ZαADAR1/Z-Z DNA complex was obtained by mixing 0.8 mM Zα with 0.2 mM DNA duplex. 
The mixture was incubated at room temperature for 1 h before crystallization trials. Best 
diffracting crystals were obtained, in two different conditions, by the hanging drop vapor 
diffusion method at 20 ° , using 1 μL of the mixture with 1 μL of the reservoir solution containing 
16% PEG 2000 monomethyl ether), 0.1 M Hepes, pH 7.0, 0.2 M ammonium acetate or 17% 
PEG 2000, 0.1 M Tris-HCl, pH 7.0, 0.2 M ammonium acetate. Platelet-like crystals were grown 
in both conditions. Then 20% PEG 400 was added as cryoprotectant, and the crystals were 
flash-cooled in liquid nitrogen. X-ray diffraction data were measured at 100 K at the European 
Synchrotron Radiation Facility (Grenoble) on beam lines ID23EH2 or ID14EH4 and at Diamond 
Light Source. Two datasets were collected from single crystals, grown with either in Hepes or 
Tris as a buffer, to 2.65 and 2.8 Å resolution, respectively. Diffraction data was integrated and 
scaled using MOSFLM/SCALA (CCP4, 1994; Leslie, 2006) with final Rmerge of 9.2 (Hepes) and 
8.3 (Hepes-free). The crystals belong to the orthorhombic P212121 space group with similar unit 
cell parameters of a = 30.67 Å, b =102.21 Å, c = 105.89 Å, α = β =γ = 90º and a = 29.28 Å, b = 
99.76 Å, c = 106.48 Å, α = β = γ = 90º (for the Hepes and Tris crystals, respectively). See Table 
2.4.2 for data collection and processing statistics. 
 
Structure Determination of ZαADAR1:Z-Z-DNA 
ZαADAR1/Z-Z DNA structure was solved by molecular replacement using a single Zα domain 
bound to a single strand (CG)3 oligonucleotide (PDB ID code 1QBJ) as a search model making 
use of the program PHASER (McCoy et al., 2007). We were able to identify four molecules in 
the asymmetric unit. The structure was refined with PHENIX (Adams et al., 2002) and model 
building was carried out using COOT (Emsley and Cowtan, 2004). The structure from Hepes-
crystal was refined to a final Rfactor of 0.23 (Rfree 0.28) at 2.65 Å resolution, whereas the structure 
from Tris-crystal was refined to a final Rfactor of 0.23 (Rfree 0.27) at 2.8 Å. Non-crystallographic 
symmetry was used throughout the refinement process relating portions of the four Zα 
monomers. The general quality of the electron density maps were very good for all protein 
residues, with exception of the C-terminal amino acid residues V199-Q202 (for all chains) and 
the solvent exposed side chains of Q141, K145, E152, K170, and K187; and the two DNA 
overhanging bases, which were not visible in the electron density maps. Both ZαADAR1/Z-Z DNA 
structures show good geometry/stereochemistry, where 94.4% (for Hepes) and 91.8% (for Tris) 
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of the amino acid residues belong to the most favored regions of the Ramachandran plot, and 
all other residues are found within the allowed regions of the plot. Analysis of the Z-DNA helix 
parameters was performed with 3DNA (Lu and Olson, 2003). The two structures have been 
deposited at the Protein Data Bank (PDB) database with ID codes 3IRQ (Tris) and 3IRR 
(Hepes).  
 
Circular Dichroism (CD) Spectroscopy 
CD measurements were performed on several samples using a Jasco J-815 CD system in a 
0.1-mm cuvette asdescribed:  
Z-Z-DNA: A variable quantity (5–10 μM) of the Z-Z-DNA duplex was mixed with different 
concentrations of ZαADR1 to final molar ratios of 1∶0, 1∶1, 1∶2, 1∶4, and 1∶6. Kinetics 
characterization of the B → Z conversion was followed at single wavelength (254 nm) and CD 
spectra were collected in 1-nm steps from 230 to 330 nm after 10 min of incubation when 
absorbance changes reach a plateau. Experiments were performed at 25 °  in 10 mM Hepes, 
pH 7.0, 20 mM NaCl or 10 mM Tris-HCl, pH 7.0, 20 mM NaCl. 
Z-Z-RNA and A-Z-RNA: 10 µM of RNA duplex is mixed with ZαADAR1 to a final molar ratio 1:4. 
Experiments were performed at 45ºC or 37ºC in 10 mM Hepes, pH 7.0, 20 mM NaCl or 10 mM 












2.4. Results and Discussion 
 
Protein Production 
The gene coding for ZαADAR1 was successfully expressed and the protein purified by 
immobilized metal ion affinity chromatography (IMAC). The His-tag was removed by thrombin 
cleavage and further purified with a Mono-S HP 5/5 column. The purity of the protein sample 
was confirmed by SDS-PAGE (Figure 2.4.1). The estimated yield of production was 16.5 mg/L 
of culture. After each protein purification batch, the protein was divided in small aliquots and 




Figure 2.4.1. SDS-PAGE after His-tag cleavage and ion-exchange chromatography. 
Layer 1: Protein Markers; 2: Sample after Ni-NTA column (His-Tagged protein); 3: flow-through of Ni-NTA 
column; 4 to 6: protein sample eluted after Mono-S HP 5/5 column. 
 
Crystallization of a Z-Z-RNA and a A-Z-RNA junction bound to ZαADAR1 Domain 
The crystallization of Z-Z-RNA/A-Z-RNA junctions bound to ZαADAR1 domain was successfully. 
After the first hints found in the crystallization screenings, a 5 week-period of optimization was 
necessary to obtain suitable diffraction crystals. In the best conditions described, crystals 
appear in just 2 to 3 days and grow for one week in both cases (Figure 2.4.2). With exception 
for the Z-Z RNA junction experiments (Figure 2.4.2a-f), where several trials were performed to 
improve crystal quality. Despite the well defined external shape, all the crystals were very small, 
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and did not diffract well. Both streak seeding and macroseeding fail to show good results. After 
3 weeks of crystallization trials with additives, some nucleation and crystals were visible; those 
kept growing for more than 2 weeks, having a final size of 150 μm (Figure 2.4.4c). 
Regarding the A-Z-RNA trials (Figure 2.4.2g-l), the additives trial did not show successful 










































A-Z-RNA incubated with 4M NaClO4 
A-Z-RNA only A-Z-RNA + 4M NaClO4, t = 0' 






















A-Z-RNA incubated with 8M NaClO4 
A-Z-RNA only A-Z-RNA + 8M NaClO4, t = 0' 
A-Z-RNA + 8M NaClO4, t = 10' A-Z-RNA + 8M NaClO4, t = 40' 
A-Z-RNA + 8M NaClO4, t = 6h10' 
RNA conformational changes studied by CD spectroscopy 
Previous experiments showed that the A form of RNA [r(CG)6] is characterized by a positive 
band at 263 nm and a broad negative elipticity peak at 292 nm. The spectrum changes upon 
addition of sodium perchlorate (6.5 M) with the negative band becoming positive at 285 nm, and 
the band at 263 nm shifting to 258 nm, with reduced intensity (Brown and Rich, 2001). 
Each experiment should be started by measuring a spectrum of 10 µM RNA only, protein only, 
and salt only. This way, the absorbing spectrum of each component is individually evaluated. 
RNA only is our control, having a CD spectrum characteristic of the A-RNA form, to check for 
conformational changes upon addition of highly concentrated salts or micromolar (µM) amounts 
of ZαADAR1. Each solution should have a final volume of 250 µl, and for stability purposes, should 
be prepared on ice. Upon preparation, we immediately start following the CD spectra of the 
solution. 
First experiments were conducted at 45ºC, since it was known that RNA requires higher energy 
for the conformational change from A- to Z- RNA. This would allow us to explore lower 
concentration of salts, and test for the successful ones at lower temperatures, as 37ºC. If in a 
specific condition, there is no change at 45º , it’s improbable that any change would happen at 
a lower temperature.  
 
 
Figure 2.4.3. CD measurements on A-Z-RNA oligonucleotide incubated with different 
concentrations of NaClO4. 
Evaluation of conformational change of A to Z RNA by incubation of the AZ oligonucleotide with (left) 4M 
NaClO4 and (right) 8M NaClO4. 
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The first experiments with high salt concentration revealed that conformational changes are only 
visible with a high excess (8 M) of NaClO4 (Figure 2.4.3), where the negative band at 292 nm 
becomes positive and shifts to 270 nm (Figure 2.4.3, right). These results agree with the reports 
that RNA needs high excess salt to change conformation to Z-RNA. It is visible a first change 
(red and blue line), within the first minutes of incubation, followed by a second alteration (green 
and yellow line), revealing a increased intensity of the positive 270 nm band, which is then 
maintained constant over time. We can think of plausible explanations for this change. One 
hypothesis is that there is a first transition to ZD-RNA and then to ZR-RNA (Trulson et al., 1987). 
Trulson described the ZR-RNA as a structure prone to be formed in the presence of high 
concentrations of NaBr and NaClO4, exhibiting a unique CD signature (Trulson et al., 1987). 
Moreover, ZD-RNA is found in concentrated MgCl2 solutions and has a similar CD signature as 
Z-DNA. Here, we see differences in intensity of the positive band, but not in the negative band, 
so the transition ZR-RNA  ZD-RNA is not likely, as both of these RNA forms have different 
base-stacking geometry. Another hypothesis is that the addition of salt destabilizes the RNA 
structure. Furthermore, some of the A-RNA is not in the right conformation (A conformation), 
which results in a weaker signal. In summary, most likely, the difference in intensity is caused by 
this destabilization effect at the initial incubation period with high salt concentration. 
Subsequently, we tested the incubation of A-Z-RNA with 40 µM cobalt hexammine chloride 
[Co(NH3)6Cl3] at 45º C. Cobalt hexamine chloride has been described as an inducer of Z-DNA 
(Filimonova et al., 2008). In this experiment, there is no change conformational observed of the 
RNA, even in the presence of higher concentrations (2 mM) of Co(NH3)6Cl3. We also did some 
studies with NiCl2 (nickel chloride). According to previous studies, this salt can induce the 
conformational change from B to Z-DNA (Balaz et al., 2006), however there is no evidence or 
study supporting the same effect on the transition to Z-RNA. The experiment was performed by 
using 10 mM of NiCl2 at 37ºC, and no changes were observed in the CD spectrum. Changes 
were only observed when using 30 mM NiCl2 at 45ºC. Also, MgCl2 was tested until a 






Figure 2.4.4. A-Z-RNA oligonucleotide incubated with ZαADAR1. 




Figure 2.4.5. Z-Z-RNA oligonucleotide incubated with NaClO4. 



























A-Z-RNA incubated with Zα 
A-Z-RNA only A-Z-RNA + Zα, t = 0' A-Z-RNA + Zα, t = 15' 
























Z-Z-RNA incubated with 6M NaClO4 
Z-Z-RNA only Z-Z-RNA + 6M NaClO4, t = 0' 
Z-Z-RNA + 6M NaClO4, t = 5' Z-Z-RNA + 6M NaClO4, t = 10' 
Z-Z-RNA + 6M NaClO4, t = 25' Z-Z-RNA + 6M NaClO4, t = 45' 
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Incubation of A-Z-RNA oligonucleotide with ZαADAR1 (45ºC) alters the conformation of A-RNA to 
Z-RNA, as shown in Figure 2.4.4, but only for large incubation times. The CD spectrum (Figure 
2.4.5) clearly shows a conformation rearrangement from A to Z-RNA as a result of Z-Z-RNA 
oligonucleotide incubation with 6 M NaClO4. 
 
Toward the structure determination of A-Z-RNA and Z-Z-RNA bound to ZαADAR1 
Several crystals diffracted to high resolution and datasets were collected at synchrotron 
sources, the data was processed (Table 2.4.1, a). 
 
Table 2.4.1. X-ray diffraction data collection and processing statistics of putative RNA 
oligonucleotides in complex with ZαADAR1  
Parameters/Data sets A-Z RNA A-Z RNA Z-Z RNA 
X-ray source ID14-1 (ESRF) DLS ID23-2 (ESRF) 
Resolution limits (Å) 37.93 – 1.40 (1.40 – 1.48)
a 
37.56 – 1.55 (1.63 – 1.55)
a 
38.40 – 2.00 (2.11 – 2.00)
a 
Space Group P3 P3 P3 
Cell parameters 
a = b = 43.78 Å, c = 28.96 Å 
α = β = 90º, γ = 120º 
a =b = 43.36 Å, c = 28.78 Å 
α = β = 90º, γ = 120º 
a = b = 44.34 Å, c = 29.30 Å 
α = β = 90º, γ = 120º 


























































Autoindexing with Mosflm (Leslie, 2006; Powell, 1999), data scaling with SCALA (CCP4 package) 
(CCP4, 1994). aIn parentheses are the statistics for the outer-resolution shell. (a) Mathews Coefficient 




The crystal unit cell dimensions for the putative complexes RNA oligonucleotides with the 
ZαADAR1 domain are quite small (Table 2.4.1). The values obtained for Matthews coefficient and 
estimated solvent content considering different possibilities for the crystal of putative ZαADAR1A:Z-
Mathews Coefficient Calculations  







RNA complex are displayed in Table 2.4.1a. The calculated values, only allow for a dsRNA 
molecule to be present in our crystals, according with the processed experimental data. 
Interestingly, the reported unit cell parameters for ZαADAR1:Z-RNA complex (PDB ID 2GXB) are 
a = 73.60, b = 92.78, c = 50.23 (space group C2221). The three-dimensional structure of this 
complex shows that a dimer of ZαADAR1 binds a double-helical RNA molecule (Placido et al., 
2007). 
In order to indentify the molecular species present in our crystals, several crystals of ZαADAR1:A-
Z-RNA putative complex were pulled from crystallization droplets, washed in a drop containing 
the reservoir solution and dissolved in this buffer. This sample was subjected to mass 
spectrometry (MS) MALDI-TOF analysis. Samples containing the purified protein ZαADAR1 and 
the A-Z RNA (2 oligonucleotides available) were used as control. 
The Zα spectra (Figure 2.4.6c) has a major peak for m/z of 7363, as expected, the predicted 
molecular weight is 7.3 kDa, according to the amino acid sequence. 
For the oligonucleotides alone, the expected mass for oligo 1 is 5.38 kDa and for oligo 2 is.5.45 
kDa. In Figure 2.4.6b and c, the major peaks correspond to a m/z of 5387 and 5461, 
respectively. The major peaks of the sample containing the dissolved crystals appear in the 
region of m/z 5300 – 5600, with peaks of significant intensity at m/z 5368, 5460 and 5522. 
Therefore, we conclude that most probably our crystals comprise only double-stranded RNA, 
and no protein is present. 
Molecular replacement was done with data collected for crystals of putative ZαADAR1:Z-Z-RNA: 
using MolRep (Vagin and Teplyakov, 2010), using as a template an RNA molecule and inputing 
information on our RNA molecule sequence. The obtained solution told us that the X-ray data 
processed comprised only dsRNA in the A conformation. Model building was carried out (b) with 
Coot (Emsley and Cowtan, 2004) and one crystallographic refinement with CNS (Brünger et al., 
1998; Brunger, 2007) until convergence was reached (R = 0.337, Rfree = 0.3757). However, 
since we were interested in having a crystallographic structure from the complexed ZαADAR1:Z-


















2.4.6. MS spectra of A-Z oligos (a and b), purified ZαADAR1 (c), and crystals from the A-Z-
RNA complex (d). 
Data provide by the Mass Spectrometry Laboratory, Analytical Services Unit, Instituto de Tecnologia 




Further processment of the Z-Z-RNA dataset (higher resolution dataset) showed that our 
crystals only contained dsRNA in the A conformation.  
 
 
Figure 2.4.7. Data processing of Z-Z-RNA dataset showing A-dsRNA. 
Molecular replacement was done with MolRep (Vagin and Teplyakov, 2010) (a). Model building (b) with 
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Structure Determination of a Z-Z DNA Junction Bound by the ZαADAR1 Domain. 
Two crystal structures of the same complex between ZαADAR1 and a Z-Z junction forming the 
duplex sequence (CG)3A(CG)3, crystallized in slightly different conditions. The best diffracting 
crystals were obtained initially at pH 7.0 by using Hepes as a buffer, which has been the buffer 
used historically for ZαADAR1 purification and storage. When a molecule of Hepes was found 
located in the center of the junction, some crystallization trials of a Hepes-free sample with 
different buffers were set up in order to clarify the role of such a molecule in junction formation 
and evaluate to what extent the overall structure is affected by its presence. A second dataset 
from crystals grown in a Tris buffered solution were obtained, allowing the comparison of both 
structures. 
Whereas the best conditions for the Hepes-containing structure required an initial high 
throughput robot screening and some efforts in optimization, crystals of the Hepes-free sample 
were obtained with just minor adjustments in the original conditions. Crystals obtained in both 
conditions showed similar plate-like morphology and kinetics of formation, belonging to the 
same orthorhombic P212121 space group, with similar unit cell dimensions (Table 2.4.2). The 
quality of the two datasets collected is also equivalent: The first crystal form diffracted to 2.65 Å 
with an Rmerge of 9.2%, whereas the Hepes-free one diffracted to 2.8 Å but with a slightly better 
Rmerge equal to 8.3%. 
 







Apart from the junction, the two structures are quite similar (Figure 2.4.8). A superimposition of 
the whole complex would not be meaningful because the DNA molecule is differently kinked at 
the junction position. Instead, we cut the complex in an equatorial plane to obtain two ternary 
complexes (two ZαADAR1 molecules binding a six-mere duplex) and superimposed these 
structures. We obtained an rmsd equal to 1.18 and 0.84 Å by using all 500 of the DNA duplex 
atoms and 491 atoms of the protein backbone.  
Below, a description one of the two complexes is done, with underline the differences when it is 
appropriate. From now on, we will refer to the Hepes-free complex as the ZαADAR1/Z-Z-DNA 
structure. 
The structure was solved by molecular replacement using the first published ZαADAR1/(CG)3 
structure as the searching model [Protein Data Bank (PDB) ID 1QBJ]. More precisely, to avoid 
introduction of bias, a minimal model consisting in a single molecule of ZαADAR1 binding a single 
strand six-mer of Z-DNA was used. Four complexes in the asymmetric unit were found, and we 
could build the biological unit by reassembling the molecules to form one double-stranded Z-
DNA molecule bound by four ZαADAR1 monomers (Figure 2.4.8). 
 
 
Figure 2.4.8. Overall structure of a Z-Z junction. 
The DNA duplex is shown as a skeletal model for the Hepes-free (Left, A) and Hepes (Right, B) structures, 
respectively, colored according to atom type except for the Hepes molecule (Orange). In both cases four 
Zα domains are bound to the duplex ( G)3A(CG)3 DNA oligonucleotide and shown as ribbon diagrams. 
The molecular surface of each chain is shown transparent. We show aligned the oligonucleotide sequence 
(Middle). The helical axis for each (CG)3 segment appears as a straight line, and the angle corresponding 
to the DNA kink is indicated. 
 
 
Overall Structure and Stoichiometry of the ZαADAR1:(CG)3A(CG)3 Complex.  
Two complementary oligonucleotides were designed to study the structure of a Z-Z junction, 
consisting in two overhanging bases (A  and GT) at the 5′ followed by two ( G)3 stretches 
interrupted by an A (T in the complementary strand). Three consecutive CG repeats have been 
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identified as the minimum binding site for ZαADAR1. The two overhanging bases, even if not 
visible in most of the previously published structures, are believed to help in crystal packing. 
The out-of-phase base pair (A-T in our case) should interrupt the Z-DNA helix, because the 
repeating unit of Z-DNA is a dinucleotide. 
It is already known that the protein/DNA stoichiometry is crucial in the crystallization of Zα/Z-
DNA complexes. To determine the initial conditions for the optimal ratio ZαADAR1 to Z-DNA, 
some solution experiments by using CD were performed. The CD spectra of left- and right-
handed DNA are significantly different (Figure 2.4.9), and by using different protein/DNA ratios 
we could show that four molecules of ZαADAR1 are required to obtain full conversion of the 




Figure 2.4.9. Circular dichroism spectra of the Z-Z DNA duplex and its titration with Zα. 
CD spectra of duplex (CG)3A(CG)3 as shown for both the right-handed and left-handed form (stabilized by 
a 4× molar excess of ZαADAR1), in both Hepes (Black Lines) and Tris (Gray Lines) buffered solutions. The 
inset shows the ratio of Z-DNA over total DNA, during titration with ZαADAR1. The Z-DNA fraction was 
calculated by assuming it is equal to 0 in the absence of Zα and 1 with a sixfold excess of the protein. 
Total conversion of the oligonucleotide is obtained with a fourfold excess of ZαADAR1. 
 
Indeed, the same stoichiometry in the crystal structures was found (Figure 2.4.8). Two 
molecules of ZαADAR1 bind each of the two (CG)3 portions. Overall, the ZαADAR1 domain 
interaction with the DNA helix is similar to the one described previously for its complex with a 
single (CG)3 duplex (Schwartz et al., 1999). Not only is the broad surface of interaction the 
same, but also the intricate network of direct and indirect interactions between protein and DNA 
is conserved in our structure, as can be noted in (Figire 2.4.10). The Zα monomers show an 
average rmsd of 0.5 Å (56 Cα atoms used) when compared to the search model. 
Most of the residues involved in the interaction are located in the helix α3 and in the wing, 
(Figure 2.4.10). They can be divided into van der Waals interacting residues (Pro192 and 
Pro193), residues interacting directly through hydrogen bonds to the DNA backbone (Thr191, 




molecules as Trp195. Asn173 is at the same time able to directly bind the DNA and also interact 
with one of the conserved water molecules. These residues represent the core binding motif of 
Z-DNA and together with the complementarity of the interacting surface lead to a very high 
specificity and binding affinity. 
 
 
Figure 2.4.10 .Conservation of the protein–DNA interactions in the ZαADAR1:Z-Z DNA 
complex. 
Superimposition of the ZαADAR1 domain from the search model PDB ID 1QBJ (Cyan) and chain C of the 
Hepes-free structure of the ZZ junction (Yellow). Residues interacting with DNA are shown in stick 
representation, whereas dotted lines show hydrogen bonds. Side chains involved in interactions with DNA 
are drawn as sticks and labeled. 
 
Taken separately, the two stretches of six base-pair Z-DNA do not differ significantly from 
previously published Z-DNA structures. In fact, if we ignore the junction, our structure shows two 
Z-DNA helices that are close to ideal in conformational parameters (Tables 2.4.3 – 2.4.5). In 
particular, the slide and the twist parameters are notable because they characteristically 
alternate between purines and pyrimidines and apparently are in no way affected either by the 
crystal packing or by the presence of the junction. The unique exception is the adjacent CG 
pairs to the junction in the Hepes-free structure that show a deformation described in detail 
later. 
Z-DNA possesses a straight helical axis. In our structure the axes of the two CG hexamers form 
a sharp ∼20° angle due to the presence of the junction, resulting in an overall kinked DNA 
structure. This angle is slightly different in the two structures and equal to 20° in the Hepes 
structure and 27° in the HEPES-free structure (Figure 2.4.8). 
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Table 2.4.3. Selected conformational parameters for the Z-Z junction in Tris buffer; DNA 
conformational parameters as determined by using 3DNA (Lu and Olson, 2003). 
 
 
Table 2.4.4. Detailed conformational parameters of a Z-Z junction in Hepes buffer; local 







Table 2.4.5. Detailed conformational parameters of a Z-Z junction in Tris buffer; local 
base-pair step parameters as calculated by using 3DNA (Lu and Olson, 2003). 
 
 
A Close View of the Z-Z DNA Junction. 
Z-Z junctions have already been investigated. In particular, two structural studies have been 
published suggesting models for the Z-Z junction: An NMR investigation, carried out by Yang 
and Wang (Yang and Wang, 1997), on a structure containing mismatches at the junction site 
and in which the Z conformation was induced by organic and inorganic compounds, not by Zα. 
Another study used diethyl pyrocarbonate and hydroxylamine chemical probing along with 
molecular modeling to define features of the junction (Johnston et al., 1991). More recent work 
uses fluorescent modified bases containing 2-amino purine (2AP) to study base stacking at the 
junction site by fluorescence spectroscopy (Kim et al., 2009). The two older studies suggest that 
the junction bases remain intrahelical with the NMR study predicting that the junction bases 
form a reverse Watson–Crick base pair. In contrast, in the more recent study on the basis of 
2AP fluorescence, the authors interpreted the data with the junctional bases extruded from the 
double helix similar to what has been seen for the B-Z junction (Ha et al., 2005). The results 
show no such base extrusion. However, the base-pair formation at the junction shows 
differences from the suggested models. These differences are described below. 
During the refinement of the first structure (obtained in the presence of Hepes), a feature in the 
electron density of the junction area adjacent to the well defined base density was noticed 
(Figure 2.4.11A). An initial raised hypothesis was that this density represented some kind of 
double conformation of the bases; however, occupancy refinement showed base occupancy 
close to 1 and their electron density was well defined. Discarding this option, inspecting the 
crystallization solution composition together with electron density maps, led to a perfectly 
modeled Hepes molecule. The structure was further refined and the Hepes molecule ended up 
with a 0.8 occupancy and B factors varying between 30 and 50 Å
2
 for the ring and slightly higher 
for the hydroxyl and sulfonate groups (Table 2.4.6). The two bases of the junction show a large 
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roll and are almost orthogonal to the plane of the previous and next base pair. The A-T pair 
interacts according to a reverse Watson–Crick geometry because the hydrogen bonding atoms 
are N6-O2 and N1-N3, although the N-O hydrogen bond is very weak with a distance between 
donor and acceptor of 3.5 Å (Figure 2.4.11). 
Table 2.4.6. B factors and occupancy of the intercalating Hepes molecule. 
 
The unexpected Hepes ligand, intercalating in a cavity created between the A-T pair and the 
two C-G pairs before and after the junction (Figure 2.4.11B), seems to restore base stacking 
because its semiplanar ring is parallel to the planes of the other bases. No other interactions are 
observed between Hepes and DNA, apart from the interactions between the sulfonate group of 
the molecule with N4 of  8 and O4′ of T7 and N7 of G6. The  unctional bases are almost 
perpendicular to the rest of the bases and can be accommodated only because of the 20° kink 




Figure 2.4.11.The Z-Z junction structure in the presence of Hepes. 
(A) Electron density of the Z-Z  unction contoured at 1σ (Blue); the density for the Hepes molecule is 
shown orange. Dotted lines represent base-base hydrogen bonds. Note the perpendicular orientation of 
the A-T reverse Watson–Crick base pair. (B) Surface representation of the (CG)3A(CG)3 DNA colored 
according to atom B factors (range blue rigid—red mobile). The Hepes molecule (Stick) is seen 
intercalating at the junction site. Note the mobility of the thymine at the junction site (Yellow). The region 





Because the observed structure of the Z-Z junction might have been influenced by the 
intercalation of Hepes, we also determined the structure in Hepes-free conditions. The Hepes-
free structure is significantly different at the junction site. Whereas it maintains the kink at the 
junction, the AT base pair (A7-T7) in this structure lays on a plane that is almost parallel to the 
plane of the other base pairs (Figure 2.4.12A), and it occupies the position where the Hepes 
molecule was found in the first structure. The observed kink of the DNA helix in the absence of 
Hepes is slightly greater (27°), and in this case we find the junction bases located in the helix 
compression instead of the bulky Hepes molecule. The Hepes-free structure is consistent with 
aspects of the model predicted by Yang and Wang with the well defined adenine base 
in syn conformation like the preceding G6, maintaining stacking interactions. However, the 
electron density for the opposing base T7 demonstrates ambiguity, which is best interpreted by 
the base alternating between syn and anticonformation. This mobility of T7 is supported from 
the fact that no optimal hydrogen bonding to A7 on the opposite strand can be formed in any of 
the alternative conformations. In the anti conformation a single hydrogen bond is formed 
between O4 of T7 to N6 of A7, whereas no hydrogen bonding is observed with T7 in 
the syn conformation. Nevertheless, both conformations of ∼0.5 occupancy support partial 
stacking of this base with the rest of the helix. While stacking is maintained, formation of the 
junction in the Hepes-free structure also affects the lower G6-C8 base pair (Figure 2.4.12A and 
Table 2.4.3), resulting in a widening of the helix and hydrogen bonding distances in the range of 
3.3–3.8 Å. Interestingly, this helix deformation is asymmetric affecting only one of the two base 
pairs adjacent to the junction base pairs. 
 
Comparing the Z-Z junction with a B-Z junction 
 
 
Figure 2.4.12. The Z-Z junction structure and its comparison with a B-Z junction. 
(A) Electron density of the Z-Z junction contoured at 1σ. Dotted lines represent base-base hydrogen 
bonds. (B) Comparison of the Z-Z junction (present work) to the B-Z junction (Ha et al., 2005) PDB ID 
code 2ACJ. 
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We determined the crystal structure of a complex between a (CG)3A(CG)3 DNA duplex and the 
Zα domain of ADAR1. The (CG)3 parts of the DNA adopt a typical Z-DNA structure, but the 
overall DNA helix is significantly kinked at the junction. This kink results in the creation of a 
cavity on one side of the DNA structure and a compression on the opposite side. In the first 
attempt of structure determination it was found a Hepes molecule occupying the predicted 
location of the AT base pair with the bases themselves forming a partial base pair surprisingly 
oriented perpendicular to the plane of the other bases in the DNA. In this way the junction forms 
a cage for the buffer molecule. Whereas this obviously is a crystallization artifact, it provides 
significant insight into the dynamic nature of the junction, and it points to the fact that the 
junction bases are sterically uncomfortable and mobile. 
Determining the structure in the absence of Hepes showed that the junction bases can partially 
stack with the rest of the helix. The adenosine is found in its expected position in 
the syn conformation typical for Z-DNA but breaking the syn-anti alternation, whereas the 
thymine is partially disordered apparently occupying two positions, one in the syn and one in 
the anti orientation with occupancy of 0.5 for each orientation. Indeed the pyrimidine of the 
junction shows the most unfavorable contacts and in solution is expected to shift dynamically 
between the two conformations. 
Unlike the B-Z junction, which by fully extruding the junction bases succeeds in maintaining 
continuous stacking between the right- and the left-handed helix, bases of the Z-Z junction 
remain intrahelical and base stacking is partially lost (Figure 2.4.12). Also, unlike the B-Z 
junction, where only the Z portion is bound by ZαADAR1, in the Z-Z junction both Z-DNA helices 
are bound by the protein. We have to ask whether unfavorable protein–protein contacts affect 
the junction structure by not allowing the two 6-mers getting closer through extrusion of the 
junction bases. Indeed, modeling of ZαADAR1 binding to continuous 12-mer yields protein–protein 
clashes between Zα molecules. Thus, the presence of Zα might lead to capturing an 
intermediate state of the junction formation blocking base extrusion and stacking of the two 
hexamers. On the other hand, there is reasonable agreement of our structure with the model of 
a Z-Z junction derived from the NMR data. That model was derived from structures with 
mismatched A-A and T-T pairs at the junction and predicted intrahelical junctional bases. On the 
basis of the NMR structures, a model was proposed of an AT junction with the bases being 
in syn (A) and anti (T) conformation and forming a reverse Watson–Crick base pair. We find the 
adenosine in the syn conformation (χ = 50), whereas the thymidine appears to have more than 
one conformation. However, in none of the alternative conformations do we observe base 
pairing, which is in good agreement with the observation that the energetic cost of a Z-Z 
junction (3.5 kcal/mol) (Johnston et al., 1991) is similar to that of the mismatched junctions. 
Another important feature of the present structure that is absent in previous models is a partial 
melting of one of the adjacent CG pairs with hydrogen bonding distances that are more than 
0.5 Å longer than the average distances for the other CG base pairs of the helix (Table 2.4.3). 




results of Johnston et al. (Johnston et al., 1991) showing that a corresponding C (in this work 
the junction was a CG instead of AT) becomes hypersensitive in a Z-Z junction, whereas the N7 
of corresponding purine of the junction is shown to be protected as would be expected from our 
structure. Overall, the Hepes-free structure is in good agreement and explanatory to the 
available biochemical and NMR data. 
Another question is the extent to which the observed angle of bending (27° in the Hepes-free 
structure) is influenced by the enclosing ZαADAR1 proteins. It can be seen (Figure 2.4.8A) that the 
two ZαADAR1 molecules on the side of the bend are closer together when the angle is 27°, 
compared to 20° for the Hepes structure (Figure 2.4.8B). The two ZαsADAR1 are in van der Waals 
contact, suggesting that they may limit further bending. This observation might support the 
argument that the observed structure is trapped in an intermediate state. It is clear that this 
issue can be resolved only by further structural studies, perhaps with fewer ZαADAR1 molecules. 
In recent work, base analogs of adenosine (2AP) were used to monitor stacking of bases in 
different types of junctions using fluorescent spectroscopy. This work suggested the loss of 
stacking of the adenosine base at a Z-Z junction with a sequence similar to the one described 
here. Although we do observe loss of base stacking at the junction, this is because of the 
mobility of the thymine residue. The adenosine residue, however, is not extruded; it is well 
defined and maintains optimal stacking with the adjacent bases. The reason behind this 
disagreement is possibly because of the use of Hepes as a buffer in these fluorometric studies 
that, as we observe in the corresponding structure, results in loss of stacking for the adenosine 
at the junction. It is also possible that the 2-amino purine substitution in this context alters the 










The complexes between ZαADAR1 domain both with Z-DNA and with a small B-Z-DNA junction 
were already determined. But although these structures took us one step further and a DNA 
binding role cannot be excluded, all Z-domain carrying proteins with known functionalities are 
involved in dsRNA recognition and are predominantly cytoplasmic. It is also known that the 
isoform of ADAR1 containing the domain that binds the Z-form is only expressed in the 
cytoplasm, where no DNA is suppose to exist, so this domain should actually interact with RNA. 
The stability of the interaction between ZαADAR1 domain and a small Z-RNA was not enough to 
clarify all the questions that have been arising on the last years with the new findings on this 
subject. Also, the binding of the human ZαADAR1 domain to the RNA is expected to be related to 
the function of the protein of hyper-editing, inserting mutations on the RNA. 
Here we show a tentative approach to understand the binding of the ZαADAR1 domain with RNA, 
by studying two types of possible junctions (A-Z-RNA and Z-Z-RNA) that form upon complex 
formation, and are the predominant biological signature in nature. However, Z-RNA in complex 
with ZαADAR1 was not attainable. RNA is less stable and more difficult to handle then DNA, and, 
of course, Z-RNA formation is not a favored energetic transformation by itself. Even being 
observable by CD spectroscopy that A-Z-RNA is forming, cocrystallization was not successful. 
It is also shown how sequences containing imperfect CpG repeats can adopt the left-handed 
conformation and tolerate the formation of Z-Z junctions. This finding increases significantly the 
number of potential Z-forming sequences in genomic DNA. Because Z-forming sequences and 
CpG repeats are implicated in mammalian genomic instability (Wang et al., 2006) and cancer, 
the structure presented here provides the basis to understand some of the molecular features 
that are involved in their mutagenic role. Whereas formation of B-Z and Z-Z junctions increases 
the exposure of bases to modifying agents with mutagenic effects, the Hepes structure 
suggests also that a Z-Z junction can be a site for intercalation and a potential target of a 
number of anticancer drugs that target DNA replication. This intercalation is expected to 
stabilize the left-handed conformation by restoring base stacking to some extent. Such 
stabilization may have deleterious effects for cancer cells resulting in lethal DNA 
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The mammalian neocortex is a unique structure designed for higher cognitive and associative 
functions. It allows for the high level of advanced behavior in mammals when compared to other 
animals. From the first exquisite and detailed drawings by Santiago Ramon y Cajal of neuronal 
connectivity, to the first high-resolution microscopical maps of the human brain, was less than 
half a century of technological evolution. But even today, the way our brains store, process and 
retrieve information is still a mystery. Our personality, our reactions to the world, everything that 
makes us humans comes not only from our DNA but also from the way we are raised, the 
environment we live in. All comes together in to a complete self, the consciousness of 
existence.  
Through the application of multiple biochemical and biological techniques we elucidated the role 
of TAOK2α during the mouse brain development. From those studies, we observed multiple 
phenotypes, compriseing a disregulation of basal dendrite establishing mechanism leading to 
less complex dendritic arbors when TAOK2α was absent in the cell, while apical dendrites kept 
their expected complexity. A novel pathway, where Neuropilin 1 (Nrp1), a receptor for the 
secreted guidance cue Semaphorin 3A (Sema3A), is now known to modulate the formation of 
basal dendrites through the interaction with TAOK2α, which activates the c-Jun N-terminal 
kinase (JNK).  
Depletion of TAOK2α expression also leads to a migratory defect in the mouse neocortex. 
TAOK2α is likely to affect actin destabilization, causing a delay in migration: the neuron keeps 
the ability to migrate, but is unable to navigate the axon due to the impaired substratum 
selectivity of the growth cone. Since the cortex substratum confers information to the neurons, 
the slow migration creates a delay in the extrinsic pattern of information, causing neurons to 
surpass their true final destination, by adjustment they end more superficially than expected. 
Our study led us to further understand the biological mechanisms within our brain. It was 
described, for the first time, an intricate pattern of neuronal development specifically for the 
specification and maturation of basal dendrites versus apical dendrites. An understanding of the 
unique physiology and morphology of these neurons is crucial to the elucidation of the 
mechanisms underlying sophisticated cognitive functions in normal and disease conditions. If 
inhibiting the expression of TAOK2, as it was described, leads to such marked phenotypes, it is 
most plausible that it will have an effect in the patophysiology of an individual where the TAOK2 
gene happens to be misregulated or absent, most likely, leading to a psychiatric disorder 
associated with neocortical disconnection, the accepted model mechanism for Autism Spectrum 
Disorders. 
Despite the excitment of our discoverys, the extrapulation to other mammals, specifically 
humans, of such findings must be taken cautiously. The human brain is much more complex 
then the mouse brain. The similaritys between the mouse and the human DNA are very high, 
however, we humans, have very different capabilities and behaviors. The human neocortex is 




concerning the establishement of neuronal cytoarchitecture when compared to other mammals, 
denoted by a larger number of neuronal cells present. The findings obtained in our studies, 
althought extremely valuable, can not be extended to the human brain development. Altogether, 
assumptions must be taken carefully, as more in vivo experiments are needed to establish 
which other molecules are at play during neuronal maturation. 
Membrane protein production and purification is one of the most important remaining frontiers 
for structural biology research. hTAOK2α was used as a model to setup a GFP-based multi-host 
expression screening towards the purification of eukaryotic integral membrane proteins. The 
humanTAOK2α was used as a model to setup a GFP-based multi-host expression screening 
towards the purification of eukaryotic integral membrane proteins to determine its suitability for 
large-scale production. The application of a detergent screen since extraction, the first 
bottleneck of membrane protein purification, will be extremely usefull for production of a stable 
membrane protein. Our approach is fast and cost effective, applicable to multiple targets 
simultaneously and will give an estimate yield of expression/purification of different membrane 
protein constructs and define the suitability for large-scale production of a given target for a 
specific host. We believe this study is extremely valuable for other researchers working with 
membrane proteins. 
Our study on the Z-DNA/Z-RNA aimed to clarify the role of z conformation in biology. Despite 
our lack of success with the RNA studies, the produced B-Z-DNA structure helped us to shed 
new light on the field. First, the structure of B-Z-DNA suggested that the Z conformation of 
nucleic acids might be more frequent in the genome then previously thought. Such junction 
requires low energy, as it preserves the integrity of the double helix. So, DNA sequences 
containing imperfect CpG repeats can easily adopt the left-handed conformation and tolerate 
the formation of a Z-Z junction.  
Due to the fact that CpG stretches, and so Z forming sequences, are frequent in the genome 
and implicated with mammalian genomic instability, the presented structure provided the basis 
to understand some of the molecular features that are involved in the mutagenesis related with 
CpG islands. Z-DNA junctions increase the exposure of bases modifying agents with mutagenic 
effects and allow the binding of intercalating agents at the junction site. Such agents may 
stabilize the left-handed conformation and be used, in the future, as anticancer drugs.  
Although the structure of this junction provided insights into the biological relevance of the Z 
















































































Figure A1.2. SDS-PAGE of overexpressed constructs in E. coli B834 self-induced. C5: 321-370-SUMO3C 



















Figure A1.3. SDS-PAGE of overexpressed constructs in E. coli B834 self-induced, insoluble fraction. H2: 



















Figure A1.4. SDS-PAGE of overexpressed constructs in E. coli Rosetta induced with IPTG, soluble 




















Figure A1.5. SDS-PAGE of overexpressed constructs in E. coli Rosetta self-induced, soluble fraction. E2: 
321-750 47Kda; F4: 460-750-SUMO (48 kDa); H4: 2-370-SUMO (54 kDa); A6: 460-750-MBP (77 kDa); 








Figure A1.6. SDS-PAGE of overexpressed constructs in E. coli Rosetta self-induced, insoluble fraction. 
B2: 595-900 (37 kDa); G2: 590-750 (21 kDa); H2: 2-370 (43 kDa); A4: 460-900-SUMO (64 kDa); B4: 595-
900-SUMO (48 kDa); E4: 370-750-SUMO (58 kDa); F4: 460-750-SUMO (48 kDa); G4: 595-750-SUMO (32 
kDa); A6: 460-750-MBP (77 kDa); B6: 595-750-MBP (61 kDa); C6: 2-370-MBP (84 kDa); F6: 321-370-


















A2. OPPF constructs tested in-house 
 
 
Figure A2.1. Expression tests realizes on OPPF A01 (hTAOK2-GFP) and OPPF F02 (aa 460-750-
hTAOK2).  SDS-PAGE showing the results for the expressions tests  done in E. coli strains BL21, C43 and 
Rosetta with three different induction points – NI, non induced; 6h, 6 hours induction; ON, induction 














A3. Solubilization screen strep-GFP-hTAOK2, Hi5 cells 
 
 
Figure A3.1. Pictures of in-gel fluorescence from SDS-PAGE gels after solubilization test with 96 detergent 










A4. Solubilization screen His-GFP-hTAOK2, HEK293T cells 
 
 
Figure A4.1. Pictures of in-gel fluorescence from SDS-PAGE gels after solubilization test with 96 detergent 
screen plate (A1 to H12) – soluble fraction. M, molecular weight marker. 
 
 
